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CHAPTER I 
SCOPE OF THE INVESTIGATION 
Cowpea mosaic virus (CPMV) is the type member of a group of plant 
viruses, the comoviruses, with a genome consisting of two single 
stranded RNA molecules separately encapsidated in icosahedral particles. 
A characteristic feature of the two genome RNAs is that they are both 
polyadenylated at their 3'-terminus and supplied with a small protein 
at their 5'end. The genetic information encoded in the virus RNAs 
is expressed by translation of each RNA into large-si zed proteins 
referred to as polyproteins because these primary translation products 
are subsequently cleaved by specific proteolytic cleavages ("proteolytic 
processing") into a number of smaller-sized proteins, each with a spe-
cific function during virus multiplication. The research reported in 
this thesis deals with the identification of the proteolytic activities 
involved in this processing and their specificity. 
We have been able to demonstrate that the larger of the two virus 
RNAs, which contains the information necessary for virus RNA replication, 
also encodes two different proteolytic activities. One proteolytic 
activity is responsible for the cleavage of the overlapping polypro-
teins produced by the smaller of two virus RNAs and releases the two 
capsid proteins, encoded by this RNA (Chapter III and V), whereas the 
other proteolytic activity achieves the processing of the polyprotein 
produced by the larger RNA (Chapter VII). Besides this functional dif-
ference the two proteolytic activities recognise peptide bounds between 
different specific amino acid pairs (Chapter VI and VIII). The results 
of our studies have led to a detailed model for the processing of the 
proteins encoded on the two CPMV RNAs. 
The striking analogy between the plant comoviruses and the animal 
picornaviruses, like poliovirus and foot-and-mouth-disease virus, with 
regard to genome structure, replication, expression strategy and func-
tional organisation of genes has prompted us to study the homology in 
amino acid sequences between corresponding proteins of the two groups 
of virus. It was found that some of the non-structural proteins of CPMV 
and the picornaviruses exhibit significant homology in amino acid se-
quence (Chapter VIII). These results suggest that animal picorna-
viruses and plant comoviruses have a common ancestor and throw a light 
on the evolution of RNA viruses. 
CHAPTER II 
GENERAL INTRODUCTION 
1. Classification of aowpea mosaic virus. 
Based on their type of genome and on their expression mechanism 
RNA viruses have been divided in four classes (Baltimore, 1971; for 
an extended description see Luria et al. , 1978). One of these classes 
are the double-stranded RNA viruses which produce upon infection mRNAs 
by asymmetrical transcription of their double-stranded genome. Examples 
of this type of viruses are the animal reoviruses and the plant viruses 
rice dwarf virus and wound tumor virus. A second class of RNA viruses, 
the retroviruses, encapsidate single-stranded RNA which is copied in 
the host cell into DNA, that acts as template for the synthesis of viral 
mRNAs and progeny virus RNA. So far, retroviruses have only been found 
in animals and not in plants. The third and fourth class of RNA viruses 
are the positive- and negative-strand RNA viruses respectively. Both 
classes have single-stranded RNA genomes but the difference is that the 
genomic RNA of positive-strand viruses can directly act as messenger 
RNA, whereas the genomic RNA of the negative-strand RNA viruses is not 
messenger-sense. Particles of negative-strand RNA viruses contain a 
virus-encoded RNA polymerase which upon infection transcribes the geno-
mic RNA into mRNAs. Such RNA viruses are frequently found among animal 
viruses, but rarely among plant viruses. Examples are the animal rhabdo-
viruses (e.g. vesicular stomatitis virus), orthomyxo viruses (e.g. 
influenza virus) and paramyxoviruses (e.g. sendai virus), and plant 
rhabdoviruses (e.g. lettuce necrotic yellow virus and sowthistle yellow 
vein virus). Important groups of positive-strand RNA viruses are the 
animal picornaviruses, e.g. poliovirus and foot-and-mouth disease virus, 
and togaviruses while the vast majority of plant viruses also belongs 
to this class (for a recent, extensive review on RNA plant viruses see 
Dougerthy and Hiebert, 1984). 
The positive-strand RNA viruses can be further divided into two sub-
classes. One subclass comprises those viruses which generate, in addi-
tion to the full-length virus RNA, one or more subgenomic RNAs. Typical 
examples of this subclass are the animal togaviruses (e.g. semliki 
forest virus) and many groups of plant viruses such as the tobamovi-
ruses (e.g. tobacco mosaic virus), tymoviruses (e.g. turnip yellow 
mosaic virus), bromoviruses (e.g. brome mosaic virus), cucumoviruses 
(e.g. cucumber mosaic virus) and ilarviruses (e.g. tobacco streak virus). 
Viruses of the other subclass of positive-strand RNA viruses, produce 
only genome-length RNA chains which are translated into large primary 
translation products. These large proteins are then proteolytically 
cleaved to generate the functional proteins. Representatives of this 
subclass are the animal picomaviruses and plant comoviruses. CPMV 
thus belongs to this second subclass of positive-strand RNA viruses. 
Genome structure of plant RNA viruses. 
A number of positive strand RNA viruses have their genetic informa-
tion distributed among two or three single-stranded RNA molecules. 
With animal viruses this occurs rarely and has so far only been found 
for the nodaviruses (e.g. nodamura virus and black beetle virus; 
Friesen and Rueckert, 1981). The two single-stranded RNA molecules of 
nodaviruses have no base sequences in common (Clewley et al. > 1982) 
and are both required for infectivity (Friesen and Rueckert, 1982). 
On the other hand, among plant viruses a divided RNA genome is quite 
common. Moreover, if the genetic information is distributed among 
two or three positive-strand RNA molecules, these genome segments are 
almost always separately encapsidated. Ten out of twenty-six different 
groups of plant viruses have bipartite or tripartite RNA genomes. For 
plant viruses with a bipartite genome, both RNA molecules are necessary 
for infectivity and also in case of viruses with a tripartite genome 
the complete set of RNAs is required for infectivity. Table II.1 shows 
some examples of mono-, bi- and tripartite RNA plant viruses, and also 
includes data on the structural features of the virus RNAs and the 
mechanism used for their translational expression. Three different 
types of 5'-terminal structures have been found, a m Gppp (a cap), a 
di- or triphosphate and a protein, VPg (= Virus Protein genome-bound), 
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respectively. RNA segments of divided genome viruses always have the 
same structures at their 5' ends. The structure of the 3' ends also 
varies among different viruses. This may be a polyadenylate tail, a 
tRNA-like structure, which enables these RNAs to be charged with a 
specific amino acid (Hall et al., 1972; Agranovsky et al., 1981; 
Loesch-Fries and Hall, 1982), or a 3'-0H end with no additional fea-
tures. 
For comoviruses (Stanley et al. , 1980) and nepoviruses (Mayo et al. , 
1982) it has been demonstrated that VPg is specified by the virus it-
self, for the other plant viruses with a VPg linked to their 5' end, 
this has not yet been demonstrated. The role of VPg in virus infectivi-
ty and multiplication is not clear. VPg seems not to be essential for 
the infectivity of the RNAs of CPMV, PEMV and poliovirus (Stanley 
et al., 1978; Reisman and De Zoeten, 1982; Flanagan et al., 1977). In 
contrast, the infectivity of nepoviral RNAs is strongly decreased or 
even abolished upon removal of VPg with proteinase (Mayo et al., 1982). 
The extent of the decrease of infectivity varies for each nepovirus. 
The current hypothesis is that VPg is involved in the initiation of 
virus RNA synthesis by acting as a primer either directly or after tem-
plate independant addition of one or two nucleotide residues, or via 
a specific precursor form. This hypothesis is mainly based on observa-
tions with poliovirus RNA (Nomoto et al., 1977). For this virus it 
has been shown that both minus RNA strands and short nascent positive 
RNA strands possess VPg molecules (Nomoto et al. , 1977; Petterson et 
al., 1978). The primer dependence of purified poliovirus-specified RNA 
polymerase (Tuschall et al., 1982) is also consistent with a primer 
function of VPg. That VPg is required for poliovirus RNA synthesis is, 
moreover, strongly supported by the finding that anti-VPg serum is 
able to block poliovirus RNA synthesis in vitro (Baron and Baltimore, 
1982). 
On the other hand, it has been suggested that the genome-linked pro-
tein of poliovirus may play a role during the assembly of virus parti-
cles but experimental evidence to support such proposal is lacking so 
far (Wimmer, 1982). The significance of the various specific structures 
found at the 3'ends of plant viral RNAs has also remained unknown. The 
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genomic RNAs of bipartite and tripartite genome viruses (Table II. 1) 
each have a similar structure at their 3'end. This holds for the three 
genomic RNAs of BMV and CMV, which have a tRNA-like 3'end (Ahlquist 
et al., 1981) and for the two RNAs of comoviruses and nepoviruses which 
terminate with a 3' poly(A) tail (El Manna and Bruening, 1973; Mayo 
et al., 1979). For AMV, which has neither a poly(A) tail nor a tRNA-like 
structure it has been demonstrated that the nucleotide sequences at the 
3'termini of the three genomic RNAs can form the same three-dimensional 
structure (Koper-Zwarthoff et al., 1979). Since the structures at the 
3' ends seem to be conserved in the RNAs of each virus, they may be 
of functional significance for viral RNA replication. In Table II. 1 
the positive-strand RNA viruses are further grouped based on the 
mechanism used for the translational expression of the genome. The 
mechanism in which one or more subgenomic messenger RNAs are generated 
for the synthesis of virus-specific proteins is applied by several 
groups of plant viruses, both mono- and multipartite genome viruses. 
The RNAs of these viruses all have a cap structure at their 5' terminus 
while the 3' end is either tRNA-like or without any specific feature. 
So far, no poly(A) tail has been found at the 3' end of the genome RNAs 
of viruses which produce subgenomic messenger RNAs. For only one group 
of plant viruses, the comoviruses, it has been firmly established that 
it belongs to the subclass of positive-strand RNA viruses in which the 
virus RNAs are translated into polyproteins which undergo specific 
proteolytic cleavages. Comoviral RNAs are characterised by a VPg cova-
lently linked to the 5' end and a poly(A) tail at their 3' termini. For 
many other groups of plant viruses it has remained unclear which 
mechanism they use for the expression of their genetic information. Some 
groups may use a combination of mechanisms e.g. both the generation of 
subgenomic messenger RNAs and specific proteolytic cleavages of precursor 
proteins. Such a mixed mode of expression has been suggested for sobemo-
viruses and also for the potyviruses. If in all cases in which the 
genomic RNAs have a 5' VPg structure, the VPg is a virus-specific protein 
it may be postulated that proteolytic cleavages play a role at some stage 
of viral protein synthesis as usually VPg is a small protein (^  4K) and 
should be generated from a precursor protein. If however, VPg is not 
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a low molecular weight protein, as appears the case for the VPg of 
pea enation mosaic virus (molecular weight ^ 18,000), this is not 
necessarily so. 
In this thesis we report on the mechanism of expression of CPMV and 
how that mechanism has been elucidated. In the next sections of this 
chapter we shall first review some general properties of comoviruses 
and CPMV in particular as a further introduction to the subject of 
this thesis. 
2.1. Comoviruses. 
Until now twelve plant viruses have been assigned to the comovirus-
group (Bruening, 1978; Stace-Smith, 1981; see table II.2). All members 
of this group are transmitted by beetles and have a narrow host range. 
The majority of comoviruses has legumes as their natural hosts with 
only very few host plant species outside the legumes (RaMV, SqMV and 
APMV; Stace-Smith, 1981). A low level of seed transmission has been 
reported for several comoviruses. 
For a further description of the biological properties of comoviruses 
I refer to some reviews, in which these properties are discussed exten-
sively (Bruening, 1978; Van Kammen and De Jager, 1978; Stace-Smith, 
1981). Here I like to focus on the molecular biology of the comovirus 
group. Comoviruses are small icosahedral viruses with a diameter of 
about 28 nm. Purified preparations of comoviruses usually contain three 
different centrifugal components, which are referred to as Top-(T) 
middle- (M) and bottom component (B) with sedimentation coefficients 
of 54-60 S, 91-100 S and 112-127 S, respectively (Geelen, 1974, 
Bruening, 1978, 1981). T-, M- and B-components have similar protein 
capsids but differ in RNA content. M components contain a smaller RNA 
molecule (M-RNA) and B components a larger RNA molecule (B-RNA), where-
as T components are devoid of RNA (Van Kammen, 1972). Both B- and M-
components or their RNAs are necessary for infectivity (Van Kammen, 
1968; De Jager, 1976), demonstrating that the genetic information for 
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Table II.2 Members of the comovirus group 
Virus Abbreviation 
Andean potato mottle virus 
Bean pod mottle virus 
Bean rugose mosaic virus 
Broad bean stain virus 
Broad bean true mosaic virus 
Cowpea mosaic virus 
Cowpea severe mosaic virus 
Pea mild mosaic virus 
Quail pea mosaic virus 
Radish mosaic virus 
Red clover mottle virus 
Squash mosaic virus 
APMV 
BPMV 
BRMV 
BBSV 
BBTMV 
CPMV 
CPSMV 
PMMV 
QPMV 
RaMV 
RCMV 
SqMV 
virus multiplication is distributed between both genome segments. The 
molecular weight of B RNAs and M RNAs reported for different comoviruses 
are in the range of 2.0 - 2.2 x 106 and 1.2 - 1.4 x 106 respectively. 
(Reijnders et al., 1974; Bruening, 1978). Top components do not seem 
to have a specific function in virus infectivity. The amount of T 
component produced varies for different comoviruses and even for dif-
ferent variants of the same virus, and seems also to be dependent on 
the conditions of growth of the virus (Van Kammen, 1972; Siler et al., 
1976). CPMV is the type member of the group and by far the most studied 
and best characterised comovirus. In the next section the data on the 
molecular properties of CPMV will be discussed in more detail. 
A common feature of comoviruses is that their protein caps ids are 
constructed of 60 copies of each of two different proteins, a larger 
one and a smaller one. This has been demonstrated for CPMV (Wu and 
Bruening, 1971; Geelen et al., 1972), CPSMV (Beier et al., 1981), SqMV 
(Hiebert and Purcifull, 1981) and RCMV (Oxelfelt, 1976). The molecular 
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weights of the two coat proteins differ among the various comoviruses 
and are in the range of 22,000-25,000 (smaller coat protein) and 37,000-
44,000 (larger coat protein) respectively (Rottier, 1980; Hiebert and 
Purcifull, 1981; Beier et al., 1981). The available data indicate that 
the genetic information for both coat proteins is located on the middle-
component RNA (CPMV: Gopo and Frist, 1977; Franssen et al., 1982, 
SqMV: Hiebert and Purcifull, 1981). 
Another characteristic feature of comoviruses is that their genome 
RNAs have a polyadenylate sequence (poly A tail) at their 3'terminal 
end and a small protein (VPg) covalently bound to the 5' end. The 
presence of VPg molecules has been demonstrated for the RNAs of all 
comoviruses tested sofar, i.e. BBTMV, CPMV, SqMV and CPSMV (Stanley 
et al., 1978; Daubert et al., 1978; Daubert and Bruening, 1979). The 
occurrence of a poly(A) tail has been detected in the genome of BPMV, 
CPMV and RCMV B-RNA (El Manna and Bruening, 1973; Semancik, 1974; 
Oxelfelt, 1976). 
Only for CPMV the expression of the genetic information encoded in 
the two genome RNAs has been thoroughly studied (see for instance the 
following chapters of this thesis). The available data indicate that 
the viral RNAs are translated into large polyproteins, which are sub-
sequently cleaved into functional proteins. The few studies available 
on SqMV (Hiebert and Purcifull, 1981; Goldbach and Krijt, 1982), CPSMV 
(Beier et al., 1981; Goldbach and Krijt, 1982; Rezelman, Van der Krol 
and Goldbach, unpublished results) and BPMV (Gabriel et al., 1982) 
indicate that these comoviruses apply an expression strategy similar 
to that of CPMV. 
The different comoviruses have genetically considerably diverged 
which can be concluded from early experiments in which bottom compo-
nents of one comovirus were combined with middle components of another 
comovirus. So far such pseudorecombinants have not been found to yield 
viable virus preparations. The very low nucleotide sequence homology 
observed between CPMV RNAs and the RNAs of BPMV and RCMV, respectively 
(Van Kammen, 1972) and between CPMV M RNA and the M RNAs of CPSMV and 
SqMV (Goldbach and Van der Krol, unpublished results) provide further 
support for the distant relatedness among comoviruses. The low serolo-
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gical relationship observed between CPMV and CPSMV (Goldbach and Krijt, 
unpublished results) underlines this as well. 
2.2. Cowpea mosaic virus (CPMV) 
The two capsid proteins of CPMV have molecular weights of 37,000 
and 23,000 (Wu and Bruening, 1971; Geelen et al., 1972) and are refer-
red to as VP37 and VP23, respectively. The larger capsid protein VP37 
is blocked at its N-terminal end by a N-acetylated methionine residue 
(Bruening, 1981). Partridge et al. (1974) have determined the carbohy-
drate composition of CPMV. From these results it can be calculated that 
in each protein shell only 6-7% of the capsid proteins are glycosylated. 
The occurrence of glycoproteins in the viral capsid has been proposed 
to be linked to seed transmissibility (Partridge et al., 1974). The 
middle and bottom component RNA of CPMV have molecular weights of 
1.37 x 106 and 2.02 x 106 respectively (Reijnders et al., 1974). VPg 
has been shown to be linked through a phosphodiester bound to the 5' 
terminal uridilyl residue in both RNAs (Stanley et al., 1978). The amino 
acid involved in this linkage is probably a serine residue (Zabel et al., 
1984). The poly(A) tail at the 3' terminus of B-RNA has been estimated 
to be about 87 nucleotides in length, whereas the poly(A) tail of M-RNA 
has an average of about 160 adenylate residues and is more variable in 
lenght (Ahlquist and Kaesberg, 1979). 
Recently, the complete nucleotide sequences of both M and B-RNA 
have been elucidated (Van Wezenbeek et al. , 1983; Lomonossoff and 
Shanks, 1983). M-RNA has a sequence of 3481 nucleotides and B-RNA of 
5889 nucleotides, excluding their poly(A) tails. Zabel et al. (1984) 
have determined that VPg consists of a polypeptide of approximately 
30 amino acid residues. Using limited amino acid sequence data they 
were able to locate the coding region for VPg on B-RNA and to derive 
the amino acid sequence of VPg. 
Although both B and M components or their RNAs are necessary for 
virus multiplication the B component exhibits a partial independence 
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from the M component. When isolated cowpea mesophyll protoplasts were 
infected with separate B and M components it appeared that B-RNA is 
capable to replicate itself (Goldbach et al., 1980). Apparently B-RNA 
encodes functions involved in viral RNA replication. On the other hand, 
the replication of M-RNA appeared to be fully dependent on the presence 
and expression of B-RNA. In protoplasts infected with only B components, 
all non-structural viral proteins were found but not the capsid proteins, 
whereas in protoplasts infected with B + M components these proteins 
were abundantly synthesized. This finding indicated that M-RNA might 
carry the information for the structural proteins of the virus, and 
B-RNA (most of) the non-structural proteins. Previous, experiments in 
which M and B components of different CPMV mutants were combined (Gopo 
and Frist, 1977; De Jager, 1976, 1978; Bruening, 1977) already sugges-
ted that capsid protein synthesis is under control of M-RNA. In the 
course of our studies we obtained independent and direct evidence of 
such a distribution of genetic information between M and B-RNA and 
these data will be presented in chapters III-VII. 
2.3. Proteins synthesised by CPMV. 
Upon Inoculation of cowpea mesophyll protoplasts with CPMV up to 
70-90% of the protoplasts can become infected (Hibi et al. , 1975; 
Rottier et al., 1979, 1980). When such infected protoplast suspensions 
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are incubated in the presence of [ S]methionine the synthesis of 
at least ten virus-specific proteins can be followed. The apparent 
molecular weights of these proteins as determined by SDS-polyacrylamide 
gel electrophoresis are 200, 170, 110, 87, 84, 60, 58, 37, 32 and 
23K respectively (Rottier et al., 1979, 1980; Goldbach et al., 1980; 
Rezelman et al. , 1980). 
Among these virus-specific proteins the 37K and 23K polypeptides 
represent the capsid proteins VP37 and VP23. The other eight polypep-
tides are also found in protoplasts infected with B-components alone 
(Goldbach et al., 1980; Rezelman et al., 1980) and are therefore ap-
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parently encoded by B-RNA. The sum of the molecular weights of these 
polypeptides (^  800.000) exceeds the coding capacity of B-RNA, which 
amounts approximately 230.000 dalton. In order to explain the number 
of different B-RNA encoded polypeptides the possible precursor-product 
relationship of these polypeptides was studied both by comparison of 
their peptide patterns obtained by limited digestion with Staphylococcus 
aureus protease V8, and by serological comparison (Goldbach et al., 
1982; Zabel et al., 1S82). These studies demonstrated a relationship 
between the 170K, 110K and 87K polypeptides at the one hand and the 
170K, 84K, 60K and 58K polypeptides at the other hand suggesting that 
the 170K polypeptide is the common precursor to the other polypeptides 
(Rezelman et al., 1980; Goldbach et al., 1982). Using antiserum against 
VPg it was shown that the 60K polypeptide is the direct precursor of 
VPg. The results of these analyses allowed to propose a model for the 
expression of B-RNA as depicted in Fig. II.1. In this model B-RNA is 
expressed by translation into a single 200K polyprotein, which is 
first cleaved into 32K and 170K polypeptides. Subsequently the 170K 
polypeptide is further cleaved into 60K and 110K polypeptides or, alter-
natively, into 84K and 87K polypeptides. The 60K polypeptide is cleaved 
Fig. II.1.: Model for the expression of CPMV B-RNA. 
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to release VPg and the 58K polypeptide, the 110K can probably be further 
cleaved into 28K and 87K polypeptides. In an alternative processing 
pathway the 84K polypeptide can be cleaved into 58K, VPg and 28K respec-
tively. Thus both processing routes result in the same final cleavage 
products of respectively 32K, 58K, VPg, 28K and 87K. The model for the 
expression of B-RNA has been confirmed by in vitro translation experi-
ments and by data derived from the complete nucleotide sequence of 
B-RNA (Lomonossoff and Shanks, 1983). 
The 28K polypeptide indicated in Fig. II.1 has so far not been detec-
ted in vivo. In chapters VII and VIII of this thesis the occurrence and 
possible function of this polypeptide will be discussed in more detail. 
Dorssers et al. (1983, 1984) have recently demonstrated that the 
B-RNA encoded 110K polypeptide is the only virus-specified protein 
present in highly purified viral RNA replication complexes, which are 
capable of elongating nascent RNA chains in vitro into full-size M and 
B-RNA molecules. Their findings strongly indicate that the 110K polypep-
tide may be the viral RNA replicase. In Chapter VIII of this thesis we 
present data which support this hypothesis. The proteolytic activities 
involved in the processing of the virus-encoded proteins, and their 
cleaving specificity are the major subject of this thesis. The results 
will be discussed in Chapters III, V and VII. 
In vitro translation of B and M-RNA. 
In both the messenger-dependent rabbit reticulocyte system (Pelham 
and Stuik, 1977) and in wheat germ extracts (Davies et al., 1977) the 
CPMV RNAs direct the synthesis of large primary translation products. 
B-RNA produces a 200K polypeptide and M-RNA two polypeptides with mol. 
weights of 105K and 95K respectively (Goldbach et al., 1981). The 200K 
polypeptide specified by B-RNA corresponds to 85% of the coding capacity 
of B-RNA (Pelham, 1979; Stuik, 1977). The complete nucleotide sequence 
of B-RNA (5889 nucleotides, excluding the poly(A) tail) reveals the 
presence of only one large open reading frame starting at position 207 
and continuing until a UAG stopcodon at position 5805. This reading 
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frame corresponds to a primary translation product with a mol.weight of 
207.766, which is in good agreement with the experimental value. 
The 200K primary translation product obtained by in vitro transla-
tion of B-RNA is rapidly cleaved into 32K and 170K polypeptides, provi-
ded that ATP and 2 mM dithiothreitol are present in the incubation mix-
ture (Pelham, 1979; Goldbach et al., 1981). Further studies using 
various protease inhibitors (a.o. N-ethylmaleimide, ZnCl«, phenylmethyl-
sulphonylfluoride) reveals that the proteolytic act ivi ty involved in 
this cleavage is a thiol-type protease (Pelham, 1979). In chapter VII 
our experimental data are presented which indicate that a B-RNA encoded 
proteolytic act ivi ty is engaged in this cleavage step. Pulse labelling 
experiments indicated that the 32K and 170K polypeptides were derived 
from the amino terminal and carboxyterminal end of the 200K precursor 
respectively (Pelham, 1979). By comparison of the peptide patterns 
obtained from the 170K and 32K polypeptides found in B-infected proto-
plasts with those produced by in vitro translation of B-RNA (Rezelman 
et al. , 1980) showed that the 32K and 170K polypeptides made in vitro 
were identical to those found in vivo. In further studies Goldbach and 
Rezelman (1983) determined the orientation (amino terminally/carboxy 
terminally) of the 60K and 110K polypeptides within the 170K polypep-
tide (Fig. I I . l ) by comparing the proteolytic peptide patterns of the 
in vivo polypeptides with those of 170K polypeptides translated from 
B-RNA in vitro and pulse-labelled at either amino- or carboxy-terminal 
end. These results on the in vitro translation of B-RNA complement the 
data used for the model of the expression of B-RNA i l lustrated in 
Fig. I I . l . 
The two polypeptides with mol.weights of 105K and 95K translated 
from M-RNA in in vitro protein synthesizing systems, have overlapping 
amino acid sequences (Pelham, 1979). The larger polypeptide corresponds 
to about 75% of the coding capacity of M-RNA. Pelham (1979) postulated 
that the 105K and 95K polypeptides arise by the presence of two 
in i t ia t ion sites on M-RNA and that the 105K and 95K polypeptides have 
identical carboxy-termini. This conclusion was based on ribosome 
binding experiments which indicated that (a minority of) M-RNA molecules 
are capable to bind two ribosomes. However, Filipowitz and Haenni 
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(1979) and Ahlquist et al. (1979) later showed that there is no direct 
correlation between the number of ribosomes bound and the number 
of translation initiation sites and took away the basis for the hypo-
thesis of Pelham. Our experiments on the processing of the 105K and 
95K polypeptides, described in Chapter III of this thesis, independent-
ly show that the 105K and 95K polypeptides have the same carboxy termi-
nal end. This was further confirmed when the complet nucleotide sequence 
of M-RNA was elucidated (Van Wezenbeek et al. , 1983). The nucleotide 
sequence of M-RNA (3481 nucleotides, excluding the poly(A) tail of 
variable length) contains a single open reading frame starting at posi-
tion 161 and extending to a UAA stop codon at position 3299, which pro-
bably encodes the 105K polypeptide. Two AUG codons at positions 512 and 
524 within this reading frame may be used as start codons for the syn-
thesis of the 95K polypeptide. 
Pelham (1979) showed that the primary translation products of M-RNA 
can be cleaved by a proteolytic activity present in the in vitro trans-
lation products of B-RNA. This proteolytic cleaving generated 41K, 54K 
and 57K polypeptides but no mature capsid proteins. The protease invol-
ved in this cleavage step appeared to be of the thiol type, similar to 
the proteolytic activity responsible for the cleavage of the B-RNA 
encoded 200K polypeptide into 32K and 170K polypeptides. In Chapter III 
of this thesis our studies on the in vitro processing of the primary 
translation products of M-RNA are described. The identification of the 
protease involved in at least one of the cleavage steps is reported in 
Chapter V. In Chapter VI we report on the amino acid sequence analyses 
of M-RNA encoded proteins which allowed the design of a model for the 
expression of M-RNA. 
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The expression of the middle-component (M) RNA of cowpea mosaic virus was 
studied by means of in vitro translation. In both the wheat germ extract and the 
rabbit reticulocyte lysate, M RNA was translated into two overlapping polypep-
tides of 95 and 105 kilodaltons. Incubation of these polypeptides with 30,000 x g 
supernatant fractions from cowpea mesophyll protoplasts inoculated with com-
plete virus or with separate bottom (B) components alone resulted in extensive 
processing, yielding polypeptides of 60, 58, 48, and 47 kilodaltons. Similar 
proteolytic activity was found associated with the in vitro translation products 
from the bottom-component RNA, demonstrating that the protease present in 
infected cells is encoded by B RNA. Using antisera raised against the separate 
capsid proteins VP23 and VP37, it was shown that the 60-kilodalton cleavage 
product is the precursor to both capsid proteins. Cleavage of nascent 95- and 105-
kilodalton polypeptides by the in vivo protease demonstrated that this capsid 
protein precursor is located C terminally within both polypeptides and that the 
synthesis of these two overlapping polypeptides is the result of two initiation sites 
on middle-component RNA. In addition, a second virus-induced proteolytic 
activity, capable of releasing VP23 from the 95- and 105-kilodalton polypeptides, 
was detected in leaves of infected plants, but not in infected mesophyll proto-
plasts. A model for the expression of the middle-component RNA is presented. 
In cowpea mesophyll protoplasts infected proteolytic cleavages to produce the HOK, 87K, 
with cowpea mosaic virus (CPMV), at least nine 84K, 60K, and 32K polypeptides (19). Among 
virus-coded polypeptides have been detected, these B RNA-encoded polypeptides the 60K 
with sizes of 170, 110, 87, 84, 60, 37, 32, 23, and polypeptide represents the direct precursor to 
4 kilodaltons (K) (9, 19). The 37K and 23K VPg (P. Zabel, M. Moerman, F. van Straaten, 
polypeptides represent the capsid proteins (de- R. Goldbach, and A. van Kammen, manuscript 
noted as VP37 and VP23) and the 4K polypep- in preparation). As M RNA is not replicated in 
tide represents the genome-linked protein VPg, the absence of B RNA, the expression in vivo of 
attached to the 5' ends of both bottom (B)- and this RNA cannot be studied directly. VP23 and 
middle (M)-component RNA (4, 27). Upon in- VP37 are not formed in B-infected protoplasts 
fection of protoplasts with purified B compo- and are therefore probably coded for by M 
nents, the seven noncapsid polypeptides are still RNA. Larger M RNA-coded (precursor-) poly-
synthesized, but VP37 and VP23 are lacking (9, peptides have not been detected in vivo (9, 19). 
19, 26). On the other hand, inoculation with the Therefore, we have studied the expression of M 
M component does not result in detectable syn- RNA by in vitro translation, using two different 
thesis of any viral protein. These findings have cell-free systems, the wheat germ system and 
been explained by the independent replication of the rabbit reticulocyte lysate. In both systems M 
B RNA (molecular weight, 2.02 x 106 [18]), a RNA is translated into two large polypeptides of 
property not associated with M RNA (molecular approximately 95K and 105K with overlapping 
weight, 1.37 x 106 [18]) (9). Therefore, direct in amino acid sequences (10, 16). Since B RNA is 
vivo studies on the expression of B RNA have translated properly in these systems, resulting in 
been possible, and a model has been proposed in a 200K polypeptide which is cleaved into 170K 
which this RNA is translated into a 200K poly- and 32K polypeptides also found in CPMV-
protein which is processed by three different infected cells (19), the M RNA-encoded 95K or 
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105K polypeptide, or both, may well represent 
proper primary translation products, which re-
main undetectable in vivo. Previously, it has 
been shown by Pelham (16) that either the 170K 
or the 32K polypeptide translated from B RNA 
in reticulocyte lysate possesses proteolytic ac-
tivity which accomplishes cleavage of these two 
M RNA-encoded in vitro products. Here we 
show that this B RNA-encoded protease is actu-
ally produced in CPMV-infected cells and that it 
cleaves the M RNA-coded 105K and 95K pri-
mary translation products in vitro, generating a 
60K precursor to both capsid proteins VP23 and 
VP37. Besides, a second virus-specific proteo-
lytic activity, present in leaves of infected plants 
but not detectable in infected protoplasts, is able 
to cleave only VP23 from the M RNA-coded in 
vitro products. A model for the expression of M 
RNA is discussed. 
MATERIALS AND METHODS 
Virus and RNA. CPMV was grown in cowpea plants 
(Vigna unguiculata L., "California Blackeye"), and B 
and M components were purified and separated as 
previously described (9, 12). CPMV RNAs were ex-
tracted from separated components as described by 
Davies et al. (6). Quality and purity of B and M RNA 
preparations were tested by electrophoresis in 1% 
agarose gels (8). 
Translation in wheat germ extracts. Wheat germ 
(General Mills Inc., Vallejo, Calif.) was extracted as 
described by Davies et al. (5). RNA (0.5 u.g) was added 
to a 15-ul reaction mixture containing 7.5 p.1 of wheat 
germ extract, 20 mM yV-2-hydroxyethylpiperazine-N'-
2-ethanesulfonic acid (HEPES)-KOH, pH 7.5, 2.9 mM 
magnesium acetate, 90 mM potassium acetate, 0.4 mM 
spermidine-hydrochloride, 2.5 mM ATP, 0.375 mM 
GTP, 10 mM creatine phosphate, 10 \i.g of creatine 
kinase per ml, 2 mM dithiothreitol, 5 u.g of human 
placental RNase inhibitor (2, 21) per ml, 25 p.mol of 
each amino acid (except methionine), and 2 to 5 u.Ci of 
["Slmethionine (1,000 to 1,100 Ci/mmol, Radiochemi-
cal Centre, Amersham, England). Incubation was for 1 
h at 30°C. 
Translation in reticulocyte lysates. Translation in an 
mRNA-dependent rabbit reticulocyte lysate (a gener-
ous gift of H. R. B. Pelham and R. J. Jackson, 
Department of Biochemistry, University of Cam-
bridge, Cambridge, England) was performed as previ-
ously described (10, 14, 16). [35S]methionine (2 to 5 
u.Ci per 15-ul reaction mixture) was used as radioac-
tive amino acid, and incubation was for 1 h at 30°C. 
Preparation of subcellular fractions from uninfected 
and CPMV-infected ceils. Extracts were prepared from 
both uninfected and CPMV-infected cowpea leaves 
and cowpea mesophyll protoplasts. Extracts from 
leaves were prepared by the method of Zabel et al. (30, 
31) for the preparation of solubilized viral replicase. 
Portions of 10 to 12 g of freshly harvested primary 
leaves of 13-day-old cowpea plants (uninfected or 
infected on day 9) were homogenized at 0°C in 35 ml of 
homogenization buffer (HB buffer), containing Tris-
acetate (pH 7.4), 10 mM potassium acetate, 1 mM 
EDTA, 10 mM dithioerythritol, and 0.5 mM phenyl-
methylsulfonyl fluoride. The homogenate was filtered 
and centrifuged at 1,000 x g for 15 min at 4°C. The 
supernatant was adjusted to 20% (vol/vol) glycerol and 
centrifuged at 30,000 x g for 30 min at 4°C. The 30,000 
x g pellet was extracted by resuspension in TGKEDP 
buffer, containing 50 mM Tris-acetate (pH 8.2), 25% 
(vol/vol) glycerol, 50 mM potassium acetate, 1 mM 
EDTA, 10 mM dithioerythritol and 0.5 M phenylmeth-
ylsulfonyl fluoride (1 ml for each gram of leaf tissue 
used), and was centrifuged at 30,000 x g for 60 min at 
4°C. The resulting 30,000 x g pellet extract was used 
for the in vitro processing experiments and has been 
stored at -80°C for at least several months without 
any loss of proteolytic activity. Extracts from proto-
plasts were prepared as follows. Mesophyll proto-
plasts were prepared and infected with either complete 
virus (B + M) or purified B component as previously 
described (19, 20). Forty hours after infection, por-
tions of 2.5 x 106 protoplasts were collected by 
centrifugation (2 min, 600 x g) and disrupted by 
homogenization for 5 min in a small Thomas tissue 
homogenizer with 0.5 ml of HB buffer containing 10% 
sucrose. Intact cells were removed by centrifugation 
for 15 min at 1,000 x g and 4°C. The homogenate was 
then centrifuged for 30 min at 30,000 x g and 4°C to 
give the 30,000 supernatant, to be used in the in vitre 
processing experiments. Such preparations have been 
stored at -80°C for at least several months without 
any loss of proteolytic activity. 
Processing of in vitro translation products by subcel-
lular fractions from CPMV-infected cells. One volume 
of in vitro translation products from CPMV M RNA 
(as obtained after 1 h of translation at 30°C in either 
wheat germ extract or reticulocyte lysate) was mixed 
with an equal volume of extract from either CPMV-
infected or uninfected cells and incubated for 1 h at 
30°C. As a control, a 1:1 (vol/vol) mixture of M RNA 
in vitro products and TGKEDP buffer (see above) was 
incubated under the same conditions. Processing was 
followed by electrophoresis of samples in Polyacryl-
amide gels. 
SDS-polyacrylamide slab gel electrophoresis. Sam-
ples of radiolabeled proteins were mixed with one-
third volume of a fourfold concentrated sample buffer 
(4 x SB: 40 mM Tris-hydrochloride (pH 8.0), 4 mM 
EDTA, 40% [vol/vol] glycerol, 8% [wt/vol] sodium 
dodecyl sulfate [SDS], 20% [vol/vol] ß-mercaptoeth-
anol, and 0.004% [wt/vol] bromophenol blue). After 
heating for 3 min at 100°C, samples were analyzed in 
Polyacrylamide gels containing 12.5% acrylamide 
(with 0.09% bisacrylamide) as previously described 
(13), using spacers of 4% acrylamide with 0.10% 
bisacrylamide. Gels were dried and autoradiographed 
with Kodak Royal X-Omat film. 
Antisera. Antisera against the electrophoretically 
separated capsid proteins VP23 and VP37 were pre-
pared by directly immunizing rabbits with Polyacryl-
amide containing denatured antigen, in principle as 
described by Tjian et al. (29) and Schiff and Grandgen-
ett (22) but with some modifications. CPMV particles 
(1.5 mg) were diluted in 1 x SB (see above), heated for 
3 min at 100°C, and electrophoresed in a 15% Poly-
acrylamide gel (containing 0.10% bisacrylamide). Af-
ter electrophoresis, capsid proteins were visualized by 
staining with Coomassie brilliant blue. The separate 
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VP37 and VP23 bands were excised from the gel and 
washed successively with 25% isopropanol and 10% 
methanol. Washed gel slices were then chopped up, 
lyophilized, and ground in a mortar. The resulting 
powder was mixed with approximately 1 to 2 ml of 10 
mM sodium phosphate (pH 7.2)-0.9% NaCl and emul-
sified with an equal volume of Freund complete adju-
vant (final volume, 2 to 4 ml). The emulsion was 
injected subcutaneously in the neck region of New 
Zealand White rabbits; injection was repeated twice, 
at 4-week intervals and using Freund incomplete adju-
vant. Specificity of the anti-VP23 and anti-VP37 sera 
was tested as described later in the text. 
J. VIROL. 
Immunoprecipitation. For immunoprecipitation 5 to 
10 uJ of protein sample was adjusted to PBSTDS (10 
mM sodium phosphate, pH 7.2, 0.9% NaCl, 1% Triton 
X-100,0.5% sodium deoxycholate, and 0.1% SDS) in a 
total volume of 100 M.1 and was incubated for 16 h at 
4°C in the presence of 5 ul of preimmune serum, anti-
VP23 serum, or anti-VP37 serum. Finally, 25 u.1 of a 
10% (wt/vol) suspension of Staphylococcus aureus 
cells (IgGsorb from the Enzyme Center Inc., Boston, 
Mass.) in PBSTDS (containing 10 mg of bovine serum 
albumin per ml) was added, and incubation at 4°C was 
continued for 1 h. Samples were then centrifuged 
through a sucrose cushion, consisting of a 0.5-ml layer 
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FIG. 1. Detection of a B RNA-encoded protease activity in extract of CPMV-infected cowpea mesophyll 
protoplasts. Panel A: M RNA was translated in rabbit reticulocyte lysate, and portions (4 (xl) of the products 
obtained were added to an equal volume of HB buffer (lane 1) or 30,000 x g supernatant fraction from protoplasts 
which were inoculated with either complete virus (lane 2) or B components alone (lane 4) or were uninfected 
(lane 3). Incubation was continued for 1 h at 30°C, and samples were analyzed in a 12.5% Polyacrylamide gel. 
Panel B: B RNA was translated for 1 h in reticulocyte lysate either in the presence of [33S]methionine or 
unlabeled methionine. The products formed were added to [35S]methionine-labeled in vitro translation products 
from M RNA, and incubation was continued for 1 h at 30°C. Lane 1, labeled in vitro translation products from B 
RNA; lane 3, labeled in vitro translation products from M RNA; lane 2, same as lane 3 but mixed with an equal 
volume of labeled in vitro translation products from B RNA; lane 4, same as lane 3 but mixed with an equal 
volume of 30,000 x g supernatant from B-inocuIated protoplasts; lanes 5 and 6, same as lane 3 but mixed with 1 
(lane 6) or 10 (lane 5) volumes of unlabeled in vitro translation products from B RNA. Lane 7 contains 
[35S]methionine-labeled polypeptides from CPMV-infected protoplasts. Samples were analyzed on a 12.5% 
Polyacrylamide gel. Numbers indicated at the left side of the gel refer to the molecular weights (xlO -3) of the in 
vitro polypeptides; numbers indicated at the right side of the gel refer to the molecular weights (x 10~3) of the 
viral polypeptides visible in lane 7. The endogenous activity (no RNA added) of the reticulocyte lysate used was 
undetectable (data not shown). 
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FIG. 2. Characterization of the antisera against the 
separate capsid proteins VP23 and VP37. Unlabeled 
proteins from CPMV-infected protoplasts were sepa-
rated in a 12.5% SDS-polyacrylamide gel and blotted 
onto nitrocellulose filters (0.45-u.m pore size) by the 
method of Bowen et al. (3). The nitrocellulose filters 
were incubated with preimmune serum (lane 1), anti-
VP23 serum (lane 3), or anti-VP37 serum (lane 4), and 
immunocomplexes were visualized by using 125I-la-
beled protein A from 5. aureus as described in detail 
elsewhere (P. Zabel, M. Moerman, F. van Straaten, R. 
Goldbach, and A. van Kammen, manuscript in prepa-
ration). To test the fidelity of the protein-blotting 
technique 35S-labeled proteins from CPMV-infected 
protoplasts were included in the original gel (lane 2). 
The small capsid protein VP23 occurs in two size 
classes (23K and 22K) (20). 
of 1 M sucrose and a 0.25-ml layer of 0.5 M sucrose, 
both in PBSTDS, at 17,000 x g for 30 min. The 
precipitate was washed three times in PBSTDS, dis-
solved in 1 x SB, heated for 3 min at 100°C, and 
analyzed in Polyacrylamide gels. 
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RESULTS 
B RNA-coded protease active in CPMV-infect-
ed cells. Pelham (16) has shown that one of the in 
vitro translation products from B RNA (i.e., 
either the 170K or the 32K polypeptide) is able 
to cleave the M RNA-encoded 95K and 105K 
polypeptides. To verify whether this B RNA-
encoded protease occurs in vivo, we prepared 
30,000 x g supernatant fractions from both 
infected and uninfected protoplasts. M RNA in 
vitro products (as obtained after 1 h of transla-
tion) were mixed with these protoplast extracts 
and incubated at 30°C for another hour. The 
results shown in Fig. 1A indicate that indeed a 
proteolytic activity was present in cells infected 
with complete virus (lane 2) or with B compo-
nent alone (lane 4), but not in uninfected proto-
plasts (lane 3). This B component-induced activ-
ity was capable of cleaving both 95K and 105K 
polypeptides into polypeptides of 60K, 58K, and 
48K. To test whether this activity was identical 
to the proteolytic activity of B RNA in vitro 
products previously described (16), the 95K and 
105K polypeptides were mixed with B RNA in 
vitro products. As in vitro translation of isolated 
B RNA yielded, along with the 200K, 170K, and 
32K polypeptides, a large number of minor 
products (Fig. IB, lanes 1 and 2) (16, 17) which 
obscured the emergence of new polypeptide 
bands in acrylamide gels, B RNA was translated 
in an unlabeled reaction. The unlabeled products 
were mixed with labeled M RNA products, and 
the mixture was incubated for 1 h at 30°C. 
Significant processing occurred only upon addi-
tion of 10 volumes of unlabeled B RNA products 
to 1 volume of labeled M RNA products (cf. 
lanes 5 and 6 in Fig. IB), resulting in the same 
cleavage products (60K, 58K, 48K, and some-
times 47K) as obtained with extract of B-infect-
ed protoplasts (cf. lanes 4 and 5 in Fig. IB). This 
experiment proves that the protease present in 
infected cells is indeed coded for by B RNA. 
Additional .support for this conclusion comes 
from the fact that the in vivo and in vitro 
protease activities were both sensitive to the 
same inhibitors: ZnCU, N-ethylmaleimide, and 
chymostatin (results not shown). 
Characterization of the cleavage products. As 
the capsid proteins VP23 and VP37 are absent in 
protoplasts inoculated with only B components, 
suggesting that they are coded for by M RNA 
(9), the in vitro cleavage products were analyzed 
by using antisera raised against the separate 
capsid proteins. To test the specificity of the 
antisera used in these experiments, the anti-
VP23 and anti-VP37 sera were incubated with 
proteins from virus-infected cells which were 
separated in a 12.5% SDS-polyacrylamide gel 
and subsequently blotted onto a nitrocellulose 
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FIG. 3. In vitro processing and immunoprecipitation of translational products from CPMV M RNA. M RNA 
was translated for 1 h in either reticulocyte lysate (lanes 3-7) or wheat germ extract (lanes 8-12). Portions (2 (xl) 
of the translation products were mixed with an equal volume of either HB buffer (lanes 7 and 8), 30,000 x g 
supernatant fraction from B-inoculated protoplasts (lanes 5, 6, 9, and 10), or unfractionated homogenate of M + 
B-inoculated protoplasts (lanes 3, 4,11, and 12). Incubations 4 and 11 included unfractionated CPMV RNA (250 
fig/ml). All mixtures were incubated for 1 h at 30°C, and samples 5 and 10 were immunoprecipitated with anti-
VP23 serum. Molecular weight markers included 35S-labeled polypeptides from CPMV-infected protoplasts (lane 
1) and (in lane 2) 14C-methylated myosin (210,000), Phosphorylase b (100,000 and 92,500), bovine serum albumin 
(68,000), ovalbumin (46,000), and carbonic anhydrase (30,000). 
filter (as described by Bowen et at. [3]). Of these The 58K and 48K cleavage products did not 
polypeptides only VP23 reacted with anti-VP23 react with anti-VP23 serum. The 60K polypep-
serum and only VP37 reacted with anti-VP37 tide was also the only cleavage product precip-
serum, without any cross-reaction (Fig. 2). Of itated by anti-VP37 serum (Fig. 4, lane 1). The 
the processed M RNA in vitro products the only results shown in Fig. 3 and 4 demonstrate con-
polypeptide precipitating with anti-VP23 serum clusively that M RNA encodes both capsid 
was the 60K polypeptide, except for some minor proteins. In view of its size, it is attractive to 
polypeptides, which were also present in un- propose the 60K polypeptide as the common 
treated M RNA product (Fig. 3, lanes 5 and 10). precursor to VP23 and VP37. Since the 95K and 
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FIG. 4. Immunoprecipitation of CPMV M RNA 
translation^ products. M RNA was translated in retic-
ulocyte lysate, and the products obtained were incu-
bated for 1 h at 30°C with either HB buffer (lanes 4-6) 
or 30,000 x g supernatant fraction from B-inoculated 
protoplasts (lanes 1-3). Samples 1 and 6 were immuno-
precipitated with anti-VP37 serum; samples 2 and 5, 
with anti-VP23 serum. Analysis was on a 12.5% Poly-
acrylamide gel. 
105K polypeptides were both efficiently precip-
itated by at least the anti-VP23 serum (Fig. 3, 
lane 5, and Fig. 4, lanes 2 and 5), the 60K 
polypeptide must originate from both these pri-
mary products. The size difference between the 
95K and 105K polypeptides should therefore 
correlate with the difference in size between the 
cleavage products of 58K and 48K. A reason 
that anti-VP37 serum reacted only weakly with 
95K and 105K may be the considerably lower 
titer of this antiserum compared with that of the 
EXPRESSION OF CPMV M RNA 
anti-VP23 serum used, and possibly the internal 
location of the VP37-sequence within both 95K 
and 105K (see below). 
Mapping of the cleavage products. To map the 
cleavage products more precisely within 95K 
and 105K, M RNA was translated in a wheat 
germ extract, and samples were taken at inter-
vals of 10 min and processed by addition of 
30,000 x g supernatant of B-inoculated proto-
plasts. Full-length (95K and 105K) products 
were detectable only after 30 min (Fig. 5). Proc-
essing of the 20-min sample, exclusively con-
taining incomplete primary products, revealed 
that the 48K and 58K sequences were synthe-
sized first (and simultaneously) and are there-
fore located N terminally within both the 95K 
and 105K polypeptides, respectively (Fig. 5). 
The 60K capsid protein precursor clearly ap-
peared last, when full-size 95K and 105K poly-
peptides were produced, indicating that its se-
quence is located C terminally within both 105K 
and 95K polypeptides. This finding implies that 
the full-size 95K and 105K polypeptides differ in 
their N termini and confirms that there are two 
initiation sites on M RNA in vitro. Whether two 
different initiation sites on M RNA are actually 
used in vivo or are just the result of artificial 
events in the cell-free systems remains to be 
answered, however. 
Attempts to cleave the 60K polypeptide into 
mature capsid proteins. The finding that a B 
IVKA-coded protease present in vivo is capable 
of specifically releasing a 60K capsid protein 
precursor from M RNA in vitro products strong-
ly suggests that the in vitro studies reflect the 
situation within the infected cell. The question 
arises then of why the 60K precursor was not 
further processed into the mature capsid pro-
teins. A possibility might be that this final cleav-
age is generated by a second protease which is 
membrane bound and therefore absent from the 
30,000 x g supernatant fraction of CPMV-infect-
ed protoplasts. Unfractionated homogenate of 
protoplasts infected with complete virus (M + 
B) displayed only the same proteolytic activity 
as was found in the 30,000 x g supernatant 
fraction, however (Fig. 3, lanes 3 and 12). A 
second possibility is that the 60K polypeptides 
have to be assembled into a procapsid structure 
and that the presence of unpackaged viral RNA 
is necessary for maturation of this procapsid. 
Addition of excess viral RNA to a mixture of M 
RNA in vitro product and unfractionated ho-
mogenate of CPMV-infected protoplasts did not 
show any effect (Fig. 3, lanes 4 and 11). On the 
other hand, when M RNA products were incu-
bated with a membrane protein fraction (the so-
called 30,000 x g pellet extract; for details, see 
Materials and Methods) prepared from intact 
leaves of infected plants, 93K, 79K, and 23K 
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FIG. 5. Time course of appearance of in vitro translation products. CPMV M RNA was translated in wheat 
germ extract. Samples were removed from the translation mixture at the times indicated and were either treated 
with an equal volume of 30,000 x g supernatant fraction from B-inoculated protoplasts (+) or left untreated (-); 
they were analyzed on a 12.5% Polyacrylamide gel. 
polypeptides were generated, in addition to the 
60K, 58K, and 48K products (Fig. 6, lanes 4 and 
5). Extracts from uninfected leaves did not con-
tain this proteolytic activity (Fig. 6, lane 2). The 
23K cleavage product comigrated with the small 
capsid protein VP23 (cf. lanes 3-5 in Fig. 6) and 
precipitated with anti-VP23 serum (result not 
shown). Since VP37 was not produced by this 
leaf extract, the 95K and 105K polypeptides 
were apparently cleaved into a polypeptide of 
79K and VP23 and into a polypeptide of 93K and 
VP23, respectively, by a proteolytic activity 
recognizing the cleavage site between the VP23 
and VP37 sequences. This activity seemed to be 
independent from the activity present in infected 
protoplasts, as incubation of the 95K and 105K 
polypeptides in a 1:1 (vol/vol) mixture of leaf 
and protoplast extracts did not result in further 
cleavage of the 60K polypeptide (data not 
shown). The release of VP23 and not of VP37 
from 95K and 105K polypeptides enables us to 
map both capsid proteins within the 60K precur-
sor, as summarized in the cleavage model of Fig. 
7. 
DISCUSSION 
We have previously found (9, 19) that in 
cowpea protoplasts B RNA is replicated inde-
pendently, i.e., in the absence of M RNA, 
allowing in vivo studies on the expression of this 
RNA. On the other hand, M RNA is not replicat-
ed independently from B RNA. Therefore, a 
direct study of the expression of M RNA in vivo 
has been impossible. The results presented in 
this paper show that the translation strategy and 
coding function of M RNA can be studied by 
supplying extracts of CPMV-infected plant cells 
to the M RNA-encoded 95K and 105K polypep-
tides synthesized in cell-free systems. It has 
been demonstrated now that a B RNA-coded 
protease present in both infected leaves and 
infected mesophyll protoplasts is capable of 
cleaving the M RNA in vitro translation prod-
ucts, generating a 60K precursor to both capsid 
proteins VP23 and VP37. Complementation 
studies using particles from different CPMV 
isolates have suggested that at least one of the 
capsid proteins is coded for by M RNA (11, 28). 
We have now definitely established that M RNA 
encodes both VP23 and VP37. The cleavage map 
shown in Fig. 7 summarizes the results de-
scribed in this paper. The model proposes that 
M RNA is translated in vitro into two overlap-
ping polypeptides of 95K and 105K which are 
cleaved into pieces of 60K, 58K, 48K, and 47K 
by a protease translated from B RNA in vivo. Of 
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generating cleavage between the VP23 and VP37 
sequence within 95K and 105K, the conditions 
necessary for final processing of the 60K precur-
sor are not yet understood and are the subject of 
further investigation. Neither mixing of leaf and 
protoplast extract nor addition of excess viral 
RNA resulted in cleavage of the 60K polypep-
tide. A possibility is that the 60K polypeptides 
should be arranged in a specific procapsid struc-
ture to allow final cleavage and that this assem-
bly does not occur in vitro. A similar phenome-
non has been described for the assembly and 
maturation of picornaviruses (for review, see 
23). After the viral RNA has been packaged, the 
final maturation step in poliovirus (and encepha-
lomyocarditis [EMC] virus) particles is cleavage 
of VPO (EMC virus: e) into the mature capsid 
proteins VP2 and VP4 (EMC virus: e -» ß + 5). 
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FIG. 6. In vitro processing of CPMV M RNA 
translational products using extracts from CPMV-
infected cowpea leaves. M RNA was translated in 
wheat germ extract, and portions (4 jjtl) of the products 
obtained were mixed with an equal volume of either 
TGKEDP buffer (sample 1) or 30,000 x g pellet extract 
(for details, see Materials and Methods) from CPMV-
infected (samples 4 and 5) or uninfected (sample 2) 
cowpea leaves. They were incubated for 1 h at 30°C. 
Samples 4 and 5 were treated with different leaf 
extracts. Products were analyzed in a 12.5% Poly-
acrylamide gel. Lane 3 contains [55S]methionine-la-
beled polypeptides from CPMV-infected protoplasts. 
The numbers indicated at the right side of the gel refer 
to the molecular weights ( x 10~3) of the (processed) in 
vitro products. 
these cleavage products the 60K polypeptide 
represents the direct precursor to VP23 and 
VP37, whereas the function of the other prod-
ucts is as yet unknown. Although a second 
virus-specific protease activity has been detect-
ed in extracts from infected leaves, capable of 
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FIG. 7. Model for the expression of CPMV M 
RNA. In cell-free protein-synthesizing systems M 
RNA is translated into two overlapping polypeptides 
of 95 and 105K, which differ in their N termini as a 
result of two active initiation sites on M RNA in vitro. 
Both polypeptides are cleaved by a B RNA-encoded 
protease present in infected cells, resulting in polypep-
tides of 60, 58, 48, and 47K. The 60K polypeptide 
represents a precursor to both capsid proteins VP23 
and VP37. As this precursor is generated by a viral 
protease from infected cells, it is proposed that the 
model presented reflects the translation strategy of M 
RNA in vivo. The dotted lines represent the products 
generated by a second virus-induced protease detect-
able in infected leaves but not in infected protoplasts. 
The genome-linked protein VPg at the 5'-end of both 
CPMV RNAs (4, 27) has been indicated with a box, 
and the polyadenylate tail at the 3' end (1, 7) has been 
indicated with a zigzag line. It is not known whether 
translation of CPMV RNA is preceded by removal of 
VPg. 
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In reticulocyte lysates polioviral (and EMC vi-
ral) RNA is translated into a large polyprotein 
which is then processed extensively (15, 24, 25). 
One of the products is VPO (EMC virus: c), 
which is not processed further, however, indi-
cating that final assembly of virions also has 
been impeded. 
The experiments presented in this paper con-
firm the observation of Pelham (16) that in vitro 
M RNA contains two active initiation sites. The 
overlapping 95K and 105K polypeptides are 
synthesized in two different cell-free systems 
(Fig. 3) (10), but it is not known whether they are 
both produced in vivo. The production of poly-
peptides with completely overlapping amino 
acid sequences does not appear useful and might 
be the result of the artificial conditions in cell-
free extracts. In view of the faithful translation 
of B RNA in both in vitro translation systems 
(10, 19) and the generation of a specific 60K 
capsid protein precursor upon cleavage by an in 
vivo B RNA-coded protease, at least one of the 
M RNA in vitro products probably represents a 
correct primary translation product even if it has 
not been detected in vivo. The use of in vitro 
protein-synthesizing systems, in combination 
with well-defined subcellular fractions from in-
fected cells, may provide the means for studying 
the remaining coding functions of M RNA and 
the mechanism of CPMV assembly. 
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SUMMARY 
Electron microscopic analyses have revealed that the bottom (B) component of 
cowpea mosaic virus alone induces cytopathic structures in cowpea mesophyll 
protoplasts, similar to those induced by the complete virus [i.e. B plus middle (M) 
components]. This indicates that the development of such structures is not linked to 
accumulation of virus particles but to virus RNA replication and expression. When 
purified B component was inoculated to primary cowpea leaves, symptoms were 
not produced and B component RNA was incapable of spreading to surrounding 
cells. The results are discussed in terms of limits to the independence of B component 
RNA and of possible functions for M component RNA-encoded proteins. 
INTRODUCTION 
Cowpea mosaic virus (CPMV) is a plant virus with an RNA genome distributed between 
two nucleoprotein particles, the bottom (B) and middle (M) component (Van Kammen, 
1972). Both components, or their RNAs (denoted B RNA and M RNA, with mol. wt. 2-02 x 
10' and 1-37 x 106 respectively; Reijnders et al., 1974) are necessary for virus multiplication 
(Bruening, 1977; Van Kammen, 1968). We have shown previously that B component RNA is 
able to replicate independently (i.e. in the absence of M component), a property not 
associated with M component RNA (Goldbach et al., 1980). Direct studies on the expression 
of B component RNA in vivo have therefore been possible (Rezelman et al., 1980; Goldbach 
étal., 1982). 
CPMV infection is accompanied by the appearance of characteristic cytopathic structures 
(Assink et al., 1973; De Zoeten et ai, 1974). These structures consist of amorphous 
electron-dense material and a large number of vesicles. We have now investigated whether the 
B component alone is able to induce these cytopathic structures in protoplasts. Furthermore, 
as the replication and expression of B component RNA has mainly been studied in isolated 
mesophyll protoplasts, we have now followed its fate in the intact host. We have studied 
whether B RNA is capable of spreading to surrounding cells in the absence of M RNA. This 
property has been reported for the large RNA (RNA-1) of another two-component virus, 
tobacco rattle virus (TRV) (Sänger & Brandenburg, 1961; Cadman, 1962; Lister, 1968, 
1969). 
The results presented in this paper demonstrate that the independence of the B component 
is limited. 
METHODS 
Virus purification and separation of B and M components. CPMV was propagated in 
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cowpea plants (Vigna unguiculata L. 'California Blackeye') and purified as described 
previously (Van Kammen, 1967). B and M components were separated in a linear 15 to 30% 
sucrose gradient by zonal centrifugation (Beekman Ti 15 rotor, 16 h, 23000 rev/min at 
10 °C). This procedure was repeated twice to give an M component free of B, and a B 
component contaminated with less than 0-2% of M, as determined by the local lesion 
infectivity test (De Jager, 1976). 
Protoplast isolation and inoculation. Cowpea mesophyll protoplasts were isolated and 
inoculated with CPMV components [5 fig of M components, 5 //g of B components, or 10 fig 
of a 1:1 (w/w) mixture of both components per 5 x 10' protoplasts per ml inoculum] or left 
untreated as described in detail previously (Hibi et al., 1975; Rottier et al., 1979). Inoculated 
protoplasts were incubated in culture medium at 25 °C as described by Rottier et al. (1979). 
In some experiments protoplasts were reinoculated with CPMV components 24 h after their 
preparation. For that purpose, protoplasts incubated for 23 h in culture medium were 
sedimented and resuspended in a solution of 0-5% (w/v) cellulase in 0-6 M-mannitol pH 5-6. 
After 1 h incubation at 25 °C the protoplasts were washed twice with 0-6 M-mannitol and 
resuspended in 0-6 M-mannitol, 0-01 M-potassium citrate pH 5-2, containing 0-5 or 1-0 fi$ 
poly-L-ornithine (PLO) (Pilot Chemicals, New England Nuclear) per ml. Concurrently, a 
solution of unfractionated virus (5 //g/ml) or purified M component (2-5 ftg/m\) was made in 
the same buffer (also containing 0-5 or 1 0 jUg/ml PLO). Both the virus solution and the 
protoplast suspension were kept for 5 min at room temperature. The protoplasts were then 
sedimented and resuspended in the virus solution. After 15 min the protoplasts were washed 
three times in 0-6 M-mannitol containing 10 mM-CaCl2, and were finally resuspended and 
incubated in culture medium. 
Electron microscopy. Samples of protoplasts were collected by centrifugation (2 min, 600 
g) 24 h or 40 h after inoculation and incubated in 2% glutaraldehyde, 0-1 M-sodium 
phosphate pH 7, 0-6 M-mannitol for 1 h at 4 °C. After five successive washes with 0-1 
M-sodium phosphate pH 7, they were fixed in 1 % osmium tetroxide in 0-1 M-sodium 
phosphate pH 7 for 1 h at 4 °C, washed in double-distilled water and in 0-14 M-veronal 
acetate pH 5 (containing 0-577 g sodium barbiturate and 0-38 g sodium acetate per 100 ml) 
successively, and stained for 1 h in 2% uranyl acetate in 0 1 4 M-veronal acetate pH 5. 
Finally, the fixed protoplasts were washed in veronal acetate (0-14 M, pH 5), dehydrated in 
ethanol and acetone, and embedded in a prepolymerized mixture of methacrylate and divinyl 
benzene by the method of Kushida (1961). Polymerization took place in gelatin capsules at 
50 °C for 48 h. Ultrathin sections made with an LKB Ultrotome III ultramicrotome were 
stained with uranyl acetate and lead citrate by the method of Reynolds (1963), and examined 
in a Siemens Elmiskop 101 electron microscope, operated at an accelerating voltage of 80 
kV. 
Assay for spreading of CPMV components in cowpea leaves. Primary leaves of 8- or 
9-day-old cowpea plants were inoculated with B component (5 fig in 100 fà 0 0 1 M-sodium 
phosphate pH 7 per leaf) or with a mixture of M + B components (5 fig of each in 100 /il of 
the same buffer). After 24 or 48 h protoplasts were isolated from the inoculated leaves. 
Protoplasts prepared from B-inoculated leaves were divided into three aliquots at a 
concentration of 5 x 10' protoplasts per ml. One portion was inoculated with M component 
(5 fig per 5 x 10' protoplasts), and, to verify whether the protoplasts were infectable with 
CPMV, a second portion was inoculated with a mixture of B and M components (5 fig of 
each per 5 x 10s protoplasts). A third portion was left untreated. Protoplasts isolated from 
M + B-infected leaves were left untreated to measure the spreading of the complete virus. To 
determine the percentage of cells containing virus particles, samples of protoplasts were 
stained with fluorescent antibodies against CPMV (Hibi et al., 1975) 0, 25 and 42 h after 
inoculation. 
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Fig. 1. Electron micrographs of cowpea mesophyll protoplasts: (a) uninoculated; (b) inoculated with B 
component; (c) inoculated with a 1:1 (w/w) mixture of B + M components. Portions of protoplasts 
were mounted for electron microscopy 24 h after inoculation. Arrows indicate the characteristic 
cytopathological structures (i.e. electron-dense material); N, nucleus. Bar marker represents 1 fim. 
RESULTS 
Electron microscopy 
Cowpea mesophyll protoplasts, inoculated with B, M, or B + M components, were 
analysed by electron microscopy 24 h and 40 h after inoculation. Cytopathic structures were 
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Fig. 2. Electron micrographs of cowpea mesophyll protoplasts: (a) uninoculated; (b) inoculated with B 
component; (c) inoculated with a 1:1 (w/w) mixture of B + M components. Portions of protoplasts 
were mounted for electron microscopy 40 h after inoculation. Arrows indicate the characteristic 
cytopathological structures (i.e. vesicles); N, nucleus. Bar marker represents 1 //m. 
found in protoplasts inoculated with complete virus and in protoplasts inoculated with only B 
component, but not in protoplasts inoculated with M component (Fig. 1, 2). The morphology 
of the cytopathic structures in the inoculated protoplasts changed during the time after 
inoculation. Twenty-four h after inoculation (Fig. 1) these structures contained amorphous 
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Table I. Induction ofcytopathic structures in cowpeaprotoplasts by components ofCPMV 
Percentage of cells containing 
Inoculum c.p.s.* CPMV particlesf 
0 0 
B 71 4 
M O 0 
B + M 68 67 
* c.p.s., Cytopathic structures. 
t As determined by staining with fluorescent anti-CPMV serum. 
electron-dense material clustered within membrane structures. Forty h after inoculation (Fig. 
2) the amount of electron-dense material diminished, but the number of vesicles surrounding 
the remaining electron-dense material increased. Such structures were absent in both healthy 
protoplasts (Fig. la, 2a) and in M component-inoculated protoplasts (data not shown). The 
results indicate that B component alone is capable of inducing the cytological alterations 
typical of CPMV infection. The data presented in Table 1 show that in the case of inoculation 
with B + M particles the percentage of protoplasts containing cytopathic structures (68 %) 
and the percentage of infected protoplasts as determined by fluorescence (67%) were in good 
agreement. This correlation strongly suggests that all virus-containing cells contain 
cytopathic structures. In the case of B-inoculated protoplasts, the percentage of cells 
containing cytopathic structures was as high (71 %) as for the B + M-inoculated cells, but the 
percentage of fluorescent cells was only 4%. Production of capsid proteins by these cells must 
have resulted from minor (0-2% or less) contamination of the B component preparation with 
M components. Therefore, it appears that B component alone is capable of inducing 
cytopathic structures in protoplasts with the same efficiency as the complete virus. 
Is B RNA capable of spreading to surrounding cells? 
In protoplasts inoculated with B component alone, B RNA is replicated and expressed to 
the same extent as it is in protoplasts inoculated with B + M components (Goldbach et al., 
1980; Rezelman et al., 1980). To investigate whether B RNA is also able to act independently 
from M RNA in the host plant, we have followed the fate of this RNA upon infection of 
primary cowpea leaves with B component. Since transfer of B RNA from cell to cell is 
necessary for detectable expression of B component RNA in leaves, we have determined the 
number of leaf cells containing B RNA upon inoculation with B component. For that 
purpose, protoplasts from B-inoculated leaves were prepared at various times after 
inoculation, and these protoplasts were subsequently inoculated with excess M particles. The 
rationale was that B RNA-containing cells which become inoculated with M particles should 
begin production of B and M particles, which can easily be detected by staining these cells 
with fluorescent antibodies against CPMV. Table 2 shows that the complete virus (M + B) 
rapidly spreads throughout the leaf, reaching up to 40% of the cells within 48 h. In contrast, 
the number of fluorescent protoplasts from B-inoculated leaves hardly increased (from 1 to 
4%, Table 2 and Fig. 3) within the first 48 h after inoculation of leaves. Since addition of 
excess M particles to these cells did not further increase the number of fluorescent cells (Table 
2 and Fig. 3) we conclude that the number of cells containing only B component RNA was 
negligible. The reliability of the assay used in this experiment was verified by inoculating one 
portion of protoplasts from B-inoculated leaves with a 1:1 (w/w) mixture of B + M 
components. Approximately 40 to 50% (Table 2) of these protoplasts produced virus 
particles, demonstrating that they were accessible to infection by CPMV particles. 
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Fig. 3. Transport of CPMV components throughout the cowpea leaf. Leaves were inoculated with a 
1:1 (w/w) mixture of B + M components, or with B component alone. Protoplasts were prepared from 
these leaves at the times indicated. • , B + M-inoculated leaves; O, B-inoculated leaves. One portion of 
protoplasts prepared from B-inoculated leaves was inoculated with excess M component (•). After 42 h 
incubation of the protoplasts, percentages of infected cells were determined by staining with fluorescent 
anti-CPMV serum. 
Table 2. Spreading of CPMV components throughout the cowpea leaf 
Leaf 
inoculum 
B 
B 
B + M 
B + M 
B + M 
Preparation of 
protoplasts 
(h post-inoculation)* 
24 
48 
2 
24 
48 
Protoplast 
inoculum 
f -
l M 
IB + M 
f -
1 M 
[B + M 
-
-
-
f 
0 ht 
0 
4-4 
5-5 
39-9 
CPMV-infected cells (% 
A 
25 ht 
0-6 
0-7 
48-4 
3 0 
3-5 
41-7 
8-2 
35-5 
)t 
42 ht 
1-4 
1-8 
53-0 
3-8 
4-4 
37-0 
<10 
10-6 
39-7 
* Protoplasts were isolated from leaves at the times indicated, 
t As determined by staining with fluorescent anti-CPMV serum. 
X Time of incubation of protoplasts. 
Table 3. Reinoculation of cowpea protoplasts with CPMV components 
Inoculum* 
-
-
-
B 
B 
B 
B 
B 
Reinoculumt 
B + M 
B + M 
B + M 
-
B + M 
B + M 
M 
M 
PLO 
(/ig/ml)* 
-
0-5 
1-0 
-
0 5 
10 
0-5 
10 
CPMV-infected 
cells (%)§ 
1-5 
32 
35 
6 
12 
20 
16 
20 
* Inoculated immediately after isolation of protoplasts. 
t Reinocutated 24 h after isolation of protoplasts. 
t Concentration of poly-L-ornithine used for reinoculation. 
§ As determined by staining with fluorescent anti-CPMV serum 67 h after isolation of protoplasts. 
46 
Independence ofCPMV B RNA 
To exclude the possibility that, in protoplasts isolated from B-inoculated leaves, B RNA 
was not able to support the replication and expression of newly entered M RNA, the 
following control experiment was performed. Protoplasts inoculated with B component were 
first incubated for 23 h under standard conditions. They were then treated with cellulase (to 
remove the newly formed cell walls) and reinoculated with M component. Forty-four h later 
(i.e. 67 h after the first inoculation) they were stained with fluorescent anti-CPMV to 
determine the number of CPMV-producing cells. Whereas PLO is not necessary for efficient 
infection of freshly prepared protoplasts (Hibi et al, 1975; Rottier et al, 1979), its presence 
appeared to be a prerequisite for infection of protoplasts aged for 24 h. In the absence of 
PLO, only 1-5% of such protoplasts were infected upon inoculation with CPMV (B + M), 
whereas in the presence of PLO (0-5 or 1-0 /Jg/ml) this percentage was approx. 30 to 35% 
(Table 3). Using 1 -0 //g/ml PLO, reinoculation of protoplasts with M component, 24 h after 
they had been inoculated with B component, resulted in 20% CPMV-producing cells, 
compared to only 6% if these protoplasts had not been reinoculated with M component 
(Table 3). As the same percentage (20%) was reached after reinoculation with complete virus 
(Table 3) this result shows that at least in a major part of cells, which have been first 
inoculated with B component and 24 h later with M component, B RNA can support the 
replication and expression of M RNA. The low number of protoplasts from B-inoculated 
leaves which fluoresce after inoculation with M component (Table 2) therefore reflects the 
inability of B RNA to spread independently to surrounding cells. 
D I S C U S S I O N 
It has been previously shown that the B component RNA of CPMV is capable of self 
replication (Goldbach et al., 1980) whereas M RNA is not. In studies on the expression of B 
RNA in mesophyll protoplasts, at least seven B RNA-coded proteins with sizes of 170K, 
110K, 87K, 84K, 60K, 32K and 4K could be detected (Rezelman et al., 1980; Stanley et al., 
1980). Although functions could not be assigned to any of these polypeptides, at least one of 
them should be involved in virus RNA replication (Goldbach et al., 1980) and another should 
represent the protease responsible for the in vitro cleavage of the M RNA-coded primary 
translation products (Pelham, 1979; Goldbach et al, 1981; Franssen et al, 1982). As it has 
recently been shown that M RNA encodes both capsid proteins (Franssen et al, 1982), B 
RNA should exist as an unencapsidated molecule in B component-inoculated protoplasts. In 
this paper we have shown that this unencapsidated B RNA and its products, rather than the 
accumulation of virus particles, are responsible for the induction of the characteristic 
cytopathic structures in CPMV-infected cells. Our results are consistent with the finding of 
Hibi et al. (1975) that RNA replication is associated with the appearance of the cytopathic 
structures. Furthermore, the electron microscopic analyses presented here show that 24 h 
after infection these structures mainly consist of electron-dense material as described 
previously (Assink et al, 1973; Hibi et al, 1975) but that with advancing time (i.e. 40 h after 
infection) the infected cell develops a large number of vesicles. Although B RNA appears to 
replicate independently in isolated protoplasts, our results demonstrate that non-packaged B 
RNA is unable to spread throughout leaves (Table 2 and Fig. 3). This indicates that M RNA 
encodes one or more proteins essential for the transport of the virus RNA molecules. In this 
context, it is worth mentioning that apart from the capsid proteins, two other polypeptides 
(58K and 48K) are translated from M RNA in vitro (Franssen et al, 1982). For TRV, a 
rod-shaped two-component virus, it has been shown (Lister, 1968, 1969) that the RNA from 
the long particle (which does not carry the information for the virus coat protein) can 
replicate by itself and this replication is accompanied by spreading of the virus RNA through 
the infected plant and by the production of symptoms. Although B RNA of CPMV is unable 
to cause local lesions in cowpea leaves, this does not mean a priori that B RNA is incapable 
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of spreading as expression of B R N A in the leaf may not have been associated with visible 
symptoms. We have now demonstrated that the lack of symptom development is related to 
the inability of B R N A to spread. The question as to whether encapsidation is solely essential 
for transport of C P M V R N A s or whether another M RNA-encoded function is involved-in 
this process needs further investigation. 
We thank R. Brouwer for help in initial experiments and H. Lohuis for technical assistance. This 
work was supported by the Netherlands Foundation for Chemical Research (SON) with financial aid 
from the Netherlands Organization for the Advancement of Pure Research (ZWO). 
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Translation of middle-component RNA of cowpea mosaic virus in vitro produced two polypeptides of 95 
and 105 kilodaltons (95K and 105K, respectively) with overlapping amino acid sequences, which were 
specifically cleaved by a protease encoded by the bottom-component RNA. The proteolytic cleavage was 
studied by the addition of antibodies raised against various bottom-component RNA-encoded proteins to 
extracts prepared from bottom-component RNA-inoculated cowpea protoplasts. Since antiserum to the 
32K polypeptide efficiently inhibited the proteolytic activity of such extracts, although antiserum to VPg or 
to the 170K polypeptide did not, evidence was obtained which indicates that the 32K polypeptide represents 
the protease involved. Fractionation of proteoiytically active extract by glycerol gradient centrifugation 
demonstrated that 32K polypeptides do not exist as free proteins but are aggregated to the bottom-
component RNA-encoded 170K, 84K, 60K, or 58K polypeptides. Maximal proteolytic activity was 
observed for 32K polypeptides associated with 170K polypeptides, suggesting that the activity was unstable 
and confined to newly synthesized molecules. 
Among plant viruses, cowpea mosaic virus (CPMV), the 
type member of the comoviruses, has become one of the 
most extensively studied viruses. The genome of this virus 
consists of two separately encapsidated plus-stranded RNA 
molecules with molecular weights of 2.01 x 106 (bottom-
component [B] RNA) and 1.22 x 106 (middle-component [M] 
RNA), respectively (18. 26. 27). Both RNAs possess a 
genome-linked protein, denoted as VPg, at their 5'-terminus 
and are polyadenylated (1-3. 22. 23). Expression of the viral 
RNAs does not involve the generation of subgenomic 
mRNAs but occurs by means of proteolytic cleavages of 
long, primary translation products. Thus, it has been shown 
that B-RNA is translated into a 200-kilodalton (200K) poly-
protein which is first cleaved to give a 32K and a 170K 
polypeptide (8, 16). The 170K polypeptide is then further 
cleaved to give either 60K and 110K or 84K and 87K 
polypeptides (20). Subsequent cleavage of the 60K polypep-
tide provides VPg and a 58K polypeptide (7, '8). M-RNA is 
translated into two polypeptides of 95K and 105K with 
overlapping amino acid sequences (4, 16). These polypep-
tides are proteoiytically cleaved at the same position to give 
polypeptides of 60K, 58K, and 48K (4, 16). The 60K 
polypeptide is derived from the COOH-terminal half of both 
these polypeptides and represents the precursor to both 
capsid proteins VP37 and VP23, whereas the 58K and 48K 
cleavage products are derived from the NH2-terminal parts 
of the longer (105K) and smaller (95K) polypeptides, respec-
tively. The function of the overlapping 58K and 48K poly-
peptides is unknown as yet, but they may be involved in the 
spreading of viral RNA throughout the leaf (19). The prote-
ase responsible for the cleavage of the M-RNA-encoded 
primary translation products is obviously coded for by the B-
RNA, since both in vitro translation products obtained from 
this RNA (i.e., the 170K and 32K polypeptides [8, 16]) and 
extract from cowpea mesophyll protoplasts inoculated with 
" Corresponding author. 
purified B-RNA (4) exhibit this activity. Until now, howev-
er, it has not been possible to elucidate which B-RNA-
encoded polypeptide actually represents the protease in-
volved. This report presents evidence that the proteolytic 
activity resides in the 32K polypeptide. 
MATERIALS AND METHODS 
Virus and RNA. CPMV was propagated in cowpea plants 
(Vigna unguiculata L. "California Blackeye") as described 
previously (12, 25). Separate B- and M-components were 
obtained by three cycles of centrifugation in a linear 15 to 
30% (wt/vol) zonal sucrose gradient (16 h, 23,000 rpm at 
10°C; Beekman Ti 15 rotor) as previously described (6, 20). 
M-RNA was isolated as follows: purified M-components 
were disrupted by adding an equal volume of 4% (wt/vol) 
Sarkosyl NL97-2% (wt/vol) sodium tri-isopropylnaphtha-
lene sulfonate-0.02 M Tris-hydrochloride (pH 7.4)-02 M 
NaCl-0.004 M EDTA and by heating for 5 min at 60°C. The 
RNA was purified by three extractions with phenol (saturat-
ed at pH 8) and precipitated with two volumes of ethanol at 
-20°C. The precipitate was dried and dissolved in water and 
then subjected to a linear 15 to 30% (wt/vol) sucrose gradient 
centrifugation (16 h, 22,500 rpm at 20°C; Beekman SW27 
rotor). Fractions containing intact RNA were pooled and 
precipitated with two volumes of ethanol at -20°C. The 
RNA precipitate obtained was washed three times with 
absolute ethanol, dried, and dissolved in water at a concen-
tration of 1 mg/ml. 
Incubation of protoplasts, labeling of proteins, and subcellu-
lar fractionation. Cowpea mesophyll protoplasts were pre-
pared, inoculated, and incubated as described previously 
(11, 20). When labeled proteins were required, protoplast 
suspensions (5 ml, 5 x 10s cells per ml) were supplied with 
portions (150 u,Ci) of [35S]methionine (1,100 Ci/mmol; New 
England Nuclear Corp.) at 18 and 25 h after inoculation. 
Forty-four hours after inoculation, protoplasts were collect-
ed by centrifugation (2 min, 600 x g), suspended in 0.5 ml of 
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FIG. 1. Inhibition of the protease activity by antiserum raised against the 32K polypeptide. Increasing volumes of anti-32K, anti-170K, or 
preimmune sera were added to2-u.l portions of the S30 fraction from B-c <r. ponent-inoculated protoplasts, in a total volume of 20 u,l ofTKED 
buffer. After incubation for 1.5 h at 0°C. 2 u.1 of [,5S]methionine-labeled in vitro translation products of M-RNA was added, and incubation 
was continued for 1.5 h at 30°C. Proteolytic cleavage of the 105K and 95K polypeptides was determined by electrophoresis in a 12.5% 
Polyacrylamide gel. The arrows indicate the 60K and 48K cleavage proteins from the 95K polypeptide (the input amounts of the 105K 
polypeptide were too low to allow detection of the 58K cleavage product). Molecular weights (M.W. x 10 3) are indicated to the left of the fig-
ure. 
TKEDP buffer (50 mM Tris-acetate [pH 7.4], 10 mM potassi-
um acetate, 1 mM EDTA, 10 mM dithioerythritol, 1 mM 
phenylmethylsulfonyl fluoride) containing 10% (wt/vol) su-
crose, and disrupted by h omogen ization for 2.5 min at 0°C in 
a small Thomas tissue homogenizer. The homogenate thus 
obtained was centrifugea for 30 min at 30,000 x g and 4DC to 
give the 30,000 x g supernatant (S30) fraction, which 
contained (most of) the virus-specific proteolytic activity. 
SDS-polyacrylamide slab gel electrophoresis. Portions of 
radiolabeled proteins were mixed with one-third volume of a 
fourfold-concentrated sample buffer (40 mM Tris-hydrochlo-
ride [pH 8.0], 4 mM EDTA, 40% [vol/vol] glycerol, 8% 
[wt/vol] sodium dodecyi sulfate [SDS], 20% [vol/vol] ß-
mercaptoethanol, 0.004% [wt/vol] bromophenol blue) and 
heated for 3 min at 100°C. The samples were then electro-
phoresed at 150 V in an SDS-polyacrylamide gel containing 
12.5% acrylamide (with 0.09% bisacrylamide) by using a 
stacking gel of 4% acrylamide and 0.10% bisacrylamide, as 
previously described (13, 20). After electrophoresis, gels 
were dried either with or without preceding staining and 
autoradiographed with Kodak Royal X-omat X-ray film. 
Antisera and immunoprecipitation. Antiserum against the 
electrophoretically separated virus-coded 170K polypeptide 
was prepared by directly immunizing a New Zealand white 
rabbit with Polyacrylamide containing the denatured anti-
gen, in principle as described by Tijan et al. (24) and Schiff 
and Grandgenett (21) but with some modifications as de-
scribed elsewhere (P. Zabel and F. van Straaten, manuscript 
in preparation). Antiserum against the electrophoretically 
separated 32K polypeptide was prepared by immunizing 
rabbits with 32K polypeptide eluted with buffer (12.5 mM 
Tris-hydrochloride [pH 6.8], 0.1 mM EDTA) from gel slices 
of a nonfixed Polyacrylamide gel. Antiserum against the 
genome-linked protein VPg was prepared as described previ-
ously (28). Specificity of the various antisera raised against 
CPMV-encoded proteins was tested by immunoprecipitation 
of proteins from the S30 fraction of radiolabeled B-compo-
nent-inoculated protoplasts in a buffer (TKE-TDS) contain-
ing 50 mM Tris-acetate (pH 7.4), 10 mM potassium acetate, 1 
mM EDTA, 1% Triton X-100, 0.5% sodium deoxycholate, 
and 0.1% SDS. Immunoprecipitation was performed in 
TKE-TDS buffer as described previously (4), except as 
stated otherwise. None of the antiserum preparations used 
showed reactivity against host proteins. 
Glycerol gradient cent rif ligation. Typically, 80 u.1 of the 
S30 fraction obtained from B-component-inoculated proto-
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FIG. 2. Autoradiogram of a Polyacrylamide gel with immunopre-
cipitated CPMV polypeptides. Portions of the S30 fraction (2 u.1) 
from [15S]methionine-labeled B-component-inoculated protoplasts 
were incubated with 2 u.1 of anti-32K serum, 5 u.' of anti-170K 
serum, or 5 u.1 of anti-VPg serum, in a final volume of 20 u.1 of TKE 
buffer (without detergents, - ) or TKE-TDS buffer (with detergents, 
+ ). The two lanes on the left contain the ("S]methionine-labeled 
polypeptides from B-RNA-inoculated protoplasts without immuno-
precipitation (input) and l4C-methylated protein markers (l4C) {myo-
sin [M.W., 210,000]; Phosphorylase b [M.W., 100,000 and 92,500]; 
bovine serum albumin [M.W., 68,000]; ovalbumin [M.W., 46,000); 
and carbonic anhydrase [M.W., 30,000]), respectively. The numbers 
to the right of the figure refer to the molecular weights of the B-
RNA-encod;d polypeptides. 
plasts was layered on linear 15 to 30% (vol/vol) glycerol 
gradients in TKED buffer (i.e., TKEDP buffer minus phenyl-
methylsulfonyl fluoride). Centrifugation was carried out in a 
Beekman SW41 or SW50 rotor under conditions described in 
the figure legends. After the run, gradients were fractionated 
in 500-uJ portions which were assayed for both protease 
activity and occurrence of viral proteins. 
In vitro translation of M-RNA. CPMV M-RNA was trans-
lated in an mRNA-dependent rabbit reticulocyte lysate (a 
generous gift of R. J. Jackson, Department of Biochemistry, 
University of Cambridge, Cambridge, England) under condi-
tions as previously described (8,16, 17). [55S] methionine (10 
u.Ci per 10 u.1 of reaction mixture) was used as the radioac-
tive amino acid, and incubation was for 1 h at 30°C. 
Viral protease assay. For detection of the viral protease, 2 
to 20 p.1 of samples to be analyzed was mixed with 2 u,l of 
[35S]methionine-labeIed in vitro translation products from 
CPMV M-RNA (as obtained after 1 h of translation) in a total 
volume of 22 u.1 of TKED buffer and incubated at 30°C for 
1.5 h. To determine proteolytic activity, 5-u.l portions of 
each sample were electrophoresed in a 12.5% Polyacryl-
amide gel. 
RESULTS 
Inhibition of the protease activity by anti-32K serum. Since 
translation products obtained from B-RNA after 1 h of in 
vitro translation were proteolytically active {4,16), either the 
32K polypeptide or the 170K polypeptide must be responsi-
ble for this activity. If the proteolytic activity resides in the 
170K polypeptide, then it might be expected that one of the 
known, final cleavage products of the 170K polypeptide 
represents the mature protease. To discriminate between 
these possibilities, antisera raised against the 32K and 170K 
polypeptides were prepared and tested for their ability to 
inhibit the proteolytic activity. For this purpose, increasing 
amounts of anti-32K, anti-170K, or preimmune sera were 
added to 2-u.l portions of the S30 fraction from B-compo-
nent-inoculated protoplasts in a total volume of 20 u.1 of 
TKED buffer and incubated for 1.5 h at 0°C to allow binding 
of the immunoglobulins to the viral proteins. Possible inhibi-
tion of the proteolytic activity in these mixtures was then 
determined by addition of 2 u.1 of [35S]methionine-labeIed 
(95K and 105K) in vitro translation products from M-RNA 
and by analysis for the lack of appearance of the 60K, 58K, 
and 48K cleavage products. A significant decrease in proteo-
lytic activity was obtained with anti-32K serum, even at 
lower amounts (Fig. 1). On the other hand, preimmune 
serum, tapped from the anti-32K rabbit before immuniza-
tion, and anti-170K serum did not show any inhibitory effect 
(Fig. 1). These results suggest that the proteolytic activity 
resides in the 32K polypeptide and not in the 170K polypep-
tide. Some complications which may be important should be 
regarded, however. First, although the titer of the anti-170K 
serum used was reasonable under normal immunological 
conditions (i.e., in TKE-TDS buffer), reacting with both the 
170K polypeptide and the 110K and 87K polypeptides de-
rived from this polypeptide, this antiserum snowed a re-
duced reactivity under conditions where its possible inhibi-
tory effect on the proteolytic cleavage was tested (in TKE 
buffer, i.e., in the absence of any detergent [Fig. 2]). 
Moreover, in the absence of detergents, the anti-32K serum 
apparently bound to complexes of 32K polypeptides with the 
viral 58K, 60K, 84K. and 170K polypeptides (Fig. 2). 
Therefore, the possibility that one of these four other B-
RNA-encoded polypeptides represented the protease, the 
activity of which was inhibited by sterical hindrance of 
immunoglobulin G (IgG) molecules bound to associated 32K 
polypeptides, had to be considered. The following observa-
tions, however, provide evidence against this idea. First, 
since the 87K and 110K polypeptides were not detectable in 
complexes with the 32K polypeptide (Fig. 2), the conclusion 
can be drawn that at least these polypeptides were not 
responsible for the proteolytic cleavage. Second, antiserum 
raised against VPg did not interfere with the proteolytic 
cleavage (data not shown). This antiserum was capable of 
binding the VPg-containing 170K, 60K, and, to a lesser 
extent, 84K polypeptides, both in the presence and absence 
of detergents (Fig. 2). The results obtained with all three 
antisera are therefore consistent and indicate that neither the 
170K polypeptide nor any of its cleavage products represent 
the protease, but instead, point out that the 32K polypeptide 
bears the activity in question. 
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FIG. 3. Sedimentation of [35S]methionine-labeled CPMV polypeptides in a glycerol gradient. Eighty microliters of an S30 fraction of 
radiolabeled B-component-inoculated protoplasts was layered on a 10 to 30% (vol/vol) linear glycerol gradient either in TKE-TDS buffer (A) 
or in TKE buffer (B). Centrifugation was carried out in a Beekman SW50 rotor for 17 h at 48,000 rpm and 4°C. After the run, 500-u.l fractions 
were collected and immunoprecipitated with anti-32K serum in TKE-TDS buffer (A) or in TKE buffer without detergents (B). Samples were 
analyzed in a 12.5% Polyacrylamide gel. Lanes 1 correspond to the bottom fractions of each gradient. The central lane between (A) and (B> 
contains unfractionated ["S]methionine-labeled proteins from B-component-inoculated protoplasts. Numbers to the left of the figure refer to 
the molecular weights of some of the B-RNA-encoded proteins. 
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FIG. 4. Glycerol gradient fractionation and protease activity of B-RNA-encoded proteins. Eighty microliters of an S30 fraction of 
[35S]methionine-labeled, B-component-inoculated protoplasts was layered on a 15 to 30% (vol/vol) linear glycerol gradient (in TKED buffer) 
and centrifuged for 42 h in a Beekman SW41 rotor at 38,000 rpm and 4°C. After centrifugation, the gradient was fractionated into 20 portions of 
500 |il which were tested for protease activity (A) and the presence of viral polypeptides (B and C). (A) From each fraction, 20-|xl portions 
were taken and tested for protease activity on M-RNA-encoded polypeptides, as described in the text. Proteolytic cleavage was analyzed in a 
12.5% Polyacrylamide gel (lanes 1 to 20). Lane 1 corresponds to the bottom fraction of the gradient. Lane a contains 2 u.1 of (3;iS]methionine-Ia-
beled in vitro translation products of M-RNA not further treated. Lane b contains the same polypeptides which were incubated for 1.5 h at 
30°C with 2 (JLI of S30 fraction from B-component-inoculated protoplasts. Lane c is as lane b, but the S30 fraction was preincubated on ice for 
42 h after addition of glycerol to a final concentration of 20% (vol/vol). Lanes d and e contain [vsS]methionine-labeled proteins of B-
component-inoculated (lane d) and noninoculated {lane e) protoplasts. Numbers indicated to the left of the gel refer to the molecular weights 
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FIG. 4—Continued 
of the in vitro translation products of M-RNA and the polypeptides generated by the proteolytic activity. Numbers to the right of the gel refer 
to the molecular weights of some of the B-RNA-encoded polypeptides. (B and C) Equal amounts (150 .^1) of the glycerol gradient fractions 
were incubated either with a mixture of anti-32K and anti-VPg sera (B) or with anti-170K serum (C) in TKE-TDS buffer, and the 
immunoprecipitates were analyzed in 12.5% Polyacrylamide gels. Each gel includes lanes containing the unfractionated [33S]methionine-
labeled S30 fraction of B-component-infected protoplasts (input, lane a) and immunoprecipitates of unfractionated S30 fraction obtained with 
anti-VPg and anti-32K sera (lane b) or with anti-170K serum (lane c) in TKE-TDS buffer. Numbers indicated at both sides of the gels refer to 
the molecular weights of the viral polypeptides. The~number of crosses below the gel indicates the amount of proteolytic activity in the 
fractions, as deduced from (A). 
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FIG. 5. Model for the proteolytic processing and complexation of the CPMV RNA-encoded polypeptides. After the primary cleavage of 
the B-RNA-encoded. 200K (200) polyprotein, 32K (32) and 170K (170) polypeptides remain tightly bound in a complex in which the 32K 
polypeptide is responsible for the cleavage of the (95K [95] and 105K [105]) primary translation products from M-RNA. Further cleavage of 
the 170K polypeptide follows two different pathways (20). resulting in the release of either the 87K (87) polypeptide or the 110K (110) 
polypeptide from the complex. The 60K (60) polypeptide is the direct precursor to VPg (28), and the 110K polypeptide has recently been 
detected in the viral replication complex and might represent an RNA-dependent RNA polymerase (L. Dorssers. S. van der Krol, J. van der 
Meer, A. van Kammen, and P. Zabel, submitted for publication). VPg is supposed to be involved in viral RNA replication by acting as a 
primer (7. 28) and might be directly linked to nascent RNA chains. Open reading frames in both RNAs are indicated with double-lined bars, 
and the polyadenylated tails are indicated with a zigzag line. VPg is indicated with a black box. 58. 48, and 84 indicate polypeptides of 58K, 
48K, and 84K. respectively. 
Glycerol gradient centrifugation of the proteolytic activity. 
Complexation of the 32K polypeptide to other B-RNA-
encoded polypeptides was confirmed and further investigat-
ed by glycerol gradient centrifugation of the S30 fraction 
from protoplasts inoculated with B-RNAs and labeled with 
[35S]methionine. In a 5-ml linear 10 to 30% (vol/vol) glycerol 
gradient made up in TKE-TDS buffer and run for 17 h at 4°C 
and 48,000 rpm in a Beekman SW50 rotor, 32K. polypeptides 
sedimented as free proteins to approximately the middle of 
the gradient (lanes 4 through 6, Fig. 3A). When a similar 
gradient was made up in TK.E buffer only (i.e., buffer 
without detergents), the 32K polypeptides sedimented faster 
(lanes 1 through 5 from the bottom, Fig. 3B). Under these 
conditions, the 32K polypeptides were apparently associated 
with the cosedimenting 58K, 60K, 84K, and 170K polypep-
tides, which, indeed, were all coprecipitated by anti-32K 
serum. Since in this gradient a slight separation was obtained 
between the 170K polypeptides on the one hand (peak 
fractions 1 through 3 [Fig. 3, lanes 1 through 3]) and the 84K, 
60K and 58K polypeptides on the other hand (peak fractions 
2 through 5 [Fig. 3, lanes 2 through 5]) a longer and less steep 
glycerol gradient volume of 11 ml (15 to 30% [vol/vol] 
glycerol, Beekman SW41 rotor) was run with the purpose of 
optimizing this separation and for assaying the separated 
complexes for protease activity. Again, no detergents were 
present in the gradient, but for obtaining a complete picture 
of the position of the viral proteins throughout the gradient. 
and not only of those proteins associated with 32K polypep-
tides, immunoprecipitations with anti-32K, anti-VPg, and 
anti-170K sera were carried out in buffer containing deter-
gents (TKE-TDS). In this gradient, the protease activity 
sedimented into lanes 5 through 12 (Fig. 4A) from the 
bottom, with the main activity confined to lanes 6 through 9 
(Fig. 4A). Screening of the gradient fractions with a mixture 
of anti-VPg and anti-32K sera (Fig. 4B) or with anti-170K 
serum (Fig. 4C) indicated that the protease-containing frac-
tions all contained 32K polypeptide (Fig. 4B). The 84K and 
60K polypeptides (Fig. 4B) and the 110K and 87K polypep-
tides (Fig. 4C) were mainly present in lanes 9 through 12 
(Fig. 4B and C) and appeared not to be responsible for the 
(main) protease activity. The occurrence of the 170K. poly-
peptide in lanes 6 through 9 (Fig. 4B and C), however, 
corresponded strikingly to the peak of the protease activity 
in the gradient (cf. A, B, and C in Fig. 4), although this 
polypeptide could not be detected in lanes 11 and 12, which 
contained minor proteolytic activity. On the other hand, the 
broad sedimentation profile of the 32K polypeptide which 
must be caused by separate association to either 170K 
polypeptides (lanes 5 through 9) or to the smaller 84K, 60K, 
and 58K polypeptides (lanes 9 through 13), respectively, did 
not nicely fit with the protease activity profile. Lanes 6 
through 9 (with most of the activity) and lanes 10 through 12 
(with significantly less activity) contained approximately 
equal amounts of 32K polypeptide (Fig. 4B). Therefore, it 
seems that not all 32K polypeptide molecules possessed 
proteolytic activity. A possible explanation for this finding 
will be discussed below. 
DISCUSSION 
As was first shown by Pelham (16), in vitro translation 
products from B-RN A possess a proteolytic activity which is 
capable of cleaving the 95K and 105K. primary translation 
products from M-RNA. Later experiments (4) demonstrated 
that one of the cleavage products represents a specific 
precursor to both capsid proteins VP37 and VP23. Since 
upon in vitro translation of B-RNA only the 32K and 170K 
polypeptides are produced (8, 16), it can be deduced that 
either the 32K or the 170K polypeptide possesses the 
proteolytic activity involved. The protease inhibition studies 
presented in this report provide evidence that the 32K 
polypeptide represents the protease in question. The proteo-
lytic cleavage of the M-RNA-encoded 95K and 105K poly-
peptides by extract from B-component-inoculated proto-
plasts is efficiently inhibited by antiserum raised against the 
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32K polypeptide, but not by anti-170K, anti-VPg, or preim-
mune sera (Fig. 1). Further experiments, in which the 
reactivity of these antisera was analyzed under conditions 
where this inhibition was tested, demonstrated, however, 
that care should be taken from directly drawing conclusions 
from such experiments. Anti-32K immunoglobulins ap-
peared to bind to 32K polypeptides associated in complexes 
with 58K, 60K, 84K, and 170K polypeptides. The binding of 
heterologous viral polypeptides, apparently present in pro-
tein aggregates, has also been reported for poliovirus with 
antiserum directed against the polioviral protease (10). Addi-
tional experiments, in which proteolytic extract from B-
component-inoculated cells was fractionated in glycerol gra-
dients, demonstrated that the protease activity can only be 
correlated with 32K polypeptides or uncleaved 170K poly-
peptides. Therefore, two possibilities still remain: the prote-
ase activity resides either in the 170K precursor polypeptide 
or in the 32K polypeptide. For several reasons the first 
possibility seems to be unlikely, (i) If the 170K polypeptide is 
proteolytically active, then one might expect that, in analogy 
with, for instance, the animal picornaviruses (9, 10, 14, 15). 
one of the cleavage products from this precursor represents 
the mature protease. There is no evidence for such a mature 
protease, however. The experiments shown in Fig. 2 and 4 
indicate that none of the 110K, 87K, 84K, or 60K polypep-
tides possess significant proteolytic activity, (ii) Anti-VPg 
immunoglobulins which are capable of reacting with the 
170K (and 60K) polypeptides under nondenaturing condi-
tions (Fig. 2) do not interfere with the proteolytic cleavage. 
Therefore, it is reasonable to propose that the 32K polypep-
tide represents the protease. Indeed, antiserum raised 
against this polypeptide efficiently inhibits the proteolytic 
activity {Fig. 1). Although other viral polypeptides were 
associated with the 32K polypeptides which might have been 
blocked in their function by the binding of IgG molecules to 
the 32K polypeptide, it should be noted that the antibody-
antigen complexes were not removed from the protease 
reaction mixture. The possibility that the 32K polypeptide is 
an activator of a cellular enzyme can readily be excluded by 
the observation that the proteolytic activity also resides in 
the in vitro product from B-RNA (16). A puzzling observa-
tion is that not all 32K polypeptides appear to be active 
molecules. Only 32K polypeptides associated with 170K. 
polypeptides seem to be involved in the proteolytic cleavage 
of the M-RNA-encoded primary translation products (cf. 
Fig. 4A and B). A possible explanation for this phenomenon 
is that the 32K polypeptides connected to 170K polypeptides 
represent newly synthesized molecules which are freshly 
cleaved from the 200K primary translation product. The 32K 
polypeptides associated with the 84K, 60K, or 58K polypep-
tides may represent significantly older molecules, which 
may have lost much of their activity. Indeed, in vitro 
cleavage of the 200K primary translation product into the 
32K and 170K polypeptides occurs as soon as the 200K 
polypeptide chain has been completed, whereas further 
cleavage of the 170K polypeptide into the 110K. 87K, 84K, 
and 60K polypeptides takes, at least in vitro, a significantly 
longer period of time, with the first cleavage products only 
visible after 6 to 8 h (H. Franssen, unpublished data). 
The information available suggests the following pathway 
of the B-RNA-encoded polypeptides (Fig. 5): soon after its 
synthesis, the 200K primary translation product is cleaved 
into the 32K and 170K polypeptides, which remain associat-
ed after cleavage. The 32K polypeptide is the protease 
involved in the cleavage of the primary translation products 
of M-RNA, and its activity decreases over the course of 
time. Further cleavage of the 170K polypeptide occurs at a 
slower rate, giving rise to complexes consisting of the 32K 
polypeptide, with decreased activity, and 84K, 60K, or 58K 
polypeptides. The 110K and 87K polypeptides, which are 
cleaved from the COOH-terminal part of the 170K polypep-
tide (5), do not remain in the complexes but are released 
(Fig. 2). It should be mentioned, however, that the viral 
protein complexes described here have been found in the 
S30 fractions, whereas considerable amounts of the 58K and 
60K polypeptides have been found in the membrane fraction 
(i.e., 30,000 x g pellet fraction) of infected cells (7, 28). 
Therefore, to obtain a complete picture of the viral protein 
complexes in infected cells, additional studies on this mem-
brane fraction are necessary. The 32K polypeptide is proba-
bly not the only protease involved in the proteolytic process-
ing of the viral polyproteins. According to the mapping of the 
coding sequences of VP37 and VP23 on the M-RNA se-
quence (27), the cleavage site of the 32K polypeptide should 
be the dipeptide sequence glutamine-methionine. The cleav-
age site used to release VP37 and VP23 from their 60K. 
precursor (4), however, is a glutamine-glycine sequence (27). 
Therefore, at least a second (plant or viral?) protease should 
be involved in the generation of the M-RNA-encoded poly-
peptides. The cleavage sites used for the processing of the B-
RNA-encoded polyprotein remain to be elucidated, and 
information about the nature of the protease charged with 
the cleavage of this protein is also not available. 
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ABSTRACT 
The amino-terminal and carboxy-terminal amino acid sequences of the two 
capsid proteins VP37 and VP23 of cowpea mosaic virus have been analysed. 
The results allow the mapping of the coding regions for VP37 and VP23 on 
the middle-component (M) RNA using the nucleotide sequence data of Van 
Wezenbeek et al. (EMBO J., 2, 941-946, 1983). These regions are 
contiguous and indicate that the cleavage sites used to release VP37 
and VP23 from the primary translation products of M RNA are a glutamine-
methionine and a glutamine-glycine dipeptide sequence, respectively. 
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INTRODUCTION 
Cowpea mosaic virus (CPMV), typemember of the comoviruses, has a 
bipartite positive-stranded RNA genome, divided between two components, 
the bottom (B) and middle (M) component (for a review see Bruening, 
1977, 1981). Both B and M RNA are supplied with a protein, called VPg, 
at their 5' end (Daubert et al., 1978; Stanley et al., 1978) and a 
poly(A) track at their 3' end (El Manna and Bruening, 1973; Ahlquist 
and Kaesberg, 1979). Both B and M particles have identical capsids 
made up of 60 copies of two different proteins, denoted VP37 (mol. 
weight 37,000) and VP23 (mol. weight 23,000). Genetic (Wood, 1972; 
Gopo and Frist, 1977) as well as biochemical (Franssen et al., 1982) 
data have indicated that the coat proteins are encoded by the M RNA. 
in vitro translation studies have revealed that M RNA is translated 
into two overlapping 105K and 95K polyproteins (Pelham 1979; Goldbach 
et al., 1981) which both contain the sequences of the capsid proteins 
(Franssen et al., 1982). These polyproteins are cleaved into products 
with sizes of 48K, 58K and 60K (Franssen et al., 1982) by the recently 
identified 32K protease encoded by B-RNA (Franssen et al., 1984). 
The 60K cleavage product is derived from the carboxy-terminal half 
of the 105K and the 95K polypeptides and represents the direct precur-
sor of the capsid proteins, VP37 and VP23 (Franssen et al., 1982). 
Since the complete nucleotide sequence of M RNA has recently been 
elucidated (Van Wezenbeek et al., 1983) it has now become possible to 
map the capsid proteins exactly on the M RNA. For this purpose the 
amino acid composition of VP37 and VP23 was determined and the amino-
terminal and carboxy-terminal amino acid sequences of these proteins 
were analysed. The information obtained reveals the presence of two 
different proteolytic cleavage sites in the primary translation pro-
ducts of M RNA. Parts of the results described here, have briefly been 
mentioned in a previous paper (Van Wezenbeek et al., 1983). 
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MATERIALS AND METHODS 
Virus purification and top component isolation. 
CPMV was grown in Vigna unguioutata L. (California Blackeye) and 
purified by butanol-chloroform extraction (Steere, 1956). Virus was 
precipitated with polyethyleenglycol/NaCl (Van Kammen, 1967), resus-
pended in sodium phosphate buffer (pH 7.2) and layered on a 50% 
sucrose cushion in the same buffer. The virus was pelleted by centri-
fugation in a Beekman Ti60 rotor for 16 h. at 30,000 rpm and 4°C. 
Top (T) components were separated from B and M components by zonal 
centrifugation in a linear 15 to 30% sucrose gradient (Beekman Ti 15 
rotor, 16 h., 23,000 rpm at 10°C). T components thus obtained were 
dialysed against distilled water and lyophilised. 
Carboxymethylation of purified virus. 
Virus particles were disintegrated in guanidium chloride-LiCl according 
to Wu (1970). The precipitated nucleic acid was removed by low-speed 
centrifugation and the dissociated capsid proteins present in the 
supernatant were then subjected to carboxymethylation with iodoacetamid 
as described by Wu (1970) and Geelen (1974). 
Separation of oarboxymethylated aapsid proteins. 
Thirty mg of lyophylised, carboxymethylated proteins were dissolved in 
6 M urea and applied to a Sephadex G-200 column (100 x 1.5 cm). Proteins 
were separated by elution with 5 M urea (flow rate of 2 ml/h). Fractions 
containing proteins were located by measuring the optical density at 
280 nm..The protein content of these fractions was analysed in 15% SDS 
Polyacrylamide gels (Laemmli, 1970; Franssen et al., 1982) and visua-
lised by silverstaining (Morrissey, 1981). Fractions containing respec-
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tively VP37 and VP23 were separately pooled and dialysed extensively 
against distilled water, which resulted in precipitation of the pro-
teins. The precipitated protein was collected by centri f ligation, 
lyophilised and stored at -80°C. 
Determination of amino aoid oomposition. 
Carboxymethylated VP37 and VP23 were hydrolysed with 6N HCl (constant 
boiling) in evacuated sealed tubes for 20-24 h at 110°C. Amino acid 
analyses were performed on a Kontron Liquimat 111 amino acid analyser 
as described by Vereijken et al. (1982). 
Determination of amino-terminal amino aoid sequences. 
Samples of protein were dissolved in 70% formic acid and subjected to 
automatic Edman degradation in a Beekman spinning cup model 890C pro-
tein sequenator using a program adapted from Brauer et al. (1975) with 
the modifications according to Hunkapiller and Hood (1978). The ami no-
terminal residues were removed in heptafluorobutyric acid (HFBA) and 
the phenylthiohydantoin derivatives of amino acids were analysed by 
high-performance liquid chromatography (Lichro Sorb. Si60-10 Merck) as 
described by Frank and Strubert (1973). 
Isolation of an amino-terminal peptide from VP37. 
Since the amino-terminal methionine residue in VP37 is acetylated 
(Bruening, 1981) this protein can not directly be subjected to Edman 
degradation. In an effort to characterise the amino-terminal sequence 
of VP37 an amino-terminal oligopeptide from this protein was isolated. 
Five to ten mg of purified carboxymethylated VP37 was digested with 
50 pg of chymotrypsin for 20 h. at 25°C. The digest was then adjusted 
to pH 3 with acetic acid and applied to a Dowex 50W-X8 column ( 5 x 1 cm) 
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equilibrated with 0.1 M acetic acid (Narita et al., 1975). The eluate 
containing the blocked ami no-terminal oligopeptide was lyophilised and 
the residue was resuspended in 6N HCl. Complete hydrolysation was 
achieved by incubating at 110°C for 24 h. The amino acid composition 
of the amino-terminal chymotryptic peptide was then determined as des-
cribed above. 
Digestion with, oavboxypeptidase Ï. 
Samples of protein were dissolved in 0.1 M ammonium acetate (pH 5.5), 
0.01% SDS and incubated with 50 yg/ml carboxypeptidase Y, according to 
Hayashi (1977). Carboxypeptidase Y (Worthington) freshly dissolved in 
distilled water to a concentration of 1 mg/ml was used. In each experi-
ment the protein-enzyme ratio was approximately 50:1 (w/w). The mixture 
was incubated at 25°C and samples were taken after 0.5, 1 and 2 h of 
incubation. Undigested peptide chains were precipitated in 2% sulpho-
salicylic acid at 4°C and removed by centrifugation. The supernatant 
fractions containing the released amino acids were diluted with lithium 
citrate to a final concentration of 0.12 M, corresponding to a pH of 
approximately 1.9, and applied to a Biotronik LC 6000 E amino acid 
analyser (Durrum - DC6a cationion exchange resin, packaged in lithium 
citrate buffer pH 2.8). Norleucine was included as internal standard. 
Elution of the amino acids was performed in a discontinuous lithium 
citrate buffer system as described by Hamilton (1963) and Benson (1973). 
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RESULTS 
Purification and séparation of oarboxymethylated VP27 and VP23. 
CPMV caps id proteins were properly separated after carboxymethylation 
and gelfiltration on a Sephadex G200 column in 5M urea (Fig. 1, 
panel A). Upon SDS-polyacrylamide gelelectrophoresis of the purified 
carboxymethylated proteins it appeared that the carboxymethylated 
VP37 ran significantly slower than the untreated protein. This might 
indicate a relatively high content of cysteine residues in VP37. The 
column fractions with carboxymethylated VP23 contained a mixture of 
at least two forms of this protein, designated VP23 (intact protein) 
and VP20, respectively (Fig. 1, panel B) the relative amounts of 
which depended on the age of the virus preparations used. It has been 
shown that this heterogeneity of the small capsid protein is due to the 
loss of a specific carboxyterminal sequence. (Geelen et al. , 1972; 
Kridl and Bruening, 1983). 
Amino-terminal amino aaid 8equenoes of VP23 and VPS7. 
Since the amino-terminal of VP37 is blocked and the size heterogeneity 
of VP23 only occurs at the carboxy-terminal of this polypeptide (Geelen 
et al., 1972; Kridl and Bruening, 1983) the amino-terminal amino acid 
sequence of VP23 could be determined by Edman degradation applied to 
purified top components. Such Edman degradation resulted indeed in a 
single unambiguous amino acid sequence. Inspection of the nucleotide 
sequence of the open reading frame in M RNA (Van Wezenbeek et al. , 
1983) revealed that this amino acid sequence matched the sequence from 
nucleotide 2660 downstream (Fig. 2, sequences underlined ). 
Assuming that the coding region of VP23 extends from this position to 
the end of the open reading frame at nucleotide 3299, the size of this 
protein would be 23.6K. This in agreement with the experimental deter-
mined size for this protein and supports the mapping of the amino-
terminal amino acid of VP23 at nucleotide 2660 of M RNA. In vitro 
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Fig. IA: Elution profile of carboxymethylated capsid proteins from 
CPMV on a Sephadex G-200 column (100 x 1.5 cm). Elution was performed 
in 5 M urea. Profiles were obtained by measuring the optical density 
at 280 nm. 
Fig. IB: Gel electrophoretic analysis of the protein content of the 
Sephadex G-200 column fractions. The numbers at the top of the gel 
correspond to the numbers of the fractions in panel A. The marker lane 
(M) contains bovine serum albumine (68K) and ovalbumine (46K). The 
lane indicated with CP contains unfractionated, non-carboxymethylated 
capsid proteins. Protein bands were visualised by silverstaining. The 
background bands in the gel around 55K and 68K are probably due to the 
staining method (Morrissey, 1981; Dorssers, 1983; Tasheva and Dessev, 
1983; Ochf, 1983; Dorssers et al. , 1984). 
translation studies have indicated that within the overlapping primary 
translation products of M RNA the VP37 sequence precedes the sequence 
of VP23 (Franssen at al. , 1982). As the ami no-terminal end of VP37 is 
known to be an aminoacetylated methionine residue (Bruening, 1981) and 
with the amino-terminal end of VP23 now being mapped, it has become 
possible to make a bid for the AUG codon within the open reading frame 
of M RNA, which might be coding the amino-terminal methionine of VP37. 
In the M RNA sequence there are only two AUG codons at positions which 
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allow a size for VP37 approximating its apparent molecular weight. 
These triplets are found at nucleotide positions 1537 and 1649 and 
would result in VP37 molecules with sizes of 41.2K and 37.2K respec-
tively. In order to discriminate between these two possibilities VP37 
was digested with chymotrypsin. The blocked ami no-terminal peptide 
was isolated by chromatography on a Dowex 50W-X8 column and analysed 
for its amino acid composition. Inspection of the M RNA sequence (Van 
Wezenbeek et al. , 1983) learns that if the methionine residue corres-
ponding to nucleotide position 1537 represents the ami no-terminal amino 
acid of VP37, the amino-terminal blocked chymotryptic peptide is expec-
ted to contain methionine, glutamic acid, glutamine, asparagine, leucine 
and phenylalanine in approximately equal amounts. On the other hand, 
if the methionine of position 1649 represents the ami no-terminal residue 
this peptide should contain methionine, alanine, glycine, aspartic acid, 
valine, leucine, glutamic acid and tyrosine in a 1:1:2:2:1:2:1:1 ratio, 
respectively. The experimentally determined amino acid composition 
(Table I) reveals that the blocked chymotryptic peptide mainly consists 
Table I. Amino acid composition of the chymotryptic peptide from the 
amino-terminal end of VP37. 
Amino acid 
glutamic acid/glutamine 
aspartic acid/asparagine 
glycine 
leucine 
phenylalanine 
nmol/100 pi* 
3.8 
2.7 
2.3 
2.2 
1.9 
* Portions of 100 pi of the hydrolysed chymotryptic peptide dissolved 
in 0.12 M lithiumcitrate pH 1.8-2.0, were used for determining the 
amino acid composition. For details see Materials and Methods. 
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of glutamic acid, aspartic acid, glycine, leucine and phenylalanine 
residues, in a ratio of roughly 2:1:1:1:1. Since the detected glutamic 
acid and aspartic acid residues may have arisen from glutamine and 
asparagine respectively by the acidic hydrolysis procedure, this 
result indicates that if the methionine of position 1537 represents 
the first amino acid of VP37 five out of the six expected amino acid 
residues are recovered (Fig. 2, sequences underlined ). On the 
other hand, if the methionine residue of position 1649 would represent 
the ami no-terminal amino acid of VP37 only four out of eight expected 
amino acids are found. In addition the relative amounts in which the 
amino acids are found clearly disagree with the latter possibility. 
Therefore it is reasonable to conclude that the coding region of VP37 
starts with the AUG triplet of position 1537. 
Amino aaid composition of purified VPZ7 and VP23. 
To verify the mapping of both VP37 and VP23 on M RNA the amino acid 
composition of both proteins was determined and compared with the 
composition of these proteins derived from the nucleotide sequence of 
the open reading frame in M RNA (Table II). The good agreement between 
the experimental values (Table II, lane A) and the theoretical values 
(lane B) confirm the mapping of VP37 and VP23 with their amino termini 
on position 1537 and 2660, respectively. 
Analyses of the carboxy-terminal amino aaid sequences of VP23 and VP37. 
To obtain additional evidence that the cistron for VP23 continues as 
far as the stopcodon at the end of the open reading frame of M RNA, 
the carboxy-terminal amino acids of VP23 were determined by limited 
digestion with carboxypeptidase Y. 
VP23 is known to be heterogeneous in size due to the loss of a 
carboxy-terminal peptide (wu and Bruening, 1972; Geelen et al., 1972; 
Siler et al., 1976; Kridl and Bruening, 1983). This nibbling at the 
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Table II: Amino acid composition of the capsid proteins of CPMV: a 
comparison of the amino acid composition determined experi-
mentally (lane A) and derived from the nucleotide sequence 
of M RNA (lane B). 
VP37 VP23 + VP20D 
amino 
asp + 
thr 
ser 
glu + 
pro 
giy 
ala 
val 
met 
ile 
leu 
tyr 
phe 
his 
lys 
arg 
trp 
cys 
acid 
asn 
gin 
A 
10.5* 
8.4 
8.8 
8.4 
4.6 
8.9 
6.7 
6.9 
3.0 
5.1 
8.2 
2.8 
5.9 
1.4 
3.7 
4.7 
N.D. 
2.0t 
B 
10.2 
8.6 
8.8 
7.0 
3.7 
8.0 
6.4 
7.0 
2.9 
5.9 
8.3 
2.7 
5.6 
1.3 
4.0 
4.3 
N.D. 
2.9 
A 
12.0 
6.7 
8.3 
8.6 
8.3 
7.6 
7.4 
7.1 
2.7 
4.7 
5.5 
2.5 
5.9 
1.2 
2.2 
4.5 
N.D. 
4.7t 
B 
11.7 
7.0 
7.0 
7.5 
8.9 
5.6 
8.4 
8.0 
3.3 
5.6 
4.7 
2.4 
6.6 
1.4 
2.4 
5.6 
N.D 
1.4 
* presented as mol percentages. 
t detected as carboxymethylated cysteine residue 
n the small capsid protein preparation was a mixture of VP23 and VP20 
in roughly 1:1 ratio. 
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carboxy-terminal end mainly results in a shortened polypeptide of 
approximately 20K, in this paper referred to as VP20. Due to this 
heterogeneity, digestion of VP23 with carboxypeptidase Y is expected 
to produce a complex mixture of amino acids. The protein preparation 
used for carboxypeptidase Y digestion contained the two forms of the 
small capsid protein in approximately 1:1 ratio, as determined by 
SDS-Polyacrylamide gelelectrophoresis (results not shown). 
Table III shows that carboxypeptidase Y digestion of this prepara-
tion mainly released two amino acid species: alanine and leucine in 
approximately equal amounts. Alanine matches the triplets at the very 
end of the reading frame of M RNA, where two adjoining codons for 
alanine are present (Fig. 2, sequences underlined ). Therefore, 
these alanine residues probably originates from the carboxy terminal 
end of VP23. Upstream in the VP23 coding region the first leucine 
codons are found at nucleotide positions 3225 and 3228. Since the 
Table III. Amino acids released from the carboxy termini of the CPMV 
capsid proteins upon incubation with carboxypeptidase Y. 
Amino acid 
alanine 
leucine 
valine 
methionine 
phenylalanine 
glycine 
isoleucine 
glutamic acid/glutamine 
VP23/VP20 
4* 
4 
2.5 
1 
1 
1.5 
-
-
VP37 
1.5 
1.2 
-
-
-
1.8 
0.4 
0.8 
* The numbers indicate nmols per 100 ul reaction mixture. 
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digestion mixture contained alanine and leucine in about 1:1 ratio 
it is probable that the leucine originated from the carboxy terminal 
of VP20 molecules ending with the leucine-residues encoded by codons 
at positions 3225 or 3228 (Fig. 2, sequences underlined • - ) . 
Since carboxypeptidase Y is not capable of releasing proline at 
carboxyl ends in a polyproline sequence (Hayashi, 1977) further release 
of residues upstream of these two leucine residues is not expected. 
The small amounts of valine, glycine and methionine detected among the 
released amino acids (Table III, lane VP23) may be due to a contamina-
tion with one or more polypeptides with a chain length between those 
of VP20 and VP23. 
Carboxypeptidase Y digestion of VP37 revealed the presence of 
glycine, alanine, leucine, glutamic acid/glutamine and isoleucine 
residues at the carboxyterminus of this capsid protein. (Table III, 
lane VP37). Since these amino acids can all be mapped on the M RNA 
nucleotide sequence in a short region preceding the coding region of 
VP23 (Fig. 2, sequences underlined - - • • - ) , this finding confirms that 
the coding regions VP37 and VP23 are contiguous. 
Fig. 2: Mapping of the carboxy-terminal and amino-terminal ends of 
VP37 and VP23 on the amino acid sequence derived from the open reading 
frame in CPMV-M RNA. The underlined sequence ( ) of the first eleven 
amino acids at the amino-terminal end of VP23 was determined by Edman 
degradation. 
The amino acids underlined by the broken lines ( ) were detected in 
the hydrolysate of the blocked chymotryptic oligopeptide from the 
amino-terminal end of VP37. 
The amino acids released from the carboxy-terminal end of VP37 by limi-
ted digestion with carboxypeptidase Y are underlined with , ,.._ . 
The amino acids released from the carboxy-terminal ends of VP23 and VP20 
by limited digestion with carboxypeptidase Y are underlined by 
and- ; respectively. 
The nucleotide sequence of M-RNA was taken from Van Wezenbeek et al., 
(1983). For details see the text. 
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F V P 3 7 AG CAA AAC UUG UUU GCC CUU UCU aap pro arg aen guy am vai. aui pne pro gm ipst glu gin aenleu phe ala leu eer 
1565 UUG GAU GAU ACA AGC UCA GUU CGU GGU UCU UUG CUU GAC ACA AAA UUC GCA CAA ACU CGA 
leu aep aap thr eer »er val arg gly eer leu leu aep thr lye phe ala gin thr arg 
1625 GUU UUG UUG UCC AAG GCU AUG GCU GGU GGU GAU GUG UUA UUG GAU GAG UAU CUC UAU GAU 
Val leu leu eer lye ala net ala gly gly aep val leu leu aep glu tyr leu tyr asp 
1685 GUG GUC AAU GGA CAA GAU UUU AGA GCU ACU GUC GCU UUU UUG CGC ACC CAU GUU AUA ACA 
val val oen gly gin aep phe arg ala thr val ala phe leu arg thr hie val He thr 
1745 GGC AAA AUA AAG GUG ACA GCU ACC ACC AAC AUU UCU GAC AAC UCG GGU UGU UGU UUG AUG 
gly lye ile lye val thr ala thr thr asn ile eer aep aen eer gly aye aye leu met 
1805 UUG GCC AUA AAU AGU GGU GUG AGG GGU AAG UAU AGU ACU GAU GUU UAU ACU AUC UGC UCU 
leu ala ile oen eer gly val arg gly lys tyr eer thr asp val tyr thr ile aye eer 
1865 CAA GAC UCC AUG ACG UGG AAC CCA GGG UGC AAA AAG AAC UUC UCG UUC ACA UUU AAU CCA 
gin aep eer met thr tvp aen pro gly aye lys lye aen phe eer phe thr phe aen pro 
1925 AAC CCU UGU GGG GAU UCU UGG UCU GCU GAG AUG AUA AGU CGA AGC AGA GUU AGG AUG ACA 
aen pro aye gly aep eer tvp eer ala glu met ile eer arg eer arg val arg met thr 
1985 GUU AUU UGU GUU UCG GGA UGG ACC UUA UCU CCU ACC ACA GAU GUG AUU GCC AAG CUA GAC 
val ile eye val eer gly trp thr leu eer pro thr ihr aap val ile ala lye leu aap 
2045 UGG UCA AUU GUC AAU GAG AAA UGU GAG CCC ACC AUU UAC CAC UUG GCU GAU UGU CAG AAU 
trp aer ile val aen glu lye oye glu pro thr ile tyr hie leu ala aep aye gin aen 
2105 UGG UUA CCC CUU AAU CGU UGG AUG GGA AAA UUG ACU UUU CCC CAG GGU GUG ACA AGU GAG 
trp leu pro leu aen arg trp met gly lye leu thr phe pro gly gly val thr eer glu 
2165 GUU CGA AGG AUG CCU CUU UCU AUA GGA GGC GGU GCU GGU GCG ACU CAA GCU UUC UUG GCC 
val arg arg met pro leu eer ile gly gly gly ala gly ala thr gin ala phe leu ala 
2225 AAU AUG CCC AAU UCA UGG AUA UCA AUG UGG AGA UAU UUU AGA GGU GAA CUU CAC UUU GAA 
aen met pro aan aer trp ile aer met trp arg tyr phe arg gly glu leu hie phe glu 
2285 GUU ACU AAA AUG AGC UCU CCA UAU AUU AAA GCC ACU GUU ACA UUU CUC AUA GCU UUU GGU 
val thr lye mat ear aer pro tyr ile lya ala thr val thr phe leu ile ala phe gly 
2345 AAU CUU AGU GAU GCC UUU GGU UUU UAU GAG AGU UUU CCU CAU AGA AUU GUU CAA UUU GCU 
aan leu aer aap ala phe gly phe tyr glu eer phe pro hie arg ile val gin phe ala 
2405 GAG GUU GAG GAA AAA UGU ACU UUG GUU UUC UCC CAA CAA GAG UUU GUC ACU GCU UGG UCA 
glu val glu glu lye aye thr leu val phe eer gin gin glu phe val thr ala trp eer 
73a 
2465 ACA CAA GUA AAC CCC AGA ACC ACA CUU GAA GCA GAU GGU UGU CCC UAC CUA UAU GCA AIM 
thr gin val aan pro org the thr leu glu ala aep gly oya pro tyr leu tyr ala ile 
2525 AUU CAU GAU AGU ACA ACA GGU ACA AUC UCC GGA GAU UUU AAU CUU GGG GUC AAG CUU GUU 
il» hia aap aar thr thr gly thr ile eer gly aap phe aan leu gly val lye leu val 
2585 GGC AUU AAG GAU UUU UGU GGU AUA GGU UCU AAU CCG GGU AUU GAU GGU UCC CGC UUG CUU 
gly ile lya aap phe oya gly ile gly eer ana pro gly ile aap gly eer arg leu leu 
— » V P 2 3 
2645 GGA GCU AUA GCA CAA GGA CCU GUU UGU GCU GAA GCC UCA GAU GUG UAU AGC CCA UGU AUG 
gly ala ile ala gin gly pro val eye ala glu ala eer aap val tyr eer pro oya met 
2705 AUA GCU AGC ACU CCU CCU GCU CCA UUU UCA GAC GUU ACA GCA GUA ACU UUU GAC UUA AUC 
ile ala aar thr pro pro ala pro phe aer aap val thr ala val thr phe aap leu ile 
2765 AAC GGC AAA AUA ACU CCU GUU GGU GAU GAC AAU UGG AAU ACG CAC AUU UAU AAU CCU CCA 
aan gly lya ile thr pro val gly aap aap aan trp aan thr hia ile tyr aan pro pro 
2825 AUU AUG AAU GUC UUG CGU ACU GCU GCU UGG AAA UCU GGA ACU AUU CAU GUU CAA CUU AAU 
ile mat aan val leu arg thr ala ala trp lya aer gly thr ile hia val gin leu aan 
2885 GUU AGG GGU GCU GGU GUC AAA AGA GCA GAU UGG GAU GGU CAA GUC UUU GUU UAC CUG CGC 
val arg gly ala gly val lya arg ala aap trp aap gly gin val phe val tyr leu arg 
2945 CAG UCC AUG AAC CCU GAA AGU UAU GAU GCG CGG ACA UUU GUG AUC UCA CAA CCU GGU UCU 
gin aer met aan pro glu aer tyr aap ala arg thr phe val ile aer gin pro gly aer 
3005 GCC AUG UUG AAC UUC UCU UUU GAU AUC AUA GGG CCG AAU AGC GGA UUU GAA UUU GCC GAA 
ala met leu aan phe aer phe aap ile ile gly pro aan aer gly phe glu phe ala glu 
3065 AGC CCA UGG GCC AAU CAG ACC ACC UGG UAU CUU GAA UGU GUU GCU ACC AAU CCC AGA CAA 
aer pro trp ala aan gin thr thr trp tyr leu gly oya val ala thr aan pro org gin 
3125 AUA CAG CAA UUU GAG GUC AAC AUG CGC UUC GAU CCU AAU UUC AGG GUU GCC GGC AAU AUC 
ile gin gin phe glu val aan met arg phe aap pro aan phe arg val ala gly aan ile 
V P 2 0 1 — , 
3185 CUG AUG CCC CCA UUU CCA CUG UCA ACG GAA ACU CCA CCG UUA UUA AAG UUU AGG UUU CGG 
leu met pro pro phe pro leu eer thr glu thr pro pro leu leu lya phe arg phe arg 
V P 2 3 « — I 
3245 GAU AUU GAA CGC UCC AAG CGU AGU GUU AUG GUU GGA CAC ACU GCU ACU GCU GCUjUAA 
aap ile glu arg aer lya arg aer val met val gly hia thr ala thr ala ala 
3002 CUCUGGUUUCAUUAAAUUUUCUUUAGUUUGAAUUUACUGUUAUUUGGUGUGCAUUUCUAUGUUUGGUGAGCGGUUUUCU 
GUGCUCAGAGUGUGUUUAUUUUAUGUAAUUUAAUUUCUUUGUGAGCUCCUGUUUAGCAGGUCGUCCCUUCAGCAAGGAC 
ACAAAAAGAUUUUAAUUUUAUU-poly(A) 
73b 
DISCUSSION 
Previous translation studies have demonstrated that the capsid proteins 
of CPMV are produced by processing of a 60K precursor protein derived 
from the C-terminal halves of the primary translation products from 
M RNA (Franssen et al., 1982). The amino acid analyses described in 
this paper allow a more precise mapping of the coding region of VP37 
and VP23 in the 3'-terminal part of the M RNA sequence. 
The coding region of VP23 starts on the M RNA sequence at nucleotide 
2660 (Fig. 2) and continues probably to the end of the open reading 
frame in M RNA (stopcodon at position 3299). Furthermore, the results 
presented here, provide evidence that the sequence of the smaller form 
of the small capsid protein, denoted VP20, ends with a leucine residue 
which probably corresponds with the triplet at nucleotide position 3228 
to 3230. This is in agreement with the previous finding of Niblett and 
Semancik (1969) that the carboxy terminal residue of VP20 is a leucine. 
Based on the tentative mapping of both VP23 and VP20 on the nucleotide 
sequence of M RNA the difference between VP20 and VP23 would be a 
carboxy-terminal peptide of 23 amino acids and a molecular weight of 
3,157. This fits properly with the difference in apparant molecular 
weight of these forms as determined by gel electrophoresis (Geelen, 
1974; Rottier et al., 1980). The release of minor amounts of glycine, 
valine and methionine from VP23 upon carboxypeptidase Y digestion 
(Table III) suggests the possible occurrence of one or more additional 
degradation products of VP23 ending near or at the triplet for glycine 
at position 3278 of the M RNA sequence. Such products would only be 
6-9 amino acids shorter than full-length VP23 and are probably not 
detected as a separate band upon SDS-polyacrylamide gelelectrophoresis 
(Fig. IB). The occurrence of some such forms of the small capsid pro-
tein has been detected previously by Rottier (1980). 
The amino acid composition of the blocked ami no-terminal peptide of 
VP37 (table I) strongly suggests that the coding region of VP37 starts 
with the AUG codon at position 1537. This mapping is further supported 
by the good agreement of the experimentally determined amino acid com-
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position of VP37 with the predicted amino acid composition of this 
protein assuming that its sequence starts at the methionine codon 
at position 1537. N-acetylated amino acids are often followed by a 
hydrophilic acidic amino acid residue (Driessen, 1983). This condition 
is indeed fulfilled at the methionine residue of position 1537, but 
not at the methionine residue of position 1641. 
Besides, evidence was obtained that the coding regions of VP37 and 
VP23 are contiguous since all amino acids released from the carboxy 
terminus of VP37 by carboxypeptidase Y are found in the amino acid 
sequence within the primary translation product of M RNA preceding the 
ami no-terminal glycine residue of VP23 (Table III). The mapping of 
both capsid proteins as described in this paper implies molecular 
weights of 41,216 and 23,681 for VP37 and VP23 respectively. The 
mapping allows furthermore for the identification of two different 
proteolytic cleavage sites in the 105K and 95K primary translation 
products from M RNA. Since in the amino acid sequence of these primary 
translation products, the amino-terminal methionine of VP37 on position 
1537 is preceded by a glutamine residue (Fig. 2) it appears that a 
cleavage of glutaminyl-methionine dipeptide sequence is utilized to 
generate the 60K capsid protein precursor (Franssen et al., 1982). 
This site is recognised by the 32K protease encoded by B RNA (Franssen 
et al., 1984). At the other hand, since the coding regions for VP37 
and VP23 are contiguous a glutaminyl-glycine bond should be cleaved to 
release VP37 and VP23 from their common precursor (Fig. 2). The protease 
responsible for this cleavage has not yet been identified. 
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Summary 
The expression of bottom component (B) RNA of cowpea mosaic virus (CPMV) 
was studied by in vitro translation, using the rabbit reticulocyte lysate system. 
Translation of B-RNA produced within 1 h a 200 kilodalton (K) primary translation 
product, which was immediately cleaved into 32K and 170K polypeptides. This 
primary cleavage also occurred on nascent polypeptide chains longer than 110K. 
Upon prolonged incubation of the translation mixture (18 h) the 170K polypeptide 
was further cleaved into 110K, 87K, 84K and 60K polypeptides, corresponding to 
those found in infected cowpea cells. In addition a fifth cleavage product of 
approximately 28K was detected, not found in vivo thus far. The faithful in vitro 
processing observed indicates that the proteolytic enzyme involved is coded for by 
the B-RNA itself. A model is proposed in which the proteolytic activity involved in 
the processing of the 200K primary translation product is located in the 28K 
polypeptide. 
CPMV, reticulocyte lysate, in vitro translation, proteolysis 
Introduction 
The extensive studies on its proteins (see e.g. Rezelman et al., 1980; Goldbach et 
al., 1982) and the recent elucidation of the complete nucleotide sequence of its 
0168-1702/84/$03.00 © 1984 Elsevier Science Publishers B.V. 
genome (van Wezenbeek et al., 1983; Lomonossoff and Shanks, 1983) make cowpea 
mosaic virus (CPMV) one of the best characterised plant viruses. The genome of this 
virus consists of two separately encapsidated RNA molecules of plus-strand polarity, 
which are 3481 (M-RNA) and 5889 nucleotides (B-RNA) long, respectively, each 
containing one, long open reading frame (van Wezenbeek et al., 1983; Lomonossoff 
and Shanks, 1983). Both RNAs are polyadenylated at their 3' terminus (El Manna 
and Bruening, 1973; Ahlquist and Kaesberg, 1979) and carry a small protein, called 
VPg, at their 5' terminus (Stanley et al., 1978; Daubert et al., 1978). Characterisation 
of the polypeptides produced by CPMV in cowpea mesophyll protoplasts (Rezelman 
et al., 1980; Goldbach et al., 1982; Goldbach and Rezelman, 1983) as well as those 
translated from its RNA in vitro (Pelham, 1979; Goldbach et al., 1981; Franssen et 
al., 1982) has revealed that this virus follows a translation strategy which involves 
proteolytic processing of large, primary translation products. Thus, it has been 
demonstrated that in vivo B-RNA is translated into a 200K polyprotein, which 
undergoes several successive cleavages. The primary cleavage generates 32K and 
170K polypeptides. Next, the 170K polypeptide is cleaved into 60K. and 110K 
polypeptides, or, alternatively, into 84K and 87K polypeptides (secondary cleavages). 
The 60K product represents the direct precursor to VPg and a 58K. polypeptide, 
which both arise from the 60K polypeptide by a single further cleavage (Zabel et al., 
1982; Goldbach et al., 1982). Furthermore, since two pairs of overlapping proteins 
arise after the alternative, secondary cleavages, it has been proposed that the 110K 
and 84K polypeptides may undergo additional cleavage to give the 87K and 60K 
polypeptides, respectively, together with a polypeptide of approximately 24K (Rezel-
man et al., 1980). Until now the existence of such a 24K polypeptide has remained a 
matter of speculation. 
In several aspects CPMV resembles the animal picornaviruses, like poliovirus and 
encephalomyocarditis virus (EMC) (for e/iews see Rueckert et al., 1979; Koch et 
al., 1981; Putnak and Phillips, 1981). These viruses also have a positive-stranded 
RNA genome, supplied with both a VPg molecule and a polyadenylate tail. 
Moreover, they use the same translation strategy, i.e. proteolytic processing of a 
large ' polyprotein'. In rabbit reticulocyte lysates translation of EMC RNA has been 
reported to be followed by almost complete processing of the primary translation 
product to give the proteins also found in vivo (Pelham, 1978; Shih et al., 1979; 
Palmenberg, 1982). In contrast to these results, so far translation of CPMV B-RNA 
in reticulocyte lysates has been reported to be followed by the primary cleavage only, 
giving the 32K and 170K polypeptides (Pelham, 1979; Goldbach et al., 1981). In the 
present paper we show, however, that in this system, after prolonged incubation, also 
further cleavage of the 170K. polypeptide can be achieved, resulting in the produc-
tion of most of the B-RNA-encoded polypeptides found in infected cells. The 
experiments described here confirm and extend the translation map of B-RNA as 
based on our previous in vivo studies, and demonstrate that the reticulocyte lysate 
may be particularly useful for studying the proteolytic pathways followed and the 
protease(s) involved. 
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Materials and Methods 
Virus and RNA 
CPMV was grown in Vigna unguiculata (L.) 'California Blackeye' and B and M 
components separated and purified as described before (Klootwijk et al., 1977; van 
Kammen, 1967). CPMV RNA molecules were extracted from separated components 
as described by Davies et al. (1978) and fragmented molecules removed by sucrose 
gradient centrifugation (Franssen et al., 1984). 
In vitro translation of CPMV RNA 
B-RNA was translated in a messenger-dependent lysate of rabbit reticulocytes (a 
generous gift of Dr. R.J. Jackson, Department of Biochemistry, University of 
Cambridge, Cambridge, U.K.) in general under the conditions as previously de-
scribed (Pelham and Jackson, 1976; Pelham, 1979), using a dithiothreitol concentra-
tion of 2 mM. [35S]Methionine (New England Nuclear, specific activity approxi-
mately 1200 Ci/mmol) was used as radioactive amino acid (10 /iCi per 10 ji\ 
reaction mixture) and incubation was at 30°C for the times indicated in the text. The 
endogenous activity of the lysate used (no RNA added) was undetectable. 
SDS-polyacrylamide gel electrophoresis 
Labelled protein samples were made up in sample buffer (SB) (Rezelman et al., 
1980), heated for 3 min at 100°C, and electrophoresed in SDS-polyacrylamide gels 
using the buffer system of Laemmli (1970). Gels contained 12.5% or 20% acrylamide 
with 0.09% or 0.07% bisacrylamide, respectively, using a stacking gel of 4% acryla-
mide (with 0.07% bisacrylamide). After electrophoresis (at 150 V) gels were dried 
either with or without prior staining, and autoradiographed. 
Immunoprecipitations 
Antiserum directed against the electrophoretically separated 32K polypeptide was 
prepared as described previously (Franssen et al., 1984). Immunoprecipitations of 
protein samples were performed in buffer containing 10 mM sodium phosphate, pH 
7.2, 0.9% NaCl, 1% Triton X-100, 0.5% sodium deoxycholate and 0.1% SDS, as 
described before (Franssen et al., 1982). 
Peptide mapping 
Bands of radiolabeled polypeptides, localized by autoradiography, were cut out 
from dried, unstained gels. The gel pieces were swollen in buffer (120 mM Tris-HCl 
(pH 6.8)/l mM EDTA/0.4% SDS) containing 150 jug of Staphylococcus aureus V8 
protease (Miles Laboratories, Inc., Elkhart, Ind., U.S.A.) per ml, and incubated for 1 
h at 30°C. The gel pieces were then transferred into slots of a 20% SDS-poly-
acrylamide gel, covered with a layer of 2 X SB (see above) and electrophoresed at 
150 V. After the run the gel was fluorographed using Enhance (New England 
Nuclear). 
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Results 
The primary cleavage of the 200K translation product 
In the reticulocyte lysate B-RNA is translated into a 200K polypeptide, which is 
then, within 1 h of incubation, cleaved into a 32K and a 170K polypeptide (Pelham, 
1979; Rezelman et al., 1980). Since the 32K polypeptide is derived from the 
amino-terminal part of the 200K polypeptide (Goldbach and Rezelman, 1983), first 
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Fig. 1. Time course of appearance of the B-RNA-encoded 32K and 170K polypeptides. B-RNA was 
translated in a rabbit reticulocyte lysate at 30°C. Samples were taken at 10, 20, 30, 40 and 60 min after 
start of protein synthesis and analysed in a 12.5% SDS-polyacrylamide gel. An additional sample taken at 
60 min was immunoprecipitated, using antiserum raised against the 32K polypeptide, and the im-
munoprecipitate obtained included in the gel (lane 60, IP). The right lane (in vivo) contains the soluble 
[35S]methionine-labeled polypeptides from B-component-inoculated cowpea protoplasts, containing the 
B-RNA-encoded 170K, 110K and 87K polypeptides. 
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it was determined whether this cleavage occurs already on short, nascent polypeptide 
chains, or only on polypeptide chains which have been completed. For this purpose 
samples were taken from a translation mixture at various times after addition of 
B-RNA. After 30 min of translation only incomplete polypeptide chains were 
synthesized, with maximal lengths of approximately 110K (Fig. 1). After 40 min 
these chains were further elongated to approximately 150K. Neither full-length 200K 
or 170K polypeptides were synthesized yet, but clearly a band of 32K polypeptide 
appeared (Fig. 1). Full-length 200K product was only detectable after 60 min of 
translation and, as follows from the amounts of 170K and 32K polypeptides present 
then, most of the chains had already undergone primary cleavage (Fig. 1). Part of the 
60 min sample was immunoprecipitated using anti-32K serum. It is clear that this 
antiserum efficiently precipitated both the 200K and 32K polypeptide, but not the 
170K polypeptide (Fig. 1, lane indicated with IP). Most of the polypeptide chains 
after 1 h of translation still shorter than 170K were also precipitated by anti-32K 
serum. Such short products are thought to be 'early quitters', due to hidden breaks 
or secondary structure in the RNA. B-RNA is known to be a difficult messenger for 
in vitro translation (Pelham, 1979; Rezelman et al., 1980). The results of Fig. 1 
indicate that the primary cleavage can take place on nascent 200K chains. Such 
cleavage only occurs if the nascent chains have a size exceeding 110K., however. 
Further cleavage of the 170K polypeptide 
Upon prolonged incubation of the B-RNA-directed translation mixture addi-
tional cleavages were observed. Whereas after 1 h mainly 170K and 32K poly-
peptides were found, further incubation of the mixture for another 17 hours led to 
the production of 5 new proteins (cf. lanes lh and 18h in Fig. 2). Two of these 
polypeptides comigrated exactly with the 110K and 87K. polypeptides specified by 
B-RNA in vivo (Fig. 2, lane B), and two other ones were found on positions in the 
gel as expected for the 84K and 60K polypeptide. This result indicates that in the 
reticulocyte lysate the 170K polypeptide can undergo the same cleavages as found in 
the infected cell (Rtzelman et al., 1980; Goldbach et al., 1982). Close inspection of 
the gel patterns in Fig. 2 reveals that some of the 87K. and 84K polypeptides were 
already produced after 1 h of translation. This suggests that the cleavage by which 
they were generated proceeded more rapidly than the cleavage by which the 110K 
and 60K polypeptides were formed. The fifth new protein migrated slightly faster 
than the 32K polypeptide (Fig. 2). This polypeptide might represent the '24K' 
polypeptide, the existence of which has been postulated, but has never been found in 
vivo so far (Rezelman et al., 1980). Such a protein could arise by further cleavage of 
the 110K and 84K polypeptides into the 87K and 60K polypeptides, respectively. 
The actual size of the protein detected, as calculated from its electrophoretic 
mobility, is approximately 28K, which is in good agreement with the theoretically 
expected size. 
Characterisation of the cleavage products 
Although the electrophoretic mobility of the four largest polypeptides generated 
by the secondary cleavages provides good evidence that they were similar to the 
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Fig. 2. Proteolytic processing of the 170K polypeptide in the reticulocyte lysate system. Lane lh the 
products obtained 1 h after addition of B-RNA; lane 18h, the products obtained 18 h after addition of 
B-RNA. Lanes 18h-Zn and 18h-a32K, idem, but 2 mM ZnCl2 or anti-32K serum (1 ^1 per 3 Ml 
translation mixture) was added 1 h after start of protein synthesis. The products were analysed in a 12 5% 
SDS-polyacrylamide gel. The left two lanes contain the 30000 X g supernatant fractions from 
I SJmethionine-labeled cowpea protoplasts, either uninoculated (-) or inoculated with B-components (B). 
The viral 84K, 60K and 58K polypeptides are not visible in lane B since these polypeptides are mainly 
membrane-bound, and almost exclusively found in the 30000 X g pellet fraction of infected protoplasts 
(see for subcellular fractionation of cowpea protoplasts Rezelman et al., 1980). 
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HOK, 87K, 84K and 60K polypeptides found in vivo, the identity of some 
polypeptides was further established by peptide mapping. For this purpose, the in 
vitro generated 170K, HOK, 84K and 60K polypeptides were sliced from an unfixed 
gel and partially digested with Staphylococcus aureus V8 protease. The resulting 
peptides were electrophoresed in a 20% Polyacrylamide gel and compared with those 
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Fig. 3. Proteolytic peptide patterns of the in vitro cleavage products. The 170K, 110K, 84K, 60K and 28K 
in vitro cleavage products obtained after prolonged incubation of a B-RNA-directed translation mixture 
were sliced from an unfixed Polyacrylamide gel and digested with Staphylococcus aureus V8 protease (for 
details see Materials and Methods). The resulting peptides were compared with the protease V8-generated 
peptides from the 170K and 110K polypeptides isolated from CPMV-infected protoplasts (lanes in vivo), 
using a 20% SDS-Polyacrylamide gel. », common peptides in the patterns of the 170K and 110K 
polypeptides; >, common peptides in the patterns of the 170K, 84K and 60K polypeptides; •, peptide 
specific for the 110K. polypeptide. The molecular weight markers used were carbonate dehydratase 
(30000), soybean trypsin inhibitor (20100) and a-lactalbumin (14400). 
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of the 170K and 110K polypeptides isolated from infected protoplasts (Fig. 3). The 
peptide patterns of the in vitro produced 170K and 110K polypeptides were similar 
to those of their equal-sized counterparts in vivo (Fig. 3, lanes indicated in vivo). The 
peptide patterns of the 110K and 60K in vitro polypeptides differed, indicating that 
these cleavage products had unique rather than overlapping sequences. From these 
data it can be concluded that the 170K polypeptide was correctly cleaved into 110K 
and 60K polypeptides, just as happens in vivo. 
Furthermore, the digests of the 60K and 84K. in vitro cleavage products were very 
similar (Fig. 3), in full agreement with previous findings (Rezelman et al., 1980; 
Goldbach et al., 1982) that both polypeptides are derived from the same part of the 
170K precursor. 
Finally, Fig. 3 includes the proteolytic peptide ' pattern' of the in vitro generated 
28K polypeptide. The digest of this polypeptide contained only one radiolabeled 
(methionine-containing) peptide of approximately 12K, which comigrated with a 
peptide unique for the digest of the 110K polypeptide (Fig. 3, peptide indicated with 
•) . Since this latter peptide is absent from the proteolytic digests of both the 170K. 
polypeptide (Fig. 3) and 87K polypeptide (not shown here, but see Fig. 3 in 
Rezelman et al., 1980), it must contain that part of the 110K polypeptide from which 
the proposed '24K' polypeptide would be derived. Therefore, the observed equal-sized 
V8 peptide obtained from the 28K polypeptide generated in vitro supports the idea 
that this cleavage product represents this postulated polypeptide. 
The proteolytic activity involved in the in vitro cleavages 
For preliminary characterisation of the protease involved in the cleavage of the 
170K polypeptide the effect of zinc ions was examined. Addition of 2 mM ZnCl2 to 
a translation mixture, 1 h after the start of translation, did block the 60K/110K. 
cleavage completely and the 84K/87K cleavage partially (Fig. 2, lane indicated Zn). 
Although this inhibitory effect of Zn2+ suggests that the responsible protease is of 
the thiol-type, further experiments are needed to verify this. The 32K polypeptide 
has recently been identified as a protease, providing for the cleavage of the 95K and 
105K proteins from M-RNA (Franssen et al., 1983). Since its activity is also 
sensitive to zinc ions (Pelham, 1979; Franssen et al., 1982) it might appear tempting 
to hold this protease to be responsible for the further cleavage of the 170K 
polypeptide. However, antiserum against the 32K polypeptide, which has been 
shown to neutralize the activity of this protease (Franssen et al., 1984), did not at all 
interfere with the processing of the 170K polypeptide (Fig. 2, lane a-32K). Thus, a 
different protease seems to be involved. 
Discussion 
In previous reports it has been shown that upon translation of CPMV B-RNA in 
a reticulocyte lysate the 200K primary translation product undergoes proper primary 
cleavage, resulting in the production of 170K and 32K polypeptides as found in vivo 
(Pelham, 1979; Rezelman et al., 1980; Goldbach et al., 1981). The experiments 
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described here demonstrate that upon prolonged incubation of the translation 
mixture proteolysis proceeds, the 170K. polypeptide being cleaved into HOK, 87K, 
84K and 60K polypeptides identical to the B-RNA-encoded proteins found in vivo. 
Moreover, a fifth cleavage product has been detected, whose size and peptide pattern 
strongly suggest that it represents the 'hypothetical' 24K polypeptide proposed by 
Rezelman et al. (1980). Thus, the present in vitro studies not only confirm the 
translational map of B-RNA as deduced from in vivo (cowpea protoplasts) analyses, 
but provide the first evidence that the 110K and 84K polypeptides are additionally 
cleaved to give the 87K and 60K polypeptides, respectively, together with a 28K 
polypeptide. As a consequence the 11 OK and 84K should be regarded as processing 
intermediates (although with long half-lives, both in vivo and in vitro). Recently the 
32K polypeptide has been identified as the B-RNA-encoded protease involved in the 
cleavage of the M-RNA-encoded 95K and 105K primary translation products 
(Franssen et al., 1983). Our results indicate that this enzyme is not involved in the 
processing of the B-RNA-encoded primary product, neither in the primary cleavage 
(by which the 32K protease is released), nor in any of the other cleavage steps: 
(1) The 32K polypeptide is not released from nascent 200K chains before these 
chains have reached a length of at least 110K (Fig. 1). If the 32K polypeptide 
would release itself autocatalytically it is hard to imagine why this does not 
occur as soon as its sequence has been completed. 
(2) Antiserum against the 32K protease, which had previously been shown to 
neutralise the activity of this enzyme, does not inhibit the secondary cleavage of 
the 170K polypeptide (Fig. 2). 
(3) The 32K protease recognizes a glutamine-methionine cleavage site within the 
M-RNA-encoded polypeptides (thereby releasing the 60K precursor to both 
capsid proteins) (van Wezenbeek et al., 1983). Inspection of the nucleotide 
sequence of B-RNA and of the amino acid sequence of the 200K primary 
translation product deduced from it (Lomonossoff and Shanks, 1983) reveals 
that glutamine-methionine dipeptide sequences are absent at or around the 
expected cleavage sites. 
Therefore, a different protease seems to be involved in the processing of the 
B-RNA-encoded 200K polypeptide. Since all processing steps occur properly in the 
rabbit reticulocyte lysate (i.e. in the absence of any plant proteins) this protease must 
be encoded by B-RNA itself. The information available to date indicates that the 
28K polypeptide might represent this protease. This would explain why the primary 
cleavage only takes place on nascent chains longer than approximately 110K. As 
shown in the translation model of Fig. 4, nascent chains shorter than 120K 
(32K + 60K + 28K) do not contain a complete 28K polypeptide sequence. Further-
more, within the 170K polypeptide the 28K polypeptide is located between the 60K 
and 87K polypeptide sequences. Therefore, if this polypeptide would be capable of 
cleaving itself out of the 170K polypeptide, first left and then right, or the other way 
around, then the simultaneous formation of the 110K, 87K, 84K and 60K poly-
peptides is readily explained (see Fig. 4). Experiments to verify this hypothesis are in 
progress. 
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* : * 
87 60 „ 28 87 
28 87 
r • ; 
60 28 
Fig. 4. Model for the proteolytic processing of the B-RNA-encoded primary translation product (cleavage 
sites are indicated with A). The primary cleavage occurs predominantly on nascent 200K chains, which 
should be longer than approximately 120K. The protease involved in this and following cleavages is 
proposed to be the 28K polypeptide. After completion of the polypeptide chain the 28K polypeptide 
releases itself by cleaving the 170K polypeptide chain, first left and then right, or the other way around. 
The cleavage step by which VPg (indicated with D) is released from its 60K precursor (Goldbach et al., 
1982) is not included in the scheme. It is not known whether VPg is present on RNA chains which are 
used as messenger. 
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Communicated by A. Klug 
Computer analyses have revealed sequence homology bet-
ween two non-structural proteins encoded by cowpea mosaic 
virus (CPMV), and corresponding proteins encoded by two 
picornaviruses, poliovirus and foot-and-mouth disease virus. 
A region of 535 amino acids in the 87-K polypeptide from 
CPMV was found to be homologous to the RNA-dependent 
RNA polymerases from both picornaviruses, the best mat-
ches being found where the picomaviral proteins most resem-
ble each other. Additionally, the 58-K polypeptide from 
CPMV and polypeptide P2-X from poliovirus contain a con-
served region of 143 amino acids. Based on the homology 
observed, a genetic map of the CPMV genome has been con-
structed in which the 87-K polypeptide represents the core 
polymerase domain of the CPMV replicase. These results 
have implications for the evolution of RNA viruses, and 
mechanisms are discussed which may explain the existence 
of homology between picornaviruses (animal viruses with 
single genomic RNAs) and comoviruses (plant viruses with 
two genomic RNAs). 
Key words: cowpea mosaic virus/picornavirus/RNA-depen-
dent RNA polymerase/protein sequence homology/evolution 
Introduction 
The comoviruses are a distinctive group of plant viruses 
which resemble the picornaviruses of animals in several 
respects. Members of both groups have positive-stranded 
RNA genomes. Their RNAs carry a small protein, called 
VPg, at their 5 ' termini and a poly(A) tail at their 3 ' termini 
(for review of picornaviruses, see Rueckert et ai, 1979; 
Putnak and Phillips, 1981; Koch et al., 1981; for como-
viruses, see Bruening, 1977, 1981). Moreover the RNAs of 
both como- and picornaviruses are translated into polypro-
teins from which the functional proteins are derived by pro-
teolytic cleavages. The major difference between the two 
groups is that picornaviruses have a single RNA while como-
viruses divide their genome between two RNAs. The larger 
RNA of comoviruses (B-RNA) can replicate on its own in 
protoplasts and so must encode any functions required for 
replication (Goldbach et ai, 1980), while the smaller RNA 
(M-RNA) encodes the structural proteins (Franssen et al., 
1982). In addition, although both groups of viruses have 
icosahedral capsids, these differ significantly in structure. 
Recently, the complete nucleotide sequence of the RNAs 
from cowpea mosaic virus (CPMV), typemember of the 
comovirus group, has been elucidated (Van Wezenbeek et al., 
1983; Lomonossoff and Shanks, 1983). Both B- and M-RNA 
(5889 and 3481 nucleotides long, excluding the poly(A) tails) 
contain a long, unique open reading frame, the length of 
which is in good agreement with the size of the primary 
translation products reported. Translation studies (see, for in-
stance, Pelham, 1979; Rezelman ef a/., 1980; Goldbach et ai, 
1982; Goldbach and Rezelman, 1983) have revealed that 
B-RNA is translated into a polyprotein of - 200 K from 
which five final cleavage products are derived in the following 
order: NH2-32 K-58 K-4 K( = VPg)-28 K-87 K-COOH. 
Several processing intermediates have also been detected in 
the infected cell (Rezelman et al., 1980) which may, in view of 
the large amounts in which they occur, represent functional 
molecules. M-RNA contains two translation initiation sites 
(Pelham, 1979; Franssen et al., 1982) and is translated into 
two C co-terminal polyproteins of ~ 105 K and 95 K, each 
containing the sequences of both capsid proteins VP37 and 
VP23 (Franssen et al, 1982). They are cleaved to give pro-
ducts in the order NH>58 K/48 K-VP37-VP23-COOH. 
Of the products specified by B-RNA, the 32-K polypeptide 
has been shown to be the protease involved in the cleavage of 
the overlapping polyproteins from M-RNA, thereby generat-
ing a 60-K precursor to both capsid proteins (Franssen et al., 
1982, 1984a). The cleavage site used by this enzyme is a glut-
amine-methionine dipeptide sequence (Van Wezenbeek et al., 
1983). The 28-K polypeptide has been proposed to represent 
the protease involved in the processing of the 200-K poly-
protein from B-RNA itself (Franssen el al., 1984b). The 
cleavage sites used in this polyprotein are not glutamine-
methionine sequences (Franssen et al., 1984b) but probably 
glutamine-serine sequences (Zabel et ai, 1984). The B-RNA-
encoded 110-K polypeptide is found in extensively purified 
CPMV replication complexes, which are able to elongate nas-
cent RNA chains to full-length RNA molecules in vitro 
(Dorssers et ai, 1984). Since this polypeptide contains the se-
quences of both the 28-K (the proposed protease) and the 
87-K polypeptide (Rezelman et ai, 1980; Franssen et ai, 
1984b) the functional organisation within the C-terminal 
parts of the B-RNA-coded polyprotein and the picomaviral 
polyprotein might be co-linear: -VPg-protease-RNA-
dependent RNA polymerase. In view of the apparent similari-
ty between the como- and picornaviruses we thought it might 
be instructive to search for amino acid sequence homology 
between both the structural and non-structural regions of the 
CPMV polyproteins and the polyproteins from two picor-
naviruses, poliovirus and foot-and-mouth disease virus 
(FMDV). The results of this search are striking and reveal the 
existence of significant sequence homology between the 87-K 
polypeptide from CPMV and the polymerase from both 
FMDV and poliovirus. In addition, the 58-K polypeptide 
specified by CPMV B-RNA exhibits sequence homology to 
polypeptide P2-X from poliovirus. The results presented here 
© IRL Press Limited, Oxford, England. 
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Table 1. Presence of homologous amino acid sequences in the proteins from 
CPMV, poliovirus and FMDV 
CPMV polyproteins 
M (105 K) B(200K) 
Pl-region 
Poliovirus P2-region 
P3-region 
FMDV capsid proteins 
polymerase 
Data were obtained from graphic matrix comparisons as described in 
Materials and methods. +, homologous sequences; - , no homologous se-
quences. 
confirm and extend the biochemical data by demonstrating 
that the 87-K domain of the 110-K polypeptide, identified as a 
component of the CPMV replication complex, is structurally 
homologous to the Picornavirus replicase subunit P3-4b. 
They thus throw a new light on the evolution of viral RNA 
genomes. 
Results 
Comparison of the polypeptides from CPMV, poliovirus and 
FMDV 
The complete nucleotide sequence of both the Mahony and 
Sabin strains of poliovirus type 1 has been determined (Kita-
mura er a/., 1981; Racaniello and Baltimore, 1981; Nomotoef 
ai, 1982). Together with amino acid sequence analyses 
(SemlereYa/., 1981a, 1981b; Kitamura et at., 1981; Larsener 
al., 1982; Emini et al., 1982) this has enabled the precise map-
ping of the viral polypeptides within the single polioviral 
polyprotein (NCVPOO mol. wt. -250 K) and the identifica-
tion of the cleavage sites used to release them. Based on the 
primary cleavages NCVPOO has been divided into three 
regions: PI, from which the four capsid proteins are derived, 
P2, the central region, and P3, the region from which VPg, 
the viral protease (P3-7c) and the RNA-dependent RNA 
polymerase (P3-4b) are derived (Kitamura et al., 1981). The 
nucleotide sequence of two parts of the genome of a second 
Picornavirus FMDV has been determined, corresponding to 
the coding regions of the capsid proteins and the viral poly-
merase (Boothroyd et al., 1982; Robertson et al., 1983). 
Comparison of the amino acid sequences of the polioviral 
and FMDV RNA polymerases showed that they were — 30% 
homologous (Robertson et al., 1983). In view of the apparent 
conservation of amino acid sequences among picornaviral 
polymerases and the similarities in genomic structure and ex-
pression between comoviruses and picornaviruses, we ex-
amined whether (any of) the CPMV polypeptides were 
related to the polymerase or to any of the other polypeptides 
specified by picornaviruses. For this purpose, the amino acid 
sequences of the polyproteins from CPMV, poliovirus and 
FMDV were first compared using graphic matrix procedures 
(McLachlan, 1971; Maizel and Lenk, 1981; Staden, 1982; see 
Materials and methods). 
Table I summarizes the comparisons made and the 
homology found. The overlapping 95-K and 105-K polypro-
teins encoded by the M-RNA of CPMV appeared not to con-
tain any amino acid sequence homologous to the structural or 
non-structural proteins from poliovirus and FMDV. On the 
other hand, the 200-K polyprotein specified by the B-RNA 
VP4 
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Fig. 1. Matrix displaying well matched blocks of amino acid sequence 31 
residues in length from the polyproteins of poliovirus Sabin-1 strain and of 
CPMV B-RNA using the computer programme DIAGON. All possible 
pairings of 31 residue blocks from the two proteins are compared by the 
programme, and all those matching with a score of 340 or greater are 
recorded by a dot on the display at the coordinates of the midpoint of the 
block. A score of >340 would be observed in comparisons of 31 residue 
blocks drawn at random from a pool of amino acids of the same composi-
tions as the real proteins with a 'double matching probability' (McLachlan, 
1971) of 1.1 x 10"*. This probability level should be sufficient to filter out 
most random matches (McLachlan, 1971), while the score, which cor-
responds to four standard deviations (S.D. = 14.12) above the mean (283), 
is above the three S.D.s thought to be a minimum criterion of significant 
relationship (Doolittle, 1981). Cleavage sites in the proteins are indicated on 
both axes, regions of marked homology by arrows. Sequence data are 
from Nomoto et al. (1982) and Lomonossoff et ai (1983). 
contained regions with homology significant at the 10 "* level 
to both the P2 and P3 region of the poliovirus polyprotein 
and to the polymerase sequence of FMDV (Table 1). A matrix 
graph (Figure 1) comparing the entire polyproteins encoded 
by CPMV B-RNA and poliovirus RNA at this significance 
level revealed two extended regions of apparent homology 
(marked by arrows). These regions map within the P2-X and 
P3-4b genes of poliovirus, which encode a protein of 
• unknown function, and the putative RNA polymerase, 
respectively. In CPMV the corresponding proteins, deduced 
from the detailed cleavage map (Goldbach el at., 1982; 
Goldbach and Rezelman, 1983) and the precise mapping of 
the VPg sequence (Zabel et al., 1984) are the 58-K polypep-
tide and the 87-K polypeptide, respectively (Figure 1). Since 
no sequence data are yet available from the central part of the 
FMDV polyprotein, neither a total comparison nor a detailed 
comparison with the polio P2-X and CPMV 58-K proteins 
could be done. The sequence of the putative FMDV replicase 
p56a was available, however, and pairwise comparisons with 
the polio P3-4b and CPMV 87-K protein sequences confirm-
ed the known homology between polio and FMDV and show-
ed that the CPMV 87-K protein was related to both 
replicases, although more distantly (Figure 2). 
Alignment of the 87-K product from CPMV and the 
polymerases from poliovirus and FMDV 
The homology between the B-RNA-encoded 87-K polypep-
tide from CPMV and the RNA-dependent RNA polymerases 
from FMDV and poliovirus has been further analysed by 
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Homologous proteins from CPMV and picomavirases 
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Fig. 2. DlAGON-generated matrices comparing the CPMV 87-K polypep-
tide and picornaviral polymerases. Block length compared was 31 (as in 
Figure 1), but the threshold scores used were 337 (corresponding to a prob-
ability of 3 x I0-*). (A) Comparison of the two polymerases from polio-
virus and FMDV. (B) Comparison of the CPMV 87-K polypeptide and 
polioviral polymerase. (Q Comparison of the CPMV 87-K polypeptide and 
FMDV polymerase. The sequence data from FMDV were from Robertson 
el at. (1983). 
alignment of their amino acid sequences. Figure 3 shows the 
aligned sequences and illustrates the existence of homology 
over a region comprising the whole picornaviral polymerase 
sequence. The 87-K product from CPMV and the polioviral 
polymerase P3-4b are 20.9% homologous (113 identical 
residues out of a total of 541 positions, including the gaps). 
Likewise, the homology between the aligned sequences of the 
FMDV enzyme and the 87-K polypeptide was estimated as 
20.9V» (over 545 positions). The homology between the 
CPMV polyprotein and the P3-region of the polioviral poly-
protein appears not to be limited to the polio polymerase se-
quence (P3-4b), but extends at the amino-terminal side 
beyond the glutamine-glycine cleavage site into the sequence 
of the protease (P3-7c) (Figure 3). Strikingly, the marked 
homology stops abruptly near position 1688 within the P3-7c 
region, i.e., at the glutamine-glycine cleavage site by which 
polypeptide P3-4a, a presumed precursor to the polymerase, 
is generated (Etchison and Ehrenfeld, 1980; Semler et al., 
1983). 
It should be noted that the glutamine-glycine dipeptide 
cleavage sites used to release polypeptides P3-4a and P3-4b 
from the polioviral polyprotein exactly match with glut-
amine-serine and glutamine-glycine dipeptide sequences 
within the CPMV protein sequence, respectively (Figure 3). 
Whether one of these dipeptide sequences is used to release 
the 87-K polypeptide remains to be verified. Moreover, the 
carboxy-terminal residue of P3-4b (phenylalanine at position 
2211) again matches with a glutamine-glycine sequence in the 
CPMV protein. This dipeptide sequence is unlikely to be used 
as a cleavage site. Cleavage at this position would generate 
polypeptides of - 6 7 K and 20 K from the 87-K product, 
which have never been observed. 
Alignment ofthe 58-Kpolypeptide from CPMV and product 
P2-X from poliovirus 
As can be deduced from the matrix graph of Figure 1, only 
the central regions of the CPMV 58-K polypeptide and P2-X 
from poliovirus exhibit clear homology, but this homology is 
the most marked in the entire polyproteins (significant at the 
1 0 _ ! level). Figure 4 shows the alignment of the amino acid 
sequences in these regions. Over a length of 143 residues the 
sequences can be matched to an homology of 30% with only 
five short gaps. The alignment contains two shorter regions 
(residue positions 521-545 and 572-598 in the CPMV se-
quence) exhibiting even greater homology (44% and 57%). 
On the other hand, since the similarity is limited to a region of 
only 143 residues, the overall homology between the 58-K 
CPMV product (553 amino acids ) and P2-X (329 amino 
acids) is substantially lower than that observed between the 
87-K polypeptide and P3-4b. 
Genetic map of the CPMV RNA genome 
Its marked similarity to the RNA-dependent RNA poly-
merases from two different picornaviruses strongly suggests 
that the 87-K polypeptide represents a 'core polymerase' do-
main of the CPMV replicase, functionally homologous to the 
Picornavirus core polymerase (Flanegan and Baltimore, 1979; 
Baron and Baltimore, 1982; Semler et ai, 1983). The 28-K 
polypeptide, adjoining this polypeptide in the CPMV B poly-
protein, has been proposed to represent a protease (Franssen 
et al., 1984b), while we have found sequence homology bet-
ween the CPMV 58-K polypeptide and P2-X from poliovirus. 
All these results are consistent with the idea that the genetic 
organisation of the 200-K polyprotein from CPMV is co-
linear with that of the carboxy-terminal half of the picor-
naviral polyprotein (Figure 5). B-RNA seems to encode one 
additional function, apparently the consequence of the divid-
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Fig. 3. Alignments of the 87-K polypeptide from CPMV and the polymerases from FMDV and poliovirus. The sequences compared start for the poliovirus 
and CPMV B polyproteins at positions 1657 and 1059, respectively. For FMDV on.y ihe sequence of the polymerase (P56a) has been shown (Robertson et 
ai, 1983), and for EMC the published (Drake et at., 1982) sequence of the carboxy-terminal part of this enzyme. Alignment was based on the published 
FMDV-poliovirus alignment of Robertson et ai (1983) plus additional alignment using D1AGON and by inspection. Residues in the CPMV 87-K polypeptide 
which are identical to those in either picornaviral protein are boxed, and gaps are indicated with lines. The best matches are found where the sequences of 
both picornaviral proteins are most conserved. The picornaviral proteins display additional homologies to each other (not shown here, but see Robertson et 
ai, 1983 and Figure 2A). 
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Fig. 4. Alignment of the 58-K polypeptide encoded by CPMV B-RNA and 
P2-X from poliovirus. The regions compared start at position 1250 in the 
poliovirus sequence and at position 476 in the CPMV sequence. 
ed genome of CPMV: the 32-K protease involved in the pro-
cessing of the polyproteins from M-RNA (Franssen et al., 
1984a). 
Discussion 
Functional implications 
This study revealed sequence homology between two of the 
non-structural polypeptides from the plant virus CPMV and 
corresponding proteins from animal picornaviruses. The 
most extensive homology was found between the 87-K 
polypeptide specified by CPMV B-RNA and the picornaviral 
RNA-dependent RNA polymerase. Therefore, it is 
reasonable to assume that the 87-K polypeptide also has a 
function related to that of the RNA-dependent RNA 
polymerase. Indeed, Dorssers el al. (1984) have recently 
reported on the presence of the B-RNA-encoded 110-K 
polypeptide in purified CPMV replication complexes. This 
product contains the sequences of both the 87-K polypeptide 
and the 28-K polypeptide (Rezelman et al., 1980; Franssen et 
al., 1984b). However, no mature 87-K polypeptide was 
detected in such preparations. This may suggest that the 
(87-K) polymerase is only active in its 110-K 'precursor' form. 
Another possibility is that the presence or absence of the 28-K 
polypeptide sequence is irrelevant to the activity of the 87-K 
domain after initiation, but that the cleavage of the 110-K 
polypeptide into the 87-K and 28-K polypeptides proceeds 
slowly. Since the 28-K polypeptide is probably the protease 
involved in the processing of the 200-K polyprotein (Franssen 
et al., 1984b) one or more proteolytic steps essential for RNA 
replication might be considered. This idea is implicit in the 
hypothesis that VPg acts as a primer in the RNA replication 
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Fig. 5. Comparison of the functional organisation of the poiyproteins from CPMV and poliovirus. M-RNA of CPMV specifies two overlapping polyproteins 
of sizes 95 K and 105 K, from which the capsid proteins VP37 and VP23 are derived, together with two polypeptides of 58 K and 48 K (Franssen el al.. 
1982). The latter products have been proposed to play a role in viral RNA transport (Rezdman et al., 1982). B-RNA of CPMV specifies a 200-K polyprotein, 
which has now been shown to contain two regions homologous to sequences in the poüovirus protein (shaded regions). Five different mature proteins are pro-
posed to be derived from the B polyprotein: a 32-K protease, involved in the cleavage of the M-RNA*encoded polyproteins (Franssen et al., 1984a); a 58-K 
protein, which - in view of the homology found - might be the counterpart of protein X from pofiovirus;'VPg, which may play a role in RNA replication; 
a 28-K protein, which has been proposed to represent a protease involved in the cleavage of the B protein (Franssen et al., 1984b); and a 87-K protein which 
has now been proposed to be the core polymerase domain of the 110-K polypeptide, previously detected in CPMV replication complexes (Dorssers el al., 
1984). The precise position of the cleavage site between the 28-K and 87-K proteins has remained unknown so far. The VPg sequence has recently been map-
ped in the 200-K sequence (Zabel el al., 1984). 
cycle which is proteolytically released from its precursor at the 
very moment of initiation of an RNA chain (for review, see 
Wimmer, 1982), but it is not clear why a protease domain 
should be retained in an enzyme preparation active only in 
elongating pre-existing chains (Dorssers et al., 1984). 
It should be noted that the tentative assignment of protease 
activity to the 28-K polypeptide (Franssen et al., 1984b) is 
now further supported by the observation that the region in 
the B polyprotein homologous to the picornaviral polymerase 
is preceded by a region homologous to the carboxy-terminal 
part of P3-7c, the protease from poliovirus (Figure 3). 
However, the precise cleavage site by which the 28-K and 
87-K polypeptides are separated is not known and detailed 
amino acid sequence analyses are necessary to verify whether 
this homology resides in the 28-K product. If this is the case 
then a glutamine-glycine sequence (at position 1155) is used to 
generate the 87-K polypeptide and not a glutamine-serine se-
quence (at position 1091), as was proposed to be the preferred 
cleavage site in the B polyprotein (Zabel et al., 1984). Alter-
natively, both sites may be used as cleavage points which 
would further enhance the analogy with poliovirus. 
A second region of homology has been mapped within the 
58-K polypeptide from CPMV and P2-X from poliovirus, 
respectively (Figure 4). The function of P2-X has not been 
biochemically defined, but it is interesting to note that in 
Cooper's genetic map of poliovirus (Cooper, 1968) mutations 
affecting double-stranded RNA synthesis occur near the mid-
dle of the map. While the co-linearity of the genetic and phys-
ical maps has not been proven, it is possible that the 58-K 
polypeptide from CPMV and P2-X are also proteins involved 
in RNA replication, and that the X-VPg-protease-core poly-
merase genes represent a module of RNA replicating func-
tions that have retained a similar organisation in both CPMV 
and picornaviruses (Figure 5). 
Evolutionary implications 
Our findings, together with the recent observation that a pro-
duct encoded by the plant DNA virus, cauliflower mosaic 
virus, exhibits homology to retroviral reverse transcriptase 
(Toh et al., 1983), and the discovery that three different plant 
RNA viruses (A1MV, BMV and TMV) encode proteins 
homologous to polypeptide ns72 from Sindbis virus (Haseloff 
et al., unpublished data) throw a new light on the evolution of 
viruses. How can viruses infecting organisms from two dif-
ferent eukaryotic kingdoms encode polypeptides with similar 
sequences? And, in the case of the comovirus and Picorna-
virus groups, how can the structural and genetic organisation 
of their genomes be similar? At least three possibilities may be 
considered to explain the similarities between comoviruses 
and picornaviruses. (i) Convergent evolution. Different 
viruses that originated independently may encode proteins in-
teracting with highly conserved host machinery and solely for 
this reason may evolve related tertiary and hence primary 
structures, (ii) Common viral ancestry. Comoviruses and 
picornaviruses may both derive from a common viral 
ancestor. If such a common ancestor arose before or at the 
time of divergence of the plant and animal kingdoms the 
residual conservation of structure must reflect extreme selec-
tive pressures, considering the rapid rate of mutation in RNA 
genomes (Domingo et al., 1978; Holland et al., 1982).Acom-
mon ancestor need not have pre-dated the evolutionary 
separation of plant and animal cells however, since viruses 
such as wound tumour virus (a plant reovirus) and potato 
yellow dwarf virus (a plant rhabdovirus) can replicate both in 
plants and in the cells of their insect vectors (for review, see 
Matthews, 1981) (it should be noted that comoviruses have 
beetle vectors). A virus ancestral to both como- and picorna-
viruses, which could replicate in both kinds of host, may 
therefore have existed relatively recently, subsequently giving 
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rise to more specialised descendants, (iii) Transduction of 
conserved host genes. Both comoviruses and picornaviruses 
may have (independently) transduced equivalent, conserved 
host genes to apply them for their own multiplication. In this 
context it is worthwhile mentioning that RNA-dependent 
RNA polymerases — the functions of which are so far 
unknown — have been reported from a number of plant 
species, among them cowpea (Vigna unguiculata) (Dorssers et 
al., 1982; Van der Meer et al., 1983). 
Both the second and third possibilities seem difficult to im-
agine without invoking some form of recombination, 
possibly at the RNA level. Given that the comovirus B-RNA 
lacks genes corresponding to the Picornavirus capsid proteins, 
the minimum rearrangement necessary would be a deletion of 
the capsid protein genes from a picornaviral-like RNA, 
perhaps in the manner known to be a preferred pathway of 
poliovirus DI RNA formation (Cole and Baltimore, 1973) 
followed by the acquisition of the entire M-RNA from 
another source. This scheme still leaves unclear the source of 
the 32-K protease, a B-RNA gene required for M-RNA 
polyprotein maturation. Most other schemes one might im-
agine would necessitate a more general form of recombina-
tion than straightforward internal deletion. It is particularly 
interesting in this regard that there is longstanding genetic 
evidence for recombination in picornaviruses (Cooper, 1977) 
which has more recently received additional biochemical sup-
port (King et al., 1982a, 1982b; Romanova et al., 1980; 
Tolskaya et al., 1983). 
It is not yet possible to judge which one, or which com-
bination of these mechanisms is most likely but we anticipate 
that further experimental work may indicate where the 
balance of probability lies. Even though evolutionary debates 
are necessarily conjectural to a degree, we suspect that more 
insight into this problem may shed light on questions beyond 
the immediate confines of RNA viral evolution. 
Materials and methods 
Nucleotide sequences of viral RNAs 
The amino acid sequences of the polypeptides compared were derived from 
the following RNA sequences: CPMV M-RNA: Van Wezenbeek et ai, 1983; 
CPMV B-RNA: Lomonossoff and Shanks. 1983; poliovirus RNA (Sabin 1 
strain): Nomoto et al., 1982, retrieved from the EMBL-database; FMDV 
RNA: Boothroyd et al., 1982; Robertson et al., 1983. 
Matrix comparisons and sequence alignments 
Initial searches for amino acid sequence homology were made using graphic 
matrix methods. Two independent searches were made. In one search, using a 
Fortran 77 programme (unpublished) basically as described by Gibbs and 
Mclntyre (1970) run on a Hitachi AS 9000 computer, all matches of three or 
more out of five amino acids were scored in all possible pairwise alignments of 
five amino acid blocks from the proteins being compared. In another search, 
using the programme DIAGON (Staden, 1982) based on the procedure of 
McLachlan(1971)ninon a VAX 11/780 computer, blocks of 31 amino acids 
were compared for their match of both identical and related amino acids. 
(DIAGON is routinely used with a block setting of 21, we increased this to 31 
for these comparisons because we have found that a longer block length 
reduces the background in some comparisons of distantly related sequences, 
although we have not explored this effect systematically.) The scoring system 
for this comparison is based on the observed frequency of substitution of one 
amino acid by another in a number of protein families (Schwartz and 
Dayhoff, 1978). Only scores above a preset threshold appear on the display, 
the threshold scores used and their probabilities of occurrence in pairs of 31 
residue random sequences are given in the text and figure legends. In both 
procedures matching blocks are marked by a dot on the display at coordinates 
corresponding to the midpoint of the blocks in the sequences of the respective 
proteins. 
Detailed alignments were made using the interactive facility of DIAGON 
and by inspection. Gaps were restricted so as not to exceed the common upper 
bound of 4/100 residues found in families of distantly related proteins (Doo-
little, 1981). 
Acknowledgements 
We thank Ab van Kammen for critical reading of the text, Piet Madern for 
printing the photographs and Marie-José van Neerven/Bea Verhaar for typ-
ing the manuscript. 
References 
Baron.M.H. and Baltimore.D. (1982) J. Virol., 43, 969-978. 
Boothroyd,J.C, Harris.T.J.R., Rowlands.D.J. and Lowe.P.A. (1982) Gene, 
17, 153-161. 
Bmening.G. (1977) in Fraenkel-Conrat.H. and Wagner.R.R. (eds.). Com-
prehensive Virology, Vol. II, Plenum Press, NY, pp. 55-141. 
Bruening.G. (1981) in Marcus.E. (ed.), The Biochemistry of Plants, Vol. 6, 
Academic Press, NY, pp. 571-563. 
Cole,C.N. and Baltimore.D. (1973) J. Microbiol., 26, 325-343. 
Cooper.P.D. (1968) Virology, 35, 584-596. 
Cooper.P.D. (1977) in Fraenkel-Conrat.H. and Wagner.R.R. (eds.). Com-
prehensive Virology, Vol. 9, Plenum Press, NY, pp. 133-207. 
Domingo.E., Sabo.D., Taniguchi.T. and Weissman.C. (1978) Cell, 13, 735-
744. 
Doolittle.R.F. (1981) Science (Wash.), 214, 149-159. 
Dorssers.L., Zabel.P., Van der Meer.J. and Van Kammen.A. (1982) Virol-
ogy, 116, 236-249. 
Dorssers.L., Van der Krol.S., Van der Meer.J., Van Kammen.A. and Zabel, 
P. (1984) Proc. Natl. Acad. Sei. USA, in press. 
Drake.N.L., Palmenberg.A.C, Ghosh,A., Omilianowski.D.R. and Kaes-
berg.P. (1982) J. Virol., 41, 726-729. 
Emini.E.A., Elzinga.M. and Wimmer.E. (1982) J. Virol., 42, 194-199. 
Etchison.D. and Ehrenfeld.E. (1980) Virology, 107. 135-143. 
Flanegan.J.B. and Balumore.D. (1979) J. Virol., 29, 352-360. 
Franssen.H., Goldbach,R., Broekhuijsen,M., Moerman,M. and Van Kam-
men.A. (1982) J. Virol.. 41, 8-17. 
Franssen.H., Moerman.M., Rezelman.G. and Goldbach,R. (1984a) /. Virol., 
in press. 
Franssen.H., Goldbach,R. and Van Kammen.A. (1984b) Virus Research, 
Vol. 1. in press. 
Gibbs.A.J. and Mclntyre.G.A. (1970) Eur. J. Biochem., 16, 1-11. 
Goldbach.R., Rezelman.G. and Van Kammen.A. (1980) Nature, 286, 297-
300. 
Goldbach.R., Rezelman.G., Zabel.P. and Van Kammen.A. (1982) J. Virol., 
42. 630-635. 
Goldbach.R. and Rezelman.G. (1983) J. Virol., 46, 614419. 
Holland.J., Spindler.K., Horodyski.F., Grabau.E., Nichol.S. and VandePol, 
S. (1982) Science (Wash.), 215, 1577-1585. 
King.A.M.Q.. McCahon.D.. Slade.W.R. and Newman,J.W.I. (1982a) J. 
Virol., 41, 66-77. 
King,A.M.Q„ McCahon.D., Slade.W.R. and NewmanJ.W.I. (1982b) Cell, 
29, 921-928. 
Kitamura.N., Semler.B., Rothberg,P.G., Larsen.G.R., Adler,C.J-, Dorner, 
A.J., Emini,E.A., Hanecak.R-, Lee.J.J., Van der Werf.S., Anderson, 
C.W. and Wimmer.E. (1981) Nature, 291, 547-553. 
Koch.G., Koch.F., Bilello.J.A., Hiller.E., Schârli.C. Warnecke.G. and 
Weber.C. (1981) in Perez-Bercoff.R. (ed.), Protein Biosynthesis in Eukary-
otes. Plenum Press, NY, pp. 275-310. 
Larsen.G.R., Anderson.C.W., Dorner.A.J., Semler.B.L. and Wimmer.E. 
(1982) J. Virol., 41. 340-344. 
Lomonossoff.G. and Shanks.M. (1983) EMBO J., 2, 2253-2258. 
Maizel.J.V., Jr. and Lenk.R.P. (1981) Proc. Natl. Acad. Sei. USA, 78, 7665-
7669. 
Matthews,R.E.F. (1981) Plant Virology, second edition, published by Aca-
demic Press, NY. 
McLachlan,A.D. (1971) J. Mol. Biol., 61, 409-424. 
Nomoto.A., Omata,T., Toyoda.H., Kuge.S., Horie.H., Kataoka.Y., Genba, 
Y., Nakano.Y. and Imura.N. (1982) Proc. Natl. Acad. Sei. USA, 79, 
5793-5797. 
Pelham.H.R.B. (1979) Virology, 96, 463-477. 
Putnak.J.R. and Phillips.B.A. (1981) Microbiol. Rev., 45, 287-315. 
Racaniello.V.R. and Baltimore,D. (1981) Proc. Natl. Acad. Sei. USA, 78, 
4887-4891. 
Rezelman.G., Goldbach.R. and Van Kammen.A. (1980) J. Virol., 36, 366-
373. 
Rezelman.G., Franssen.H.J., Goldbach.R.W., Ie.T.S. and Van Kammen,A. 
(1982) J. Gen. Virol., 60, 335-342. 
1 0 0 
HomologoiiB protdns from CPMV and pkornavlniKf 
Robertson,B.H., Morgan,D.O., Moore,D.M., Grubman.M.J., Card,J., Fis-
cher.T., Weddell.G., Dowbenko,D. and Yansura,D. (1983) Virology, 12«, 
614-623. 
Romanova.L.I., Tolskaya,E.A., Kolesnikova,M.S. and Agol.V.I. (1980) 
FEBSLett., US, 109-112. 
Ruecken.R.R., Matthews,T.J., Kew.O.M., Pallansch,M.. McLean,C. and 
Omilianowski.D. (1979) in Perez-Bercoff.R. (ed.), The Molecular Biology 
of Picomaviruses, Plenum Press, NY, pp. 113-126. 
Schwara,R.M. and Dayhoff.M.O. (1978) in Dayhoff.M.O. (ed.), Allas of 
Protein Sequence and Structure, Vol. 5, Suppl.3, National Biomedical 
Research Foundation, Washington, pp. 3S3-3S8. 
Semler.B.L., Anderson,C.W., Kitamura,N., Rothberg,P.G., Wishart,W.L. 
and Wiramer,E. (1981a) Proc. Natl. Acad. Sei. USA, 78, 3464-3468. 
Semler.B.L., Hanecak.R., Anderson,C.W. and Wimmer,E. (1981b) Vir-
ology, 114, 589-594. 
Semler.B.L., Hanecak.R., Domer.L.F., Anderson.C.W. and Wimmer.E. 
(1983) Virology, 12», 624-635. 
Staden,R. (1982) Nucleic Acids Res., 10, 2951-2961. 
Tolskaya,E.A., Romanova.L.I-, Kolesnikova,M.S. and Agol.V.I. (1983) 
Virology, 124, 121-132. 
Toh.H., Hayashida.H. and Miyata,T. (1983) Nature, 305, 827-829. 
Van der Meer.J., Dorssers.L. and ZabeLP. (1983) EMBO J., 2, 233-237. 
Van Wezenbeek,P., Verver.J., Harmsen,J., Vos,P. and Van Kammen,A. 
(1983) EMBO J., 2, 941-946. 
Wimmer,E. (1982) Cell, 28, 199-201. 
Zabel.P., Moerman,M., Lomonossofr.G., Shanks.M. and Beyreuther.K. 
(1984) EMBO J., 3, in press. 
Received on 9 January 1984 
101 
CHAPTER IX 
CONCLUDING REMARKS 
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At the beginning of the research reported in this thesis it was 
known that both B-RNA and M-RNA of CPMV are translated into large poly-
proteins. These primary translation products were clearly subjected to 
proteolytic cleavage yielding proteins with sizes in the range of 170K 
to 4K, which could be identified in CPMV-infected cowpea protoplasts. 
We made it our object to identify the proteolytic activities involved 
in the processing of the primary translation products and to define 
their specificity. For this purpose we used cell-free translation 
systems in combination with a mesophyll protoplast system. It had been 
proven that the 170K and 32K proteins produced from B-RNA in vitro 
are identical to equal-sized virus-specific products found in vivo 
(Rezelman et al., 1980), indicating that the in vitro translation of 
B-RNA reflects the in vivo process. For the expression of M-RNA how-
ever, such indication was not available. 
Since in B-component-infected protoplasts a large number of B-RNA-
specific proteins are found, which all arise by processing of a 200K 
primary translation product, the presence of a specific proteolytic 
activity in B component-inoculated protoplasts was supposed. Indeed, 
if cellular extracts from B component-infected protoplasts were added 
to the 105K and 95K in vitro translation products from M RNA, these 
were specifically cleaved into 60K, 58K and 48K polypeptides, a process 
which could not be achieved by addition of cellular extracts from non-
infected protoplasts (Chapter III). This finding demonstrated that 
B-RNA indeed specifies a protease which is capable to process at least 
the M-RNA encoded proteins. We have demonstrated that the 60K cleavage 
product represents the precursor to the two coat proteins VP37 and VP23, 
respectively (Chapter III). This observation suggested that, as with 
B-RNA, the in vitro translation of M-RNA also reflects the course of its 
in vivo expression, even if none of the products, except for the coat 
proteins, have been detected in vivo yet. We were able to map the 48K, 
58K and 60K polypeptides on M-RNA and thus provided evidence that the 
primary translation products share identical carboxy-terminal ends but 
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differ in their amino-terminal sequences. The location of the genes of 
these proteins on M-RNA was confirmed when the nucleotide sequence of 
M-RNA, elucidated by Van Wezenbeek et al. (1983), became available at 
a later stage in our research. As the in vitro processing of the M-RNA 
encoded polyproteins was also achieved with in vitro translation pro-
ducts of B-RNA, which mainly consisted of 32K and 170K proteins, we have 
concentrated our efforts on distinguishing which of these polypeptides 
harbors the proteolytic activity. Since we had the disposal of antisera 
directed against purified 32K and 170K polypeptides we investigated 
which of these sera was able to inhibit the proteolytic processing. 
This approach led to the identification of the 32K polypeptide as the 
protease involved in the primary cleavage of the 105K and 95K poly-
proteins produced by M-RNA (Chapter V). 
Amino- and carboxy-terminal amino acid sequences of the coat proteins 
were determined in order to map the position of the 60K precursor in 
the nucleotide sequence of M RNA more precisely and to elucidate the 
dipeptide sequence utilised by the 32K protease. Comparison of the 
experimentally obtained amino acid data with the amino acid sequence 
derived from the M-RNA nucleotide sequence allowed us to conclude that 
this protease recognises a glutamine-methionine dipeptide sequence 
while a glutamine-glycine dipeptide sequence is utilised to cleave the 
60K polypeptide further into coat proteins VP37 and VP23 (Chapter VI). 
We have hot been able to identify the protease repsonsible for the 
latter cleavage. In CPMV-infected leaves, however, an activity was 
detected which cleaves VP23 specifically from the primary translation 
products, but not from the 60K coat protein precursor. Since this acti-
vity was rather weak, it was not further analysed (Chapter III). Thus it 
remains a goal for the future to determine whether this activity is 
virus- or host-encoded. 
Having established the CPMV encoded protease involved in the proces-
sing of the primary translation products of M-RNA, it was obvious to 
examine whether the 32K protease played any role in the processing of the 
B-RNA encoded polyprotein. This study became possible when we observed 
that upon longer incubation, the 170K polypeptide was further processed 
in vitro into 170K, 87K, 84K and 60K polypeptides identical to the 
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in vivo detected B-RNA specific proteins. In addition, among the in 
vitro cleavage products we detected a 28K polypeptide not found in 
vivo so far. Since antiserum against the 32K protease did not interfere 
with the processing of the 170K polypeptide, the existence of another 
B-RNA-encoded proteolytic activity had to be assumed. In an attempt to 
elucidate the proteolytic activity involved in the processing of the 
B-RNA encoded polyprotein the cleavage of the 200K protein into 32K 
and 170K polypeptides was studied by time course experiments. Using 
this approach it was shown that the 32K polypeptide is only released 
from growing polypeptide chains when they exceed a size of 120K. This 
suggests that a B-RNA-encoded proteolytic activity comes available 
when the growing polypeptide chain has reached a size enclosing the 
28K polypeptide, which led us to propose that these sequences contain 
a second proteolytic activity (Chapter VII). 
In the meantime Zabel et al. (1984) elucidated the amino acid sequen-
ce of VPg which allowed the mapping of this polypeptide on the B-RNA 
nucleotide sequence, recently determined by Lomonossoff and Shanks (1983). 
As a result it is suggested that VPg is released from its precursor by 
cleavages at glutamine-serine dipeptide sequences. This same dipeptide 
sequence is probably also utilised to cleave the primary translation 
product into 32K and 170K polypeptides, since inspection of the amino 
acid sequence of the 200K primary translation product as derived from 
the B-RNA nucleotide sequence reveals the presence of a glutamine-
serine dipeptide sequence but not of a glutamine-methionine dipeptide 
sequence in the region where the cleavage is expected to occur. This 
observation provided further evidence for the involvement of a proteo-
lytic activity with a cleavage specificity different to that of the 32K 
protease in the processing of the B-RNA encoded polyprotein. The 28K 
polypeptide was proposed to be the best candidate for bearing this 
activity. Supporting evidence for this assumption was obtained as the 
amino acid sequence homology studies on the CPMV B-RNA encoded 200K 
polyprotein and the polyprotein encoded by poliovirus scored for the 
presence of amino acid sequence homology between this 28K polypeptide 
and the polioviral protease P3-7c (Chapter VIII). 
As the organisation of the genes on poliovirus RNA, i.e. VPg-protease 
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(P3-7c)-polymerase, and B-RNA, i.e. VPg-28K-core polymerase (Chapter 
VIII), thus apparently are comparable, this provides evidence that the 
28K polypeptide encloses proteolytic activity. 
The preliminary experimental data indicate that the cleavage specifi-
city of the 28K protease is a glutamine-serine dipeptide sequence. It 
has not yet been determined whether all cleavages occur on these sites. 
For instance, the sequence of the 200K polyprotein encloses behind the 
VPg-28K cleavage site a glutamine-serine dipeptide sequence that upon 
utilisation would lead to the release of a protein with a calculated 
molecular weight of 16K, instead of the apparent molecular weight of 
28K as determined by SDS-polyacrylamide gel electrophoresis. On the 
other hand by thorough inspection of the described amino acid sequence 
homology between poliovirus and CPMV encoded proteins we found support 
to the idea that also a glutamine-glycine dipeptide sequence might be 
used in the cleavage of the 170K polypeptide. Assuming that this site 
is used, which is supported by an optimal amino acid sequence homology 
between the 28K protease and the polioviral protease P3-7c, now achieved, 
a 24K protein would be generated, which is a better approach to the 
apparent molecular weight of 28K. In view of this we propose that one 
of the cleavage sites on the 200K B-RNA encoded polypeptide is a gluta-
mine-glycine dipeptide sequence. Considering that this site is recog-
nised in the processing of the 200K B-RNA-encoded polyprotein, it is 
remarkable that a similar site is utilised to generate mature caps id 
proteins from their common precursor encoded by M-RNA. It is not clear 
whether a third protease is involved or that the conformation of the 
polypeptide is such that at these positions either the 28K or the 32K 
protease has an altered cleavage specificity. The information available 
indicate that B-RNA encodes two different proteolytic activities: one 
involved in the processing of the B-RNA encoded polyprotein itself, 
and a second involved in the processing of the M-RNA encoded poly-
proteins. The 32K polypeptide which is charged with the latter process 
is cleaved off from the 200K polyprotein early in the synthesis of the 
polyprotein. After this cleavage the 32K polypeptide seems to remain 
complexed to other B-RNA encoded proteins. Whether this reflects a 
functional significance or represents an artefact of the isolation pro-
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cedure is not clear. 
For the encapsidation of each RNA 60 copies of the coat proteins 
containing precursor have to be produced. Since we detected neither this 
60K precursor nor the 105K and 95K primary translation products from 
M-RNA in vivo, the proteolytic cleavages leading to the mature capsid 
proteins are very rapidly catalysed which prevents the accumulation of 
the precursors in vivo. In contrast, intermediate products in the pro-
cessing of the B-RNA encoded 200K polyprotein are abundantly found in 
the infected cell. The processing of this polyprotein does not appear-
to be a straightforward catalytic process, but possibly occurs in close 
relation with the viral RNA replication cycle. 
Processing might be restricted to the formation of replication com-
plexes, in a way that each cleavage leads to the next step in the repli-
cation process irreversibly. In this respect it remains to be tested 
if the 28K polypeptide, completely released from the precursor protein, 
is still an active protease. The combination of data on the complete 
nucleotide sequence, the mapping of proteins on this sequence and the 
identification of various functions encoded on the RNA has enabled us 
to compare the organisation of genes and functions involved in viral 
RNA replication between CPMV and Picornavirus RNAs. A fascinating 
result is the homology found between the picornaviral and comoviral 
polymerases, suggesting a common ancest in the evolution. It will be 
of interest if these sequence homology studies can be extended to the 
proteins encoded by other plant viruses. In this respect nepoviruses 
are very promising candidates as they resemble comoviruses in various 
aspects. 
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CHAPTER X 
SAMENVATTING 
m 
Aan het begin van het onderzoek, waarover in dit proefschrift gerap-
porteerd wordt, was bekend dat de twee RNA moleculen die samen het ge-
noom van CPMV vormen vertaald worden in grote primaire transiatieproduk-
ten, z.g. polyproteinen, waaruit de functionele eiwitten door proteoly-
tische klievingen vrijkomen. Er was vastgesteld dat het grootste RNA, 
B-RNA (molecuulgewicht 2,02 x 10 ), codeert voor een polyprotein met 
een molecuulgewicht van ongeveer 200.000 (200K) en het andere RNA, 
M-RNA (molecuulgewicht 1,22 x 10 ), voor twee polyproteinen met mole-
cuulgewichten van 105.000 (105K) en 95.000 (95K). 
De doelstelling van mijn onderzoek was de proteolytische activitei-
ten die betrokken zijn bij de splitsingen van de door CPMV gecodeerde 
eiwitten te karakteriseren en hun specificiteit vast te stellen. Daarbij 
hebben we gebruik gemaakt van cel-vrije eiwitsynthetiserende systemen 
en een cowpea mesophyll protoplasten systeem. Er was al aangetoond dat 
bij vertaling in vitro het door B-RNA gecodeerde 200K gesplitst kon wor-
den in 170K en 32K eiwitten. Ook in met CPMV geinfecteerde protoplasten 
worden deze 170K en 32K eiwitten aangetroffen. Dit wijst erop dat de 
vertaling van B-RNA in vitvo overeenKomt met de expressie van dit RNA 
in vivo. Echter, voor de expressie van M-RNA ontbraken zulke aanwijzin-
gen toen nog. 
Aangezien in met B-componenten geïnoculeerde protoplasten een groot 
aantal B-RNA specifieke eiwitten aangetroffen worden, die allen ontstaan 
door klievingen binnen het primaire translatie produkt (Rezelman et al., 
1980), mocht verondersteld worden dat er in geinfekteerde protoplasten 
een enzym met een specifieke proteolytische activiteit voorkomt. Inder-
daad bleek (hoofdstuk III) dat extracten van met B-component geïnfek-
teerde protoplasten in staat zijn om althans de 105K en 95K in vitvo 
Produkten van M-RNA specifiek te klieven, en wel in eiwitten met mole-
cuulgewichten van 60.000 (60K), 58.000 (58K) en 48.000 (48K). We konden 
aantonen dat het 60K eiwit de beide mantel eiwitten VP37 en VP23 bevat 
en daarom als een precursor van de manteleiwitten beschouwd kan worden. 
Hoewel in vivo alleen de beide mantel eiwitten aangetroffen worden en de 
60K, 58K en 48K eiwitten tot nu toe in vivo niet gedetecteerd zijn, 
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wijst het feit dat door specifieke splitsing van de in vitro translatie 
Produkten van M-RNA een 60K precursor van beide manteleiwitten kan wor-
den verkregen erop dat de expressie van M-RNA in vivo eveneens langs 
deze weg verloopt. We hebben de volgorde van de coderende regios voor 
de 48K, 58K en 60K eiwitten binnen het M-RNA kunnen vaststellen. Op 
grond hiervan kon vastgesteld worden dat de primaire translatieprodukten 
gemeenschappelijk carboxy uiteinden hebben en verschillende amino uit-
einden. Aangezien het in vitro translatieprodukt van B-RNA, dat voor-
namelijk uit 32K en 170K eiwitten bestaat, eveneens in staat was om de 
in vitro translatieprodukten van M-RNA te klieven, leek het aannemelijk 
dat een van deze eiwitten de bewuste proteolytische activiteit zou be-
zitten. Omdat onze groep beschikte over antisera gericht tegen de ge-
zuiverde virus-specifieke 32K en 170K eiwitten hebben we onderzocht of 
één van deze antisera de proteolytische splitsing van de door M-RNA 
gecodeerde polyproteinen kon verhinderen (hoofdstuk V). Op deze manier 
hebben we kunnen aantonen dat het 32K eiwit het protease is dat verant-
woordelijk is voor de primaire splitsing van de 105K en 95K eiwitten. 
Door bepaling van de amino- en carboxy eindstandige aminozuurvolgorde 
van beide manteleiwitten was het mogelijk om de positie van de genen 
van deze eiwitten binnen de inmiddels bekend geworden nucleotidenvolgorde 
van M-RNA (Van Wezenbeek et al. , 1983) precies te bepalen. Vergelijking 
van de experimentele gegevens met de aminozuurvolgorde van het primaire 
translatieprodukt, zoals die uit de nucleotidenvolgorde van M-RNA af-
gelezen kan worden, maakte het mogelijk de peptide binding te identifi-
ceren die specifiek door het 32K protease gesplitst wordt (hoofdstuk VI). 
Dit bleek een glutamine-methionine binding te zijn. Anderzijds wordt een 
glutamine-glycine binding gesplitst bij de verdere klieving van het 
60K precursor eiwit in de beide mantel eiwitten. We zijn er niet in ge-
slaagd de identiteit van het protease dat deze laatste klieving bewerk-
stelligt vast te stellen. Hoewel in CPMV geinfekteerde bladeren een 
proteolytische activiteit aangetoond werd, die het manteleiwit VP23 
specifiek van de 105K en 95K eiwitten afsplitst, was deze activiteit te 
zwak om verder onderzoek mogelijk te maken (Hoofdstuk III). Het is 
daarom nog steeds niet bekend of deze activiteit door het virus dan wel 
door de waardplant gecodeerd wordt. 
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Nadat we op de hierboven beschreven wijzen het protease geïdentifi-
ceerd hadden dat voor de eerste specifieke splitsing van de primaire 
transiatieprodukten van M-RNA zorgt, lag het voor de hand om na te 
gaan of het 32K protease ook een rol speelt bij de splitsing van het 
primaire translatieprodukt van B RNA. Dit kon bestudeerd worden nadat 
eenmaal geconstateerd was dat door langdurige incubatie van de in vitro 
translatieprodukten van B-RNA het 170K eiwit verder gesplitst wordt 
in HOK, 87K, 84K en 60K eiwitten die ook in vivo door het virus gepro-
duceerd worden. Onder de in vitro gevormde splitsingsprodukten bleek 
ook een eiwit van molecuul gewicht van 28.000 (28K) voor te komen, dat 
tot nu toe niet in vivo waargenomen is (hoofdstuk VII). Antiserum ge-
richt tegen het 32K protease bleek de in vitro klieving van het 170K 
eiwit niet te remmen. Daaruit hebben we voorzichtig geconcludeerd dat 
het 32K protease niet bij dit proces betrokken is. Dit zou betekenen 
dat er zich onder de door B-RNA gecodeerde eiwitten een tweede protease 
moet bevinden. Om meer inzicht te krijgen in de manier waarop de B-RNA-
gecodeerde eiwitten uit hun 200K precursor vrijkomen is in eerste in-
stantie onderzocht hoe de klieving van het 200K eiwit in 32K en 170K 
in de tijd verloopt (hoofdstuk VII). We hebben aldus vastgesteld dat 
bij vertaling van B-RNA in vitro he'; 32K eiwit pas uit groeiende poly-
protein ketens vrij komt als deze ketens een lengte bereikt hebben die 
overeenkomt met een molecuulgewicht van 120.000. Dit wijst erop dat 
binnen het door B-RNA gecodeerde polyprotein een proteolytische activi-
teit werkzaam wordt zodra de groeiende keten de volledige sequentie van 
het 28K eiwit bevat. Op grond hiervan hebben wij gepostuleerd dat het 
28K eiwit de tweede door B-RNA gecodeerde protease is (hoofdstuk VII). 
Intussen hadden Zabel et al. (1984) de volgorde van een aantal amino-
zuren in VPg (molecuulgewicht 4.000) bepaald waardoor zij in staat 
waren om de VPg-coderende regio op de nucleotidenvolgorde van B-RNA te 
lokaliseren, die inmiddels door Lomonossoff en Shanks (1983) opgehel-
derd was. Uit deze kartering bleek dat VPg uit zijn precursor vrijkomt 
door splitsing van glutamine-serine peptide bindingen aan zowel het 
N-terminale als het C-terminale uiteinde. Deze waarnemingen ondersteunden 
de gedachte dat niet het 32K protease, dat glutamine-methionine bindin-
gen herkent, maar een ander protease betrokken is bij de splitsingen 
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in het B-RNA gecodeerde 200K eiwit. Als meest kansrijke kandidaat voor 
deze funktie werd door ons het 28K eiwit aangewezen (hoofdstuk VII). 
Verdere steun voor deze veronderstelling werd verkregen uit onder-
zoek naar het voorkomen van overeenkomsten in aminozuurvolgorde tussen 
het door B-RNA gecodeerde 200K eiwit en het polyprotein gecodeerd door 
poliovirus. Er bleek namelijk een aanzienlijke homologie in de amino-
zuur volgorde te bestaan tussen het 28K eiwit en het poliovirus speci-
fieke protease P3-7c. Aangezien verder de organisatie van genen op het 
poliovirus RNA (nl. VPg-protease (P3-7c) polymerase) en op B-RNA (nl. 
VPg-28K-core polymerase) vergelijkbaar blijkt te zijn (hoofdstuk VIII) 
lijkt het zeer aannemelijk dat het 28K eiwit inderdaad proteolytische 
activiteit bezit. De gegevens die tot nu toe verkregen zijn, hoewel 
nog onvoldoende voor een onomstotelijk bewijs, geven aan dat het 28K 
protease binnen het 200K polyprotein specifiek glutamine-serine peptide 
bindingen kan splitsen. Het is nog niet duidelijk of alle splitsingen 
bij deze peptide bindingen optreden. Zo blijkt er in de aminozuurvolg-
orde van het 200K eiwit, zoals die afgeleid kan worden uit de nucleo-
tidenvolgorde van B-RNA, een glutamine-serine dipeptide voor te komen 
achter de VPg-28K klievingsplaats, die mogelijk gebruikt kan worden om 
170K te splitsen in 84K en 87K eiwitten. Echter als splitsing van deze 
binding gebruikt zou worden in de processing van het 170K eiwit dan zou 
een eiwit met een molecuuulgewicht van 16.000 (16K) ontstaan, terwijl 
op grond van SDS-polyacrylamide gel electrophorese het molecuul gewicht 
voor dit eiwit op 28.000 geschat is. Daar staat tegenover dat uit nauw-
keurige bestudering van de beschreven (hoofdstuk VIII) overeenkomst in 
aminozuurvolgorde tussen het door poliovirus- en door CPMV gecodeerde 
polyproteinen blijkt dat mogelijk een glutamine-glycine peptide binding 
gebruikt wordt om het 170K in de 84K en 87K eiwitten te splitsen. Dit 
zou een eiwit van 24K opleveren, wat een betere benadering van de expe-
rimenteel vastgestelde grootte (28K) is, met optimale homologie ten op-
zichte van het door poliovirus gecodeerde protease P3-7c. Het is daarom 
aantrekkelijk om te veronderstellen dat er in het door B-RNA gecodeerde 
polyprotein naast glutamine-serine klievingsplaatsen tenminste één 
glutamine-glycine klievingsplaats voorkomt. Het is duidelijk dat dit 
nog verder uitgezocht dient te worden. 
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Doorgaande op deze gedachte is het echter wel opvallend dat zowel 
in het door B-RNA gecodeerde polyprotein als in de door M-RNA gecodeerde 
polyproteinen een glutamine-glycine volgorde zou voorkomen, waar 
splitsing optreedt. Het is niet duidelijk of een derde protease betrok-
ken is bij splitsing van deze bindingen of dat een van de beide virus-
specifieke Proteasen, 32K of 28K, onder bepaalde omstandigheden een 
andere splitsings specificiteit heeft. Om dit na te gaan zal de speci-
ficiteit van de virale Proteasen verder onderzocht moeten worden. 
Resumerend kan geconcludeerd worden dat B-RNA codeert voor twee ver-
schillende proteolytische enzymen. Eén is verantwoordelijk voor de pro-
teolytische splitsing van het door B-RNA gecodeerde polyprotein en het 
andere voor de klieving binnen de M-RNA gecodeerde polyproteinen. Het 
32K eiwit dat bij dit laatst genoemde proces betrokken is wordt reeds 
in een vroeg stadium van de synthese van het 200K eiwit van dit polypro-
tein afgesplitst. Het blijkt dat dit 32K eiwit gecomplexeerd blijft aan 
andere door B-RNA gecodeerde eiwitten (hoofdstuk V). Of het voorkomen 
van het 32K eiwit in complexen enige functionele betekenis heeft of dat 
dit het gevolg is van de isolatieprocedure is vooralsnog niet duidelijk. 
Om ieder geproduceerd RNA molecuul van een eiwitmantel te voorzien 
zijn 60 kopieën van de precursor voor beide mantel eiwitten nodig. Aan-
gezien we tot nu toe noch dit 60K precursor-eiwit noch de primaire 
translatieprodukten van M-RNA in vivo aan hebben kunnen tonen moeten 
we aannemen dat het 32K protease in een snelle reactie de vorming van 
60K precursors katalyseert, waarna deze vervolgens eveneens zeer snel 
gesplitst worden in rijpe mantel eiwitten. Daarentegen worden de tussen-
produkten in het splitsingsschema van het door B-RNA gecodeerde 200K 
polyprotein in aanzienlijke hoeveelheden aangetroffen in met CPMV ge-
infecteerde cellen. Wellicht ontstaan de diverse eindprodukten uit het 
200K polyprotein niet in een rechttoe-rechtaan proces, maar zijn de 
verschillende klievingen van de door B-RNA gecodeerde eiwitten nauw ge-
relateerd aan processen in de virale RNA replicatie cyclus. Mogelijk 
wordt de te volgen route in het splitsingsschema van het 200K polypro-
tein bepaald door het te vormen replicatie complex, en wel op een zo-
danige wijze dat iedere klievingsstap onvermijdelijk tot de volgende 
stap in het replicatie proces leidt. In dit verband is het zeker van 
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belang om na te gaan of het 28K polypeptide als vrij voorkomend eiwit 
nog steeds als protease actief is. 
De combinatie van gegevens over de nucleotidenvolgorde, de localisa-
tie van eiwitten op deze volgorde en de opheldering van de functie van 
verschillende virale eiwitten, heeft ons in staat gesteld om een verge-
lijking te maken tussen CPMV en picornavirussen voor wat betreft hun 
genetische organisatie (hoofdstuk VIII). Een opmerkelijk resultaat dat 
hieruit naar voren is gekomen, is het feit dat er een grote overeenkomst 
in aminozuurvolgorde bestaat tussen de RNA-afhankelijke RMA Polymerasen 
van picornavirussen en CPMV, hetgeen suggereert dat deze virussen moge-
lijk uit dezelfde voorouders geëvolueerd zijn. 
Het zou zeer interessant zijn als deze studies naar overeenkomsten in 
aminozuurvolgorde uitgebreid konden worden naar de eiwitten van andere 
plantevirussen. Wat dat betreft lijken de nepovirussen interessante 
kandidaten te zijn omdat zij in vele opzichten op comovirussen lijken. 
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